<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-2560706674003621546</id><updated>2012-02-24T10:17:05.810-08:00</updated><category term='FDA RISKS REUSED DEVICES PRION TSE'/><category term='and a recipe for disaster'/><category term='PRION TSE MADCOW PLASTIC GOD'/><category term='Microarray; Transmissible spongiform encephalopathy; PrionBSE; Orally challenged'/><category term='Prion BSE Farmed Goat Confirmed'/><category term='Atypical Scrapie NOR-98 confirmed Alberta sheep January 2012'/><category term='Prion Disease Risks in the 21st Century 2011 PDA European Virus-TSE Safety  Update on CJD and VCJD Transmission RG Will'/><category term='vCJD Canada North America BSE Mad Cow'/><category term='sCJD'/><category term='Prions'/><category term='BSE MAD COW DISEASE CANADA BSE CJD'/><category term='2006-2007 FoodNet Population Survey'/><category term='Prion TSE Blood Components CJD vCJD'/><category term='A Review of Archived Canadian Scrapie Cases for Evidence of Bovine Spongiform Encephalopathy'/><category term='URINE BSE SCRAPIE CWD CJD'/><category term='low dose'/><category term='Turkey Prion SRM BSE CJD'/><category term='WYOMING CJD CWD CWRU GAMBETTI PRION NOR-98'/><category term='Parkinson’s'/><category term='White House budget proposes cuts to ag programs including TSE PRION disease aka mad cow type disease'/><category term='Action Plan National Program 103 Animal Health 2012-2017 PRIONS AND TSE TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY'/><category term='importation'/><category term='Mad Cow Scaremongers'/><category term='BEEF TONGUES'/><category term='Prion MBM BSE Scrapie CWD CJD'/><category term='ATYPICAL L-BSE THE HAGUE NETHERLANDS 2011'/><category term='Feds back Quebec R+D for SRM removal equipment Canada'/><category term='Cynomolgus Macaques'/><category term='EFSA Network'/><category term='TSE Road map'/><category term='antibodies'/><category term='Incidents Panel'/><category term='Aerosols prion transmission'/><category term='Specified Risk Material (SRM)'/><category term='CANADA BSE PRION IMPORT ANIMAL BY-PRODUCTS BSE MRR GBR PANAMA DENMARK CJD'/><category term='RED CROSS BSE TSE PRION BLOOD'/><category term='BSE IN GOATS CAN BE MISTAKEN FOR SCRAPIE'/><category term='CATTLE HEADS WITH TONSILS'/><category term='Scrapie oral secretion prion dental dentistry'/><category term='Bovine Spongiform Encephalopathy (BSE)'/><category term='Creutzfeldt–Jakob disease; Protein aggregation; Alzheimer&apos;s disease; Parkinson&apos;s disease; Huntington&apos;s disease; Prion'/><category term='VALLEY FARM MEATS SRM BSE TSE PRION CJD'/><category term='ALS'/><category term='SPINAL CORD'/><category term='BSE'/><category term='Canada BSE MAD COW DISEASE CJD KOREA USA NORTH AMERICA PRION CWD SCRAPIE ATYPICAL OIE USDA CFIA TRADE'/><category term='cattle'/><category term='TSE'/><category term='iatrogenic'/><category term='PrPSc Detection and Infectivity in Semen Scrapie-Infected Sheep CWD BSE CJD PRION'/><category term='TAFS Atypical • bovine spongiform encephalopathy • cattle • disease control • prion • ruminants • scrapie • transmissible spongiform encephalopathies'/><category term='NOR-98'/><category term='PRION TSE CJD BLOOD PRODUCTS W.H.O.'/><category term='BSE PRION EPA PEST FRAUD CJD USA'/><category term='vCJD'/><category term='COLORADO CWD CJD TSE PRION REPORTING 2011'/><category term='cBSE lBSE hBSE atypical sCJD prion'/><category term='Novel Prion Protein in BSE-affected Cattle'/><category term='Atypical • bovine spongiform encephalopathy • cattle • disease control • prion • ruminants • scrapie • transmissible spongiform encephalopathies'/><category term='BSE CWD SCRAPIE CJD MAD COW NORTH AMERICA FUNDING'/><category term='quantitative risk assessment'/><category term='Bovine Spongiform Encephalopathy'/><category term='BSE MAD COW CJD USA JAPAN OIE MRR GBR'/><category term='atypical sCJD'/><category term='prion protein gene'/><category term='gelatin'/><category term='Council'/><category term='strains'/><category term='Cat 3 Animal By-Products'/><category term='blood-based assay'/><category term='Alzheimer&apos;s'/><category term='prion diseases; neuropathology; neurodegenerative disorders; phenotype; strain typing'/><category term='30 June 2011'/><category term='CEPs'/><category term='Vaccine Production'/><category term='BSE SCRAPIE CH1641 NOR-98 IBNC h-BSE atypical CJD'/><category term='CJD GSS FFI TSE PRION BSE MAD COW DISEASE'/><category term='TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY PRION ALZHEIMER&apos;S TAU'/><category term='sporadic CJD  14-3-3 MRI CSF sensitivity misdiagnosis Quinacrine'/><category term='Annual reports of Member States on BSE and Scrapie 2010'/><category term='cerebrospinal fluid'/><category term='CSF'/><category term='insertion/deletion polymorphism'/><category term='2011 PDA European Virus-TSE Safety Dr. Detwiler'/><category term='amyloid beta'/><category term='meeting'/><category term='Processed Animal Proteins (PAP)'/><category term='Switzerland'/><category term='Transmissible Spongiform Encephalopathies (TSEs)'/><category term='Prion TSE BSE Scrapie CWD CJD atypical cross-species transmission'/><category term='Prion disease pathogenesis'/><category term='Wisconsin Creutzfeldt Jakob Disease'/><category term='Parliament'/><category term='ICSM-35'/><category term='amyloid; prion; protein misfolding; disease transmission'/><category term='atypical BSE CJD Prion Vaccine'/><category term='CWD'/><category term='and Venison Consumption Related to Prion Disease Exposure'/><category term='Alzheimer’s'/><category term='February 2012 Update on Feed Enforcement Activities to Limit the Spread of BSE'/><category term='2011) including Texas'/><category term='and Transmissible Spongiform Encephalopathies'/><category term='prion Amyotrophic Lateral Sclerosis (ALS) Alzheimer&apos;s  Parkinson’s SOD1'/><category term='BSE CJD PRION USA CANADA MEXICO'/><category term='TSE PRION AKA MAD COW CJD HEPARIN'/><category term='TSE PRION LICHENS DEGRADATION PrPTSE'/><category term='Non-Human Primate'/><category term='NO SAFE DOSE PRIONS CJD BSE SCRAPIE CWD'/><category term='TSE PRION vertical transmission Fetuses'/><category term='Hunting'/><category term='France'/><category term='Classical scrapie'/><category term='OIE TSE PRION CWD BSE SCRAPIE TME CJD'/><category term='Travel History'/><category term='Atypical • bovine spongiform encephalopathy • cattle • CWD  disease control • prion • ruminants • scrapie • transmissible spongiform encephalopathies'/><category term='Transmissible Spongiform Encephalopathy'/><category term='prion diseases'/><category term='atypical BSE CWD Scrapie prion'/><category term='CJD BSE SCRAPIE CWD TSE PRION USA'/><category term='Risk of Prion Disease Transmission through Bovine-Derived Bone Substitutes: A Systematic Review'/><category term='FEED BAN'/><category term='EFSA OIE BSE SCRAPIE CWD CJD 2012'/><category term='SCRAPIE'/><category term='prion TSE CJD'/><category term='BSE ITALY ATYPICAL CJD PRION'/><category term='typical'/><category term='California BSE mad cow beef recall'/><category term='vCJD sCJD TSE blood donor screen UK USA'/><category term='BSE ATYPICAL PRION RUMINANT FEED BAN 2011'/><category term='BSE SCRAPIE CWD FEED FEED FEED'/><category term='TSE BSE CWD Scrapie Atypical Humans CJD Link'/><category term='BSE CJD SCRAPIE CWD PRION TSE USA'/><category term='CH1641 Scrapie'/><category term='Prion Aerosols Transmit BSE CWD Scrapie CJD'/><category term='CJD BSE BLOOD PRION'/><category term='Creutzfeldt-Jakob disease (CJD) biannual update (2011/2)'/><category term='Prion Alzheimer&apos;s SOD1 Self-propagation TSE'/><category term='RT-QUIC'/><category term='and dead stock downer livestock'/><category term='Atypical/Nor98 scrapie - H-BSE - L-BSE - Prion strain - Prion type - USA - Canada - sCJD'/><category term='Candidate Cell Substrates'/><category term='BSE PRION STRAIN ATYPICAL L-BSE HAMSTERS CJD'/><category term='CH1641'/><category term='beef'/><category term='Atypical - Atypical/Nor98 scrapie - BSE-H - BSE-L - Human - Prion disease - Prion strain - Prion type - USA - Canada - CJD'/><category term='tgmice'/><category term='Variably protease-sensitive prionopathy – Prions – Prion protein – Prion diseases – Creutzfeldt–Jakob disease – Alzheimer’s disease'/><category term='Zoonosis'/><category term='Prion TSE Corneal Donors E200K mutation'/><category term='National Anonymous Tonsil Archive'/><category term='PRION REPORTING 2011'/><category term='CJD'/><category term='EU'/><category term='Prion urinary gonadotropin formulations CJD ESHRE'/><category term='EFSA PRION TSE BSE PRION CJD MAD COW DISEASE'/><category term='Bovine Spongiform Encephalopathy BSE 31 USA SENATORS ASK PRESIDENT OBAMA TO HELP SPREAD MAD COW DISEASE 2012'/><category term='PRION'/><category term='OIE'/><category term='mad cow'/><category term='PRION TSE FUNDING OIE APHCA ASEAN USA CJD'/><category term='PRIONOPATHY'/><category term='Transmissible spongiform encephalopathies (TSEs) Sensitive detection prion proteins blood 15B3 antibody (mAb 15B3) CJD BSE SCRAPIE CWD'/><category term='Risk Prion Zoonoses bse scrapie cwd cjd tse'/><category term='Neurological disease'/><category term='HOUSE OF COMMONS'/><category term='ATYPICAL'/><category term='National Prion Disease Pathology Surveillance Center Cases Examined1 (August 19'/><category term='Creutzfeldt-Jakob Disease'/><category term='nvCJD sCJD prion dental decay hygiene'/><category term='House of Lords'/><category term='OIE BSE Scrapie CWD CJD atypical TSE prion'/><category term='2011'/><category term='road to no where'/><category term='CWD SCRAPIE CJD'/><category term='PRION 2011 NEWWORLD MONTREAL CANADA MAY 16 - 19 CJD BSE CWD SCRAPIE MAD COW DISEASE'/><category term='European Medicines Agency PDA TSE Safety Forum'/><category term='Atypical L-Type Bovine Spongiform Encephalopathy (L-BSE) Transmission'/><category term='CWD TSE PRION ZOONOSIS ENVIRONMENT'/><category term='MM2-thalamic Creutzfeldt-Jakob disease distinctive prion strain'/><category term='ICSM-18'/><category term='Novel Therapies'/><category term='CJD and PLASMA / URINE PRODUCTS EMA Position Statements Alberto Ganan Jimenez'/><category term='USA'/><category term='TME'/><category term='Scrapie Hamster BSE'/><category term='Small Ruminants'/><category term='National Meat Association v. Harris Docket No.'/><category term='North China'/><category term='TSE Prion Uptake Gut Replication'/><category term='Atypical scrapie'/><category term='PRION BSE SCRAPIE CWD CJD TSE'/><category term='USA HUMANS CJD'/><category term='spray dried blood'/><category term='feed'/><category term='QFC'/><category term='Compliance Guidelines for Use of Video or Other Electronic Monitoring or Recording Equipment in Federally Inspected Establishments'/><category term='10-224'/><category term='bovine prion BSE atypical BSE strain evolution degeneration transgenic'/><category term='bovine spongiform encephalopathy; prion protein; squirrel monkey; tau protein ; CJD'/><category term='misdiagnosis'/><category term='USDA BSE SAMPLE COLLECTION CJD'/><category term='real-time quaking-induced conversion'/><category term='Chronic Wasting Disease'/><category term='Oral Transmission of L-type Bovine Spongiform Encephalopathy in Primate Model'/><category term='PRION ATYPICAL H-BSE CJD USA NOR-98 SCRAPIE'/><category term='TSE PRION BSE SCRAPIE CWD CJD'/><category term='vCJD nvCJD sCJD BSE blood prion'/><category term='SPECIFIED RISK MATERIALS (SRM&apos;s) AND PRIONS'/><category term='Prion Japan'/><category term='TSE prion cjd tse blood test'/><category term='Facilitated Cross-Species Transmission of Prions in Extraneural Tissue'/><category term='Prion TSE CJD BSE CWD Scrapie CDC travel warning'/><category term='BSE SCRAPIE CH1641 NOR-98 CJD USA'/><category term='road map 2'/><category term='BSE: where are we now? Veterinary Record 2011;169:352-353'/><category term='FFI'/><category term='aka mad cow disease'/><category term='atypical BSE'/><category term='cjd prion bse cwd scrapie surgical medical blood'/><title type='text'>Transmissible Spongiform Encephalopathy</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://transmissiblespongiformencephalopathy.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default?start-index=101&amp;max-results=100'/><author><name>Terry S. Singeltary Sr.</name><uri>http://www.blogger.com/profile/06986622967539963260</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='22' src='http://bp2.blogger.com/_gwMAfd8g9xo/SHuerfBUR1I/AAAAAAAAAAM/nNI1xcLm_Z4/S220/scan0002.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>133</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-2560706674003621546.post-184578755882155600</id><published>2012-02-24T10:17:00.000-08:00</published><updated>2012-02-24T10:17:05.824-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='USDA BSE SAMPLE COLLECTION CJD'/><title type='text'>SAMPLE COLLECTION FROM CATTLE UNDER THE BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) ONGOING SURVEILLANCE PROGRAM 2/14/12</title><content type='html'>UNITED STATES DEPARTMENT OF AGRICULTURE FOOD SAFETY AND INSPECTION SERVICE WASHINGTON, DC FSIS NOTICE&lt;br /&gt;&lt;br /&gt;13-12&lt;br /&gt;&lt;br /&gt;2/14/12&lt;br /&gt;&lt;br /&gt;DISTRIBUTION: Electronic NOTICE EXPIRES: 3/1/13 OPI: OPPD&lt;br /&gt;&lt;br /&gt;SAMPLE COLLECTION FROM CATTLE UNDER THE BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) ONGOING SURVEILLANCE PROGRAM&lt;br /&gt;&lt;br /&gt;I. PURPOSE&lt;br /&gt;&lt;br /&gt;This notice provides Food Safety and Inspection Service (FSIS) inspection program personnel (IPP) with instructions regarding the collection of brain samples for the Animal and Plant Health Inspection Service’s (APHIS) Bovine Spongiform Encephalopathy (BSE) ongoing surveillance program. The contents in this notice were last issued in FSIS Notice 05-10.&lt;br /&gt;&lt;br /&gt;II. DEFINITION OF COLLECTION PROCEDURES&lt;br /&gt;&lt;br /&gt;A. At federally-inspected slaughter establishments that have approved alternative off-site sample collection arrangements with APHIS:&lt;br /&gt;&lt;br /&gt;1. APHIS will provide for the collection of brain (obex) samples from an allocated number of cattle 30 months and older condemned for any reason on ante-mortem inspection and from cattle of any age displaying Central Nervous System (CNS) symptoms.&lt;br /&gt;&lt;br /&gt;2. At such establishments, FSIS IPP will provide the following to plant management, to the APHIS Area Veterinarian in Charge (AVIC), and to sample collecting contractors:&lt;br /&gt;&lt;br /&gt;a. Condemn tag (Z-tag) numbers (not the Z-tag itself); and&lt;br /&gt;&lt;br /&gt;b. Disposition information (i.e., the reason for condemnation under 9 CFR Part 309), including history, clinical signs and the condemnation code assigned.&lt;br /&gt;&lt;br /&gt;B. At federally-inspected establishments that do not have approved alternative off-site sample collection arrangements with APHIS, FSIS Public Health Veterinarians (PHVs) are to:&lt;br /&gt;&lt;br /&gt;2&lt;br /&gt;&lt;br /&gt;1. Notify the APHIS AVIC when an animal has been condemned for CNS reasons and provide the information outlined in II.A.2.&lt;br /&gt;&lt;br /&gt;2. If arrangements with the APHIS AVIC cannot be made, collect appropriate BSE samples from cattle of all ages that display CNS symptoms.&lt;br /&gt;&lt;br /&gt;NOTE: Certain Alternative Off-Site Agreements that were in place during Enhanced Surveillance may no longer be in effect. Therefore, IPP may need to advise the establishment that they need to establish new agreements with APHIS and potential collectors.&lt;br /&gt;&lt;br /&gt;III. FSIS PERSONNEL RESPONSIBILITIES&lt;br /&gt;&lt;br /&gt;A. Upon receipt of this notice, the FSIS PHV is to ask establishment management whether:&lt;br /&gt;&lt;br /&gt;1. It has an approved alternative off-site sample collection arrangement with APHIS for collecting allocated samples (as per paragraph II. A.); or&lt;br /&gt;&lt;br /&gt;2. It is not an establishment that has an alternative off-site sample collection arrangement with APHIS. If the establishment does not have such an arrangement, then FSIS is to follow the directions in paragraph II.B.&lt;br /&gt;&lt;br /&gt;B. If during the meeting establishment management states that it has submitted an application to APHIS to begin off-site sampling, until APHIS approves that arrangement, FSIS PHVs are to:&lt;br /&gt;&lt;br /&gt;1. Identify all CNS animals condemned on ante-mortem with a "U. S. Condemned” tag;&lt;br /&gt;&lt;br /&gt;2. If an animal is condemned for this reason, contact the APHIS AVIC and follow the directions in paragraph II.B.;&lt;br /&gt;&lt;br /&gt;3. Ensure that the animals are humanely euthanized, unless APHIS requests that the animal not be euthanized; and&lt;br /&gt;&lt;br /&gt;4. Not allow any CNS animal condemned on ante-mortem to move off the premises of the establishment until APHIS collects the sample or APHIS requests otherwise.&lt;br /&gt;&lt;br /&gt;C. In a memorandum of interview (MOI), the FSIS PHV is to document who was present at the meeting with establishment management, the date and time of the meeting, how the establishment plans to proceed based on the choices set out in A. above, and any documents shared with management.&lt;br /&gt;&lt;br /&gt;D. If the establishment states that it has submitted a request to APHIS to begin off-site sampling, the FSIS PHV is to update the MOI as to whether the establishment reached an agreement, and in general, what the agreement was.&lt;br /&gt;&lt;br /&gt;E. The FSIS PHV is to maintain a copy of the MOI in the official government file, provide a copy to the plant management, and e-mail a copy to the APHIS AVIC. Any&lt;br /&gt;&lt;br /&gt;3&lt;br /&gt;&lt;br /&gt;changes in the agreement with APHIS for off-site sample collection are to be reflected in an updated MOI, which is then distributed as above.&lt;br /&gt;&lt;br /&gt;IV. FSIS RESPONSIBILITIES RELATED TO APPROVED ALTERNATIVE OFF-SITE SAMPLE COLLECTION&lt;br /&gt;&lt;br /&gt;A. The FSIS PHV is to complete the condemnation form, FSIS Form 6000-13 (Certification of Ante-mortem or Post-mortem Disposition of Tagged Animals), and FSIS Form 6150-1 (Identification Tag – Ante-mortem). The FSIS PHV is to pay special attention when providing a full description of the reason for the condemnation on FSIS Form 6000-13 and fill out fully FSIS Form 6150-1.&lt;br /&gt;&lt;br /&gt;B. Incoming animal identification, except the Z-tag, is to be left on these animals to provide needed identifying information on collection forms at the approved alternative off-site collection location. IPP are, or someone under their supervision is to remove Z-tags before any carcasses leave the official establishment.&lt;br /&gt;&lt;br /&gt;NOTE: Information supplied to plant management to take to the approved alternative off-site collection locations needs to be complete and accurate. FSIS PHVs need to provide a full description of the reason for the condemnation on FSIS Form 6000-13. APHIS will use this information to triage which condemned animals are sampled.&lt;br /&gt;&lt;br /&gt;V. FSIS SAMPLE COLLECTION FOR CATTLE DISPLAYING CNS SYMPTOMS&lt;br /&gt;&lt;br /&gt;A. If the establishment does not have an arrangement with APHIS for off-site sampling of cattle with CNS symptoms, the FSIS PHV is to follow the directions in paragraph II.B. The FSIS PHV is to make all final disposition decisions regarding whether to condemn cattle in accordance with 9 CFR part 309.&lt;br /&gt;&lt;br /&gt;NOTE: FSIS PHVs can find information regarding BSE sampling (e.g., forms, sampling supply information) on the FSIS intranet under Public Folders, OPPD, PDD, BSE, at:&lt;br /&gt;&lt;br /&gt;&lt;a href="http://collaboration/sites/InfoExch/OPPD/default.aspx?RootFolder=%2fsites%2fInfoExch%2fOPPD%2fOPPD%2fPDD%2fBSE%20Training%20Info&amp;amp;FolderCTID=&amp;amp;View=%7b6F518F12%2d11E4%2d4A8C%2dB891%2dAACB8FDD96BD%7d"&gt;http://collaboration/sites/InfoExch/OPPD/default.aspx?RootFolder=%2fsites%2fInfoExch%2fOPPD%2fOPPD%2fPDD%2fBSE%20Training%20Info&amp;amp;FolderCTID=&amp;amp;View=%7b6F518F12%2d11E4%2d4A8C%2dB891%2dAACB8FDD96BD%7d&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Additional BSE sampling information is provided on the APHIS website at:&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.aphis.usda.gov/animal_health/lab_info_services/downloads/BSE_Procedures_Manual.pdf"&gt;http://www.aphis.usda.gov/animal_health/lab_info_services/downloads/BSE_Procedures_Manual.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;B. If the responsibility to collect the BSE sample falls to the FSIS PHV, the FSIS PHV, or the establishment under the supervision of the FSIS PHV, is to promptly remove the head in order to collect the brain sample. If the establishment does not arrange to remove the head, the FSIS PHV may need to collect the brain sample as a priority over other ante-mortem or post-mortem procedures.&lt;br /&gt;&lt;br /&gt;4&lt;br /&gt;&lt;br /&gt;C. The FSIS PHV, being mindful of other potential CNS disease conditions of public health significance that may be present, is to collect the brain sample either in the inedible area of the establishment or in an isolated area set aside for such collection to prevent human exposure or the creation of insanitary conditions. Establishment personnel and FSIS IPP are to take proper sanitary measures before returning to edible areas of the establishment after brain sample collection, in accordance with 9 CFR 416.5.&lt;br /&gt;&lt;br /&gt;D. In situations where the FSIS PHV has missed the last UPS pick-up for the day, or the FSIS PHV collected the sample on a day when UPS does not pick up, the PHV is to refrigerate the samples until the next available UPS pick-up day. Remember, the sample is not to pass through or to be stored in areas of the establishment where the establishment produces edible product. The FSIS PHV is to maintain the sample’s chain-of-custody.&lt;br /&gt;&lt;br /&gt;E. The FSIS PHV is to verify the collection, documentation, and control of all animal identification associated with cattle condemned during ante-mortem inspection that are to be sampled by FSIS. The FSIS PHV is to attach the “U. S. Condemned” tag to cattle condemned during ante-mortem inspection in accordance with 9 CFR 309.13. This documentation will facilitate traceback in the event that the sample result is positive for BSE. The FSIS PHV is to include in the documentation all pertinent information to facilitate trace back of the animal in question in accordance with 9 CFR 320.1.&lt;br /&gt;&lt;br /&gt;F. The FSIS PHV is to verify that the presence of condemned cattle or parts does not create insanitary conditions (9 CFR Part 416). The establishment is responsible for the disposal of the condemned cattle in accordance with 9 CFR part 314. The FSIS PHV also is to verify that the establishment maintains records regarding the disposal of the condemned cattle in accordance with 9 CFR 320.1.&lt;br /&gt;&lt;br /&gt;G. IPP may inform the establishment that it may choose to hold the carcass and parts until testing results are available. If the establishment chooses to dispose of any carcass or parts before it receives test results, IPP are to advise the establishment that it must dispose of the carcass in one of the following ways:&lt;br /&gt;&lt;br /&gt;1. Render it at a facility for non-animal feed use (e.g., biofuel or cement);&lt;br /&gt;&lt;br /&gt;2. Alkaline digestion;&lt;br /&gt;&lt;br /&gt;3. Incineration; or&lt;br /&gt;&lt;br /&gt;4. Lined landfills.&lt;br /&gt;&lt;br /&gt;H. Documentation for Cattle Showing Signs of CNS Symptoms&lt;br /&gt;&lt;br /&gt;1. For locations without high-speed internet connections, the FSIS PHV is to forward the completed BSE Veterinary Services Laboratory Submissions (BSE-VSLS) sample collection sheets to the corresponding APHIS,VS area office by FAX or by e-mail. The following site lists the VS office FAX numbers and e-mail where available:&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.aphis.usda.gov/import_export/downloads/vsavic.pdf"&gt;http://www.aphis.usda.gov/import_export/downloads/vsavic.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;5&lt;br /&gt;&lt;br /&gt;NOTE: The FSIS PHV can get copies of BSE-VSLS forms by contacting the local APHIS office. The APHIS AVIC in each area office may assist with sample delivery verification and troubleshooting.&lt;br /&gt;&lt;br /&gt;2. For locations with high-speed connections, the FSIS PHV is to enter the relevant information into the BSE-VSLS.&lt;br /&gt;&lt;br /&gt;NOTE: FSIS PHVs can refer to the BSE-VSLS training for assistance getting access to BSE-VSLS and inputting information. The FSIS PHV may contact the District Office (DO) if he or she needs a copy of the training CD.&lt;br /&gt;&lt;br /&gt;VI. TEST RESULTS FOR FSIS SAMPLING FROM CATTLE SHOWING CNS SYMPTOMS&lt;br /&gt;&lt;br /&gt;A. The FSIS PHV will receive, by e-mail, a report from the AVIC on the BSE test results. The AVIC will also send copies of the results to the DO.&lt;br /&gt;&lt;br /&gt;B. If the test on the carcass condemned for CNS conditions is negative (reported as “not detected”), then any carcasses and parts the establishment has held may be released for rendering or other disposal in accordance with 9 CFR 314. C. If the test is inconclusive, the FSIS PHV will receive supervisory instruction on further actions.&lt;br /&gt;&lt;br /&gt;D. For any sample confirmed positive for BSE, the FSIS PHV is to verify that the establishment disposes of the carcasses and parts in the proper manner as set out in paragraph V. G.&lt;br /&gt;&lt;br /&gt;VII. PHIS PROCEDURES FOR BSE SAMPLING FROM CATTLE SHOWING CNS SIGNS&lt;br /&gt;&lt;br /&gt;A. Enter disposition information into PHIS in ADR.&lt;br /&gt;&lt;br /&gt;B. Enter BSE sampling information into the ADR APHIS Lab Sampling page in ADR.&lt;br /&gt;&lt;br /&gt;VIII. RABIES&lt;br /&gt;&lt;br /&gt;A. When an animal is condemned by the FSIS PHV on ante-mortem for rabies, the FSIS PHV is to contact the DO, which will advise APHIS. In these cases, APHIS will see that the animal is tested for rabies. APHIS will work with the laboratory to get appropriate samples forwarded for BSE surveillance from rabies negative animals.&lt;br /&gt;&lt;br /&gt;B. Rabies booster vaccination for PHVs collecting BSE samples is still highly recommended. PHVs can be reimbursed for rabies vaccinations or boosters. Rabies vaccinations are voluntary. Only PHVs who are actually involved with BSE sample collection will be eligible for reimbursement on the vaccination series. PHVs are to make&lt;br /&gt;&lt;br /&gt;6&lt;br /&gt;&lt;br /&gt;arrangements for the vaccinations with their private physician. PHVs are to contact their Front-line supervisor for approval on reimbursement prior to beginning the three shot vaccination series. Refer questions regarding this notice to the Policy Development Division through askFSIS at http://askfsis.custhelp.com or by telephone at 1-800-233-3935.&lt;br /&gt;&lt;br /&gt;Assistant Administrator&lt;br /&gt;&lt;br /&gt;Office of Policy and Program Development &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/OPPDE/rdad/FSISNotices/13-12.pdf"&gt;http://www.fsis.usda.gov/OPPDE/rdad/FSISNotices/13-12.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Tuesday, November 02, 2010 &lt;br /&gt;&lt;br /&gt;IN CONFIDENCE &lt;br /&gt;&lt;br /&gt;The information contained herein should not be disseminated further except on the basis of "NEED TO KNOW". &lt;br /&gt;&lt;br /&gt;BSE - ATYPICAL LESION DISTRIBUTION (RBSE 92-21367) statutory (obex only) diagnostic criteria CVL 1992 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://bse-atypical.blogspot.com/2010/11/bse-atypical-lesion-distribution-rbse.html"&gt;http://bse-atypical.blogspot.com/2010/11/bse-atypical-lesion-distribution-rbse.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;2009 UPDATE ON ALABAMA AND TEXAS MAD COWS 2005 and 2006 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://bse-atypical.blogspot.com/2006/08/bse-atypical-texas-and-alabama-update.html"&gt;http://bse-atypical.blogspot.com/2006/08/bse-atypical-texas-and-alabama-update.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;U.S.A. 50 STATE BSE MAD COW CONFERENCE CALL Jan. 9, 2001 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://tseac.blogspot.com/2011/02/usa-50-state-bse-mad-cow-conference.html"&gt;http://tseac.blogspot.com/2011/02/usa-50-state-bse-mad-cow-conference.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Harvard Risk Assessment of Bovine Spongiform Encephalopathy Update, October 31, 2005 INTRODUCTION The United States Department of Agriculture’s Food Safety and Inspection Service (FSIS) held a public meeting on July 25, 2006 in Washington, D.C. to present findings from the Harvard Risk Assessment of Bovine Spongiform Encephalopathy Update, October 31, 2005 (report and model located on the FSIS website: &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/Science/Risk_Assessments/index.asp"&gt;http://www.fsis.usda.gov/Science/Risk_Assessments/index.asp&lt;/a&gt;). &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Comments on technical aspects of the risk assessment were then submitted to FSIS. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Comments were received from Food and Water Watch, Food Animal Concerns Trust (FACT), Farm Sanctuary, R-CALF USA, Linda A Detwiler, and Terry S. Singeltary. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;This document provides itemized replies to the public comments received on the 2005 updated Harvard BSE risk assessment. Please bear the following points in mind: &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/PDF/BSE_Risk_Assess_Response_Public_Comments.pdf"&gt;http://www.fsis.usda.gov/PDF/BSE_Risk_Assess_Response_Public_Comments.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Owens, Julie From: Terry S. Singeltary Sr. [flounder9@verizon.net] &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sent: Monday, July 24, 2006 1:09 PM &lt;br /&gt;&lt;br /&gt;To: FSIS RegulationsComments &lt;br /&gt;&lt;br /&gt;Subject: [Docket No. FSIS-2006-0011] FSIS Harvard Risk Assessment of Bovine Spongiform Encephalopathy (BSE) Page 1 of 98 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/OPPDE/Comments/2006-0011/2006-0011-1.pdf"&gt;http://www.fsis.usda.gov/OPPDE/Comments/2006-0011/2006-0011-1.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;FSIS, USDA, REPLY TO SINGELTARY &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/PDF/BSE_Risk_Assess_Response_Public_Comments.pdf"&gt;http://www.fsis.usda.gov/PDF/BSE_Risk_Assess_Response_Public_Comments.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, October 10, 2011 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;EFSA Journal 2011 The European Response to BSE: A Success Story &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;EFSA and the European Centre for Disease Prevention and Control (ECDC) recently delivered a scientific opinion on any possible epidemiological or molecular association between TSEs in animals and humans (EFSA Panel on Biological Hazards (BIOHAZ) and ECDC, 2011). This opinion confirmed Classical BSE prions as the only TSE agents demonstrated to be zoonotic so far but the possibility that a small proportion of human cases so far classified as "sporadic" CJD are of zoonotic origin could not be excluded. Moreover, transmission experiments to non-human primates suggest that some TSE agents in addition to Classical BSE prions in cattle (namely L-type Atypical BSE, Classical BSE in sheep, transmissible mink encephalopathy (TME) and chronic wasting disease (CWD) agents) might have zoonotic potential. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1"&gt;http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf"&gt;http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;see follow-up here about North America BSE Mad Cow TSE prion risk factors, and the ever emerging strains of Transmissible Spongiform Encephalopathy in many species here in the USA, including humans ; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, August 12, 2010 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Seven main threats for the future linked to prions &lt;br /&gt;&lt;br /&gt;First threat &lt;br /&gt;&lt;br /&gt;The TSE road map defining the evolution of European policy for protection against prion diseases is based on a certain numbers of hypotheses some of which may turn out to be erroneous. In particular, a form of BSE (called atypical Bovine Spongiform Encephalopathy), recently identified by systematic testing in aged cattle without clinical signs, may be the origin of classical BSE and thus potentially constitute a reservoir, which may be impossible to eradicate if a sporadic origin is confirmed. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;***Also, a link is suspected between atypical BSE and some apparently sporadic cases of Creutzfeldt-Jakob disease in humans. These atypical BSE cases constitute an unforeseen first threat that could sharply modify the European approach to prion diseases. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Second threat &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.neuroprion.org/en/np-neuroprion.html"&gt;http://www.neuroprion.org/en/np-neuroprion.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, November 13, 2011 &lt;br /&gt;&lt;br /&gt;California BSE mad cow beef recall, QFC, CJD, and dead stock downer livestock &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/11/california-bse-mad-cow-beef-recall-qfc.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/11/california-bse-mad-cow-beef-recall-qfc.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Terry S. Singeltary Sr. on the Creutzfeldt-Jakob Disease Public Health Crisis &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.youtube.com/watch?v=zf3lfz9NrT4"&gt;http://www.youtube.com/watch?v=zf3lfz9NrT4&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.youtube.com/watch?v=c0tWkNvhO4g"&gt;http://www.youtube.com/watch?v=c0tWkNvhO4g&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.youtube.com/watch?v=zf3lfz9NrT4&amp;amp;feature=results_main&amp;amp;playnext=1&amp;amp;list=PL780BE2AF0B62A944"&gt;http://www.youtube.com/watch?v=zf3lfz9NrT4&amp;amp;feature=results_main&amp;amp;playnext=1&amp;amp;list=PL780BE2AF0B62A944&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;full text with source references ; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/08/terry-singeltary-sr-on-creutzfeldt.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/08/terry-singeltary-sr-on-creutzfeldt.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Friday, February 10, 2012 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Creutzfeldt-Jakob disease (CJD) biannual update (2012/1) potential iatrogenic (healthcare-acquired) exposure to CJD, and on the National Anonymous Tonsil Archive &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2012/02/creutzfeldt-jakob-disease-cjd-biannual.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2012/02/creutzfeldt-jakob-disease-cjd-biannual.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, February 12, 2012 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;National Prion Disease Pathology Surveillance Center Cases Examined1 (August 19, 2011) including Texas &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/national-prion-disease-pathology.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/national-prion-disease-pathology.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Saturday, June 25, 2011 &lt;br /&gt;&lt;br /&gt;Transmissibility of BSE-L and Cattle-Adapted TME Prion Strain to Cynomolgus Macaque &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;"BSE-L in North America may have existed for decades" &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/transmissibility-of-bse-l-and-cattle.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/transmissibility-of-bse-l-and-cattle.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, June 26, 2011 &lt;br /&gt;&lt;br /&gt;Risk Analysis of Low-Dose Prion Exposures in Cynomolgus Macaque &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/risk-analysis-of-low-dose-prion.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/risk-analysis-of-low-dose-prion.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Friday, December 23, 2011 &lt;br /&gt;&lt;br /&gt;Oral Transmission of L-type Bovine Spongiform Encephalopathy in Primate Model &lt;br /&gt;&lt;br /&gt;Volume 18, Number 1—January 2012 Dispatch &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/12/oral-transmission-of-l-type-bovine.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/12/oral-transmission-of-l-type-bovine.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;TSS&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2560706674003621546-184578755882155600?l=transmissiblespongiformencephalopathy.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://transmissiblespongiformencephalopathy.blogspot.com/feeds/184578755882155600/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/sample-collection-from-cattle-under.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/184578755882155600'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/184578755882155600'/><link rel='alternate' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/sample-collection-from-cattle-under.html' title='SAMPLE COLLECTION FROM CATTLE UNDER THE BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) ONGOING SURVEILLANCE PROGRAM 2/14/12'/><author><name>Terry S. Singeltary Sr.</name><uri>http://www.blogger.com/profile/06986622967539963260</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='22' src='http://bp2.blogger.com/_gwMAfd8g9xo/SHuerfBUR1I/AAAAAAAAAAM/nNI1xcLm_Z4/S220/scan0002.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2560706674003621546.post-5267047362441049473</id><published>2012-02-23T14:11:00.003-08:00</published><updated>2012-02-23T14:13:17.616-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Annual reports of Member States on BSE and Scrapie 2010'/><title type='text'>Annual reports of Member States on BSE and Scrapie 2010 excluding North America (for obvious reasons i.e. corruption)</title><content type='html'>&lt;div&gt;&lt;span style="font-family: Arial;"&gt;&lt;b style="list-style-image: url(&amp;quot;http://ec.europa.eu/dgs/health_consumer/design/images/bullet.gif&amp;quot;);"&gt;&lt;span style="color: #313f4b; font-size: 9pt;"&gt;BSE/Scrapie - TSE in  Goats&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="font-family: Arial;"&gt;&lt;strong&gt;&lt;span style="color: #313f4b;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="font-family: Arial;"&gt;&lt;strong&gt;&lt;span style="color: #313f4b;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: Arial;"&gt; &lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Arial;"&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://ec.europa.eu/food/food/biosafety/tse_bse/monitoring_annual_reports_en.htm" style="list-style-image: url(&amp;quot;http://ec.europa.eu/dgs/health_consumer/design/images/bullet.gif&amp;quot;); list-style-type: none;" target="_blank"&gt;&lt;span style="font-family: Arial;"&gt;&lt;span style="color: #276096; font-size: 8.3pt;"&gt;&lt;strong&gt;&lt;span style="text-decoration: none;"&gt;Annual reports of  Member States on BSE and Scrapie &lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span class="comment" style="list-style-image: url(&amp;quot;http://ec.europa.eu/dgs/health_consumer/design/images/bullet.gif&amp;quot;);"&gt;&lt;span style="font-family: Verdana;"&gt;&lt;span style="color: #428ccd; font-size: 7.5pt;"&gt;2010&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span class="comment" style="list-style-image: url(&amp;quot;http://ec.europa.eu/dgs/health_consumer/design/images/bullet.gif&amp;quot;);"&gt;&lt;span style="color: #428ccd; font-family: Verdana;"&gt;&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span class="comment" style="list-style-image: url(&amp;quot;http://ec.europa.eu/dgs/health_consumer/design/images/bullet.gif&amp;quot;);"&gt;&lt;span style="color: #428ccd; font-family: Verdana;"&gt;&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span class="comment" style="list-style-image: url(&amp;quot;http://ec.europa.eu/dgs/health_consumer/design/images/bullet.gif&amp;quot;);"&gt;&lt;span style="color: #428ccd; font-family: Verdana;"&gt;&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://ec.europa.eu/food/food/biosafety/tse_bse/docs/annual_report_tse2010_en.pdf" title="http://ec.europa.eu/food/food/biosafety/tse_bse/docs/annual_report_tse2010_en.pdf"&gt;http://ec.europa.eu/food/food/biosafety/tse_bse/docs/annual_report_tse2010_en.pdf&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span class="comment" style="list-style-image: url(&amp;quot;http://ec.europa.eu/dgs/health_consumer/design/images/bullet.gif&amp;quot;);"&gt;&lt;span style="color: #428ccd; font-family: Verdana;"&gt;&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Tuesday, February 14, 2012&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;White House budget proposes cuts to ag programs including TSE PRION disease  aka mad cow type disease&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/white-house-budget-proposes-cuts-to-ag.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/white-house-budget-proposes-cuts-to-ag.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thursday, February 16, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Bovine Spongiform Encephalopathy BSE &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;31 USA SENATORS ASK PRESIDENT OBAMA TO HELP SPREAD MAD COW DISEASE 2012  &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/bovine-spongiform-encephalopathy-bse-31.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/bovine-spongiform-encephalopathy-bse-31.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thursday, February 23, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;EIGHT FORMER SECRETARIES OF AGRICULTURE SPEAKING AT USDA'S 2012 AGRICULTURE  OUTLOOK FORUM INDUCTED INTO USA MAD COW HALL OF SHAME &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://madcowusda.blogspot.com/2012/02/eight-former-secretaries-of-agriculture.html" title="http://madcowusda.blogspot.com/2012/02/eight-former-secretaries-of-agriculture.html"&gt;http://madcowusda.blogspot.com/2012/02/eight-former-secretaries-of-agriculture.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;h2 class="date-header" style="letter-spacing: 1px; margin: 0px; text-transform: uppercase; word-wrap: break-word;"&gt;&lt;span style="letter-spacing: 1px;"&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;&lt;span style="font-size: 10.8pt;"&gt;&lt;span style="font-weight: normal;"&gt;Thursday, February 23,  2012&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;br /&gt;&lt;h2 class="date-header" style="letter-spacing: 1px; margin: 0px; text-transform: uppercase; word-wrap: break-word;"&gt;&lt;span style="letter-spacing: 1px;"&gt;&lt;span style="color: #29303b; font-family: Georgia;"&gt;&lt;/span&gt;&lt;/span&gt; &lt;/h2&gt;&lt;br /&gt;&lt;h2 class="date-header" style="letter-spacing: 1px; margin: 0px; text-transform: uppercase; word-wrap: break-word;"&gt;&lt;span style="letter-spacing: 1px;"&gt;&lt;span style="color: #29303b; font-family: Georgia;"&gt;&lt;/span&gt;&lt;/span&gt; &lt;/h2&gt;&lt;br /&gt;&lt;h2 class="date-header" style="letter-spacing: 1px; margin: 0px; text-transform: uppercase; word-wrap: break-word;"&gt;&lt;span style="letter-spacing: 1px;"&gt;&lt;span style="color: #29303b; font-family: Georgia;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;br /&gt;&lt;div class="date-posts" style="word-wrap: break-word;"&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;a href="http://www.blogger.com/" name="1749668615517378025"&gt;&lt;/a&gt; &lt;br /&gt;&lt;h3 class="post-title entry-title" style="margin: 0px;"&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #1b0431;"&gt;&lt;span style="font-size: 16.8pt;"&gt;&lt;span style="font-weight: normal;"&gt;Atypical Scrapie NOR-98 confirmed Alberta Canada  sheep January 2012 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h3&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;snip...&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;RESEARCH&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Emerging Infectious  Diseases • www.cdc.gov/eid • Vol. 17, No. 5, May  2011&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Experimental Oral Transmission of Atypical Scrapie to Sheep  &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Marion M. Simmons, S. Jo Moore,1 Timm Konold, Lisa Thurston, Linda  A. Terry, Leigh Thorne, Richard Lockey, Chris Vickery, Stephen A.C. Hawkins,  Melanie J. Chaplin, and John Spiropoulos&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;To investigate the  possibility of oral transmission of atypical scrapie in sheep and determine the  distribution of infectivity in the animals’ peripheral tissues, we challenged  neonatal lambs orally with atypical scrapie; they were then killed at 12 or 24  months. Screening test results were negative for disease-specifi c prion protein  in all but 2 recipients; they had positive results for examination of brain, but  negative for peripheral tissues. Infectivity of brain, distal ileum, and spleen  from all animals was assessed in mouse bioassays; positive results were obtained  from tissues that had negative results on screening. These fi ndings demonstrate  that atypical scrapie can be transmitted orally and indicate that it has the  potential for natural transmission and iatrogenic spread through animal feed.  Detection of infectivity in tissues negative by current surveillance methods  indicates that diagnostic sensitivity is suboptimal for atypical scrapie, and  potentially infectious material may be able to pass into the human food  chain.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;SNIP...&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Although we do not have  epidemiologic evidence that supports the effi cient spread of disease in the fi  eld, these data imply that disease is potentially transmissible under fi eld  situations and that spread through animal feed may be possible if the current  feed restrictions were to be relaxed. Additionally, almost no data are available  on the potential for atypical scrapie to transmit to other food animal species,  certainly by the oral route. However, work with transgenic mice has demonstrated  the potential susceptibility of pigs, with the disturbing fi nding that the  biochemical properties of the resulting PrPSc have changed on transmission (40).  The implications of this observation for subsequent transmission and host target  range are currently unknown.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;How reassuring is this absence of  detectable PrPSc from a public health perspective? The bioassays performed in  this study are not titrations, so the infectious load of the positive gut  tissues cannot be quantifi ed, although infectivity has been shown  unequivocally. No experimental data are currently available on the zoonotic  potential of atypical scrapie, either through experimental challenge of  humanized mice or any meaningful epidemiologic correlation with human forms of  TSE. However, the detection of infectivity in the distal ileum of animals as  young as 12 months, in which all the tissues tested were negative for PrPSc by  the currently available screening and confi rmatory diagnostic tests, indicates  that the diagnostic sensitivity of current surveillance methods is suboptimal  for detecting atypical scrapie and that potentially infectious material may be  able to pass into the human food chain undetected.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Emerging  Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 5, May  2011&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://wwwnc.cdc.gov/eid/article/17/5/pdfs/10-1654.pdf"&gt;&lt;span style="color: #473624; font-family: Georgia;"&gt;http://wwwnc.cdc.gov/eid/article/17/5/pdfs/10-1654.pdf&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;OIE Scrapie Chapter Revision • Current draft  recognizes Nor98-like scrapie as a separate disease from classical scrapie •  USDA provided comments on the draft to OIE&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: Georgia;"&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px; word-wrap: break-word;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px; word-wrap: break-word;"&gt;&lt;a href="http://www.animalagriculture.org/Solutions/Proceedings/Annual%20Meeting/2009/Sheep%20&amp;amp;%20Goat/Myers,%20Thomas.pdf"&gt;&lt;span style="color: #473624; font-family: Georgia;"&gt;http://www.animalagriculture.org/Solutions/Proceedings/Annual%20Meeting/2009/Sheep%20&amp;amp;%20Goat/Myers,%20Thomas.pdf&lt;/span&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px; word-wrap: break-word;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px; word-wrap: break-word;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px; word-wrap: break-word;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px; word-wrap: break-word;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px; word-wrap: break-word;"&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;Atypical scrapie/Nor 98 October  2009&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;div class="date-posts" style="word-wrap: break-word;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="date-posts" style="word-wrap: break-word;"&gt;&lt;div class="post-outer"&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;br /&gt;Last year, after examining member country submissions and  investigating rigorous scientific research, the World Organisation for Animal  Health (OIE) decided that Nor 98 should not be listed in its Terrestrial Animal  Health Code. The Code sets out trade recommendations or restrictions for listed  diseases or conditions, and the OIE determined there was no need for such  recommendations around Nor 98.&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;/div&gt;&lt;/span&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;a href="http://www.nzfsa.govt.nz/publications/ce-column/ce-web-nor98.htm"&gt;&lt;span style="color: #473624; font-family: Georgia;"&gt;http://www.nzfsa.govt.nz/publications/ce-column/ce-web-nor98.htm&lt;/span&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;a href="http://www.biosecurity.govt.nz/files/pests/atypical-scrapie/atypical-scrapie-faq-oct09.pdf"&gt;&lt;span style="color: #473624; font-family: Georgia;"&gt;http://www.biosecurity.govt.nz/files/pests/atypical-scrapie/atypical-scrapie-faq-oct09.pdf&lt;/span&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;Sutton reported that USDA has urged the World  Organization for Animal Health (OIE) to categorize Nor98-like scrapie as a  separate disease from classical scrapie. Currently, the OIE has proposed a draft  revision of their scrapie chapter that would exclude Nor98-like scrapie from the  chapter. USDA will be submitting it's comments on this proposal  soon.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;/span&gt;&lt;span style="font-family: Georgia;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="date-posts" style="word-wrap: break-word;"&gt;&lt;span style="font-family: Georgia;"&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;a href="http://www.ohiosheep.org/Events/ScrapieNewsletterMarch09.pdf"&gt;&lt;span style="color: #473624; font-family: Georgia;"&gt;http://www.ohiosheep.org/Events/ScrapieNewsletterMarch09.pdf&lt;/span&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;snip...&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/atypical-scrapie-nor-98-confirmed.html" title="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/atypical-scrapie-nor-98-confirmed.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/atypical-scrapie-nor-98-confirmed.html&lt;/a&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Monday, November 30, 2009&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;USDA AND OIE COLLABORATE TO EXCLUDE ATYPICAL SCRAPIE NOR-98 ANIMAL HEALTH  CODE&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://nor-98.blogspot.com/2009/11/usda-and-oie-collaborate-to-exclude.html"&gt;http://nor-98.blogspot.com/2009/11/usda-and-oie-collaborate-to-exclude.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;h2 class="date-header" style="letter-spacing: 1px; margin: 0px; text-transform: uppercase; word-wrap: break-word;"&gt;&lt;span style="letter-spacing: 1px;"&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;&lt;span style="font-size: 10.8pt;"&gt;&lt;span style="font-weight: normal;"&gt;Sunday, February 12,  2012&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;br /&gt;&lt;h2 class="date-header" style="letter-spacing: 1px; margin: 0px; text-transform: uppercase; word-wrap: break-word;"&gt;&lt;span style="letter-spacing: 1px;"&gt;&lt;span style="color: #29303b; font-family: Georgia;"&gt;&lt;/span&gt;&lt;/span&gt; &lt;/h2&gt;&lt;br /&gt;&lt;h2 class="date-header" style="letter-spacing: 1px; margin: 0px; text-transform: uppercase; word-wrap: break-word;"&gt;&lt;span style="letter-spacing: 1px;"&gt;&lt;span style="color: #29303b; font-family: Georgia;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;br /&gt;&lt;div class="date-posts" style="word-wrap: break-word;"&gt;&lt;div class="post-outer"&gt;&lt;div class="post hentry uncustomized-post-template" style="margin: 8px 0px 24px;"&gt;&lt;a href="http://www.blogger.com/" name="536815840888492447"&gt;&lt;/a&gt; &lt;br /&gt;&lt;h3 class="post-title entry-title" style="margin: 0px;"&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #1b0431;"&gt;&lt;span style="font-size: 16.8pt;"&gt;&lt;span style="font-weight: normal;"&gt;National Prion Disease Pathology Surveillance Center  Cases Examined1 (August 19, 2011) including Texas  &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h3&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/national-prion-disease-pathology.html" title="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/national-prion-disease-pathology.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/national-prion-disease-pathology.html&lt;/a&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;TSS&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;div class="post-title entry-title" style="margin: 0px;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2560706674003621546-5267047362441049473?l=transmissiblespongiformencephalopathy.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://transmissiblespongiformencephalopathy.blogspot.com/feeds/5267047362441049473/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/annual-reports-of-member-states-on-bse.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/5267047362441049473'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/5267047362441049473'/><link rel='alternate' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/annual-reports-of-member-states-on-bse.html' title='Annual reports of Member States on BSE and Scrapie 2010 excluding North America (for obvious reasons i.e. corruption)'/><author><name>Terry S. Singeltary Sr.</name><uri>http://www.blogger.com/profile/06986622967539963260</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='22' src='http://bp2.blogger.com/_gwMAfd8g9xo/SHuerfBUR1I/AAAAAAAAAAM/nNI1xcLm_Z4/S220/scan0002.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2560706674003621546.post-1749668615517378025</id><published>2012-02-23T13:00:00.001-08:00</published><updated>2012-02-23T13:04:19.891-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Atypical Scrapie NOR-98 confirmed Alberta sheep January 2012'/><title type='text'>Atypical Scrapie NOR-98 confirmed Alberta Canada sheep January 2012</title><content type='html'>Atypical Scrapie NOR-98 confirmed Alberta Canada sheep January 2012&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;PLEASE NOTE, the _spontaneous_ aspect of the rhetoric that USDA, CFIA, OIE, Australian, and every other Industry/Government is putting out, that atypical scrapie does not transmit to sheep, goat, or any other species, and that atypical Scrapie just happens spontaneously, is totally fabricated, and is not true. THERE IS NO SCIENCE showing this. IN fact, Science has shown that atypical scrapie does transmit, and it is very similar to some cases of sporadic CJD and GSS in humans. FOR the OIE et al to ratify a totally flawed trade policy, that makes legal the trading of atypical scrapie as a global commodity, is insane, and the ramifications of this insanity, will be played out for decades to come on man and animal. ...TSS&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Fatal disease confirmed in sheep  &lt;br /&gt;&lt;br /&gt;Herd quarantine unlikely&lt;br /&gt;&lt;br /&gt;Posted Feb. 23rd, 2012&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;by Mary MacArthur&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;A single case of atypical scrapie was confirmed in an Alberta sheep in January.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Dr. Bob Cooper, a veterinary program specialist with the Canadian Food Inspection Agency, said the case was discovered as part of the national surveillance program to eradicate scrapie in Canada.&lt;br /&gt;&lt;br /&gt;The surveillance program tests samples of sheep and goats for scrapie in an effort to understand where the disease is found in Canada and how to eliminate it.&lt;br /&gt;&lt;br /&gt;Scrapie is a fatal disease that affects the central nervous system of sheep and goats. It is in the same family as BSE in cattle and chronic wasting disease in deer and elk.&lt;br /&gt;&lt;br /&gt;It is a reportable disease in Canada.&lt;br /&gt;&lt;br /&gt;Unlike classical scrapie, atypical scrapie doesn’t require that sheep farms be quarantined or the flock investigated.&lt;br /&gt;&lt;br /&gt;Cooper said there would be some follow up to determine where the sheep lived its life, but there will be no large scale investigation or quarantine.&lt;br /&gt;&lt;br /&gt;The atypical scrapie case was posted on the CFIA website’s monthly reportable disease update.&lt;br /&gt;&lt;br /&gt;Canada has developed the national voluntary scrapie flock certification program in an attempt to eliminate scrapie from the national flock.&lt;br /&gt;&lt;br /&gt;Alberta Lamb Producer chair Phil Kolodychuk was relieved the case was atypical scrapie and not classic scrapie.&lt;br /&gt;&lt;br /&gt;“It’s a bad disease. We’d like to get rid of it in our country,” he said.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.producer.com/2012/02/fatal-disease-confirmed%E2%80%A8in-sheep-%E2%80%A9/"&gt;http://www.producer.com/2012/02/fatal-disease-confirmed%E2%80%A8in-sheep-%E2%80%A9/&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Current as of: 2012-01-31&lt;br /&gt;&lt;br /&gt;Date confirmed Location Animal type infected &lt;br /&gt;January 26* Alberta Sheep &lt;br /&gt;&lt;br /&gt;*Atypical scrapie&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.inspection.gc.ca/animals/terrestrial-animals/diseases/reportable/2012/flocks-infected-in-2012/eng/1329724998646/1329725166676"&gt;http://www.inspection.gc.ca/animals/terrestrial-animals/diseases/reportable/2012/flocks-infected-in-2012/eng/1329724998646/1329725166676&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Increased Atypical Scrapie Detections&lt;br /&gt;&lt;br /&gt;Press reports indicate that increased surveillance is catching what otherwise would have been unreported findings of atypical scrapie in sheep. In 2009, five new cases have been reported in Quebec, Ontario, Alberta, and Saskatchewan. With the exception of Quebec, all cases have been diagnosed as being the atypical form found in older animals. Canada encourages producers to join its voluntary surveillance program in order to gain scrapie-free status. The World Animal Health will not classify Canada as scrapie-free until no new cases are reported for seven years. The Canadian Sheep Federation is calling on the government to fund a wider surveillance program in order to establish the level of prevalence prior to setting an eradication date. Besides long-term testing, industry is calling for a compensation program for farmers who report unusual deaths in their flocks.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://gain.fas.usda.gov/Recent%20GAIN%20Publications/This%20Week%20in%20Canadian%20Agriculture%20%20%20%20%20Issue%2028_Ottawa_Canada_11-6-2009.pdf"&gt;http://gain.fas.usda.gov/Recent%20GAIN%20Publications/This%20Week%20in%20Canadian%20Agriculture%20%20%20%20%20Issue%2028_Ottawa_Canada_11-6-2009.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;J Vet Diagn Invest 21:454-463 (2009) &lt;br /&gt;&lt;br /&gt;Nor98 scrapie identified in the United States &lt;br /&gt;&lt;br /&gt;Christie M. Loiacono,' Bruce V. Thomsen, S. Mark Hall, Matti Kiupe!, Diane Sutton, Katherine O'Rourke, Bradd Barr, Lucy Anthenill, Deiwyn Keane &lt;br /&gt;&lt;br /&gt;Abstract. &lt;br /&gt;&lt;br /&gt;A distinct strain of scrapic identified in sheep of Norway in 1998 has since been identified in numerous countries throughout Europe. The disease is known as Nor98 or Not-98-like scrapic. among other names. Distinctions between classic scrapie and Nor98 scrapie are made based on histopathologv and immunodiagnostic results. There are also differences in the epidemiology, typical signalment, and likelihood of clinical signs being observed. In addition, sheep that have genotypes associated with resistance to classic scrapie are not spared from Nor98 disease. The various differences between classic and Nor98 scrapie have been consistently reported in the vast majority of cases described across Europe. The current study describes in detail the patholo gic changes and diagnostic results of the first 6 cases of' Nor98 scrapic disease diagnosed in sheep of the United States. &lt;br /&gt;&lt;br /&gt;Key words: Hisiopathology: Nor98: PrP imniunolabeling; scrapie: sheep. &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;Results &lt;br /&gt;&lt;br /&gt;Case I &lt;br /&gt;&lt;br /&gt;The first case identified as consistent with Nor98 scrapie had nonclassic PrP distribution in brain tissue, no PrPSC in lymph tissue, and nonclassic migration of protein bands on a Western blot test. The animal was an aged, mottled-faced ewe that was traced back to a commercial flock in Wyoming. ... &lt;br /&gt;&lt;br /&gt;Case 2 &lt;br /&gt;&lt;br /&gt;The second case was a clinically normal 8-year-old Suffolk ewe that had been in a quarantined flock for 5 years at a USDA facility in Iowa. &lt;br /&gt;&lt;br /&gt;Case 3 &lt;br /&gt;&lt;br /&gt;A 16-year-old, white-faced, cross-bred wether was born to a black-faced ewe. He lived his entire life as a pet on a farm in California. &lt;br /&gt;&lt;br /&gt;Case 4 &lt;br /&gt;&lt;br /&gt;The fourth case of Nor98 scrapie was identified in an approximately 8-year-old Dorset ewe that was born into a flock of approximately 20 ewes in Indiana. &lt;br /&gt;&lt;br /&gt;Case 5 &lt;br /&gt;&lt;br /&gt;The fifth case was a clinically normal, approximately 3-year-old, white-faced, cross-bred ewe from an approximately 400 head commercial flock in Minnesota. &lt;br /&gt;&lt;br /&gt;Case 6 &lt;br /&gt;&lt;br /&gt;The sixth case of Nor98 scrapie was identified in a 4-year-old, white-faced ewe that was purchased and added to a commercial flock in Pennsylvania &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;see full text ; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://ddr.nal.usda.gov/bitstream/10113/33943/1/IND44241920.pdf"&gt;http://ddr.nal.usda.gov/bitstream/10113/33943/1/IND44241920.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, October 10, 2011 &lt;br /&gt;&lt;br /&gt;EFSA Journal 2011 The European Response to BSE: A Success Story &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;EFSA and the European Centre for Disease Prevention and Control (ECDC) recently delivered a scientific opinion on any possible epidemiological or molecular association between TSEs in animals and humans (EFSA Panel on Biological Hazards (BIOHAZ) and ECDC, 2011). This opinion confirmed Classical BSE prions as the only TSE agents demonstrated to be zoonotic so far but the possibility that a small proportion of human cases so far classified as "sporadic" CJD are of zoonotic origin could not be excluded. Moreover, transmission experiments to non-human primates suggest that some TSE agents in addition to Classical BSE prions in cattle (namely L-type Atypical BSE, Classical BSE in sheep, transmissible mink encephalopathy (TME) and chronic wasting disease (CWD) agents) might have zoonotic potential. &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1"&gt;http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf"&gt;http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;see follow-up here about North America BSE Mad Cow TSE prion risk factors, and the ever emerging strains of Transmissible Spongiform Encephalopathy in many species here in the USA, including humans ; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, November 30, 2009 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;USDA AND OIE COLLABORATE TO EXCLUDE ATYPICAL SCRAPIE NOR-98 ANIMAL HEALTH CODE &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://nor-98.blogspot.com/2009/11/usda-and-oie-collaborate-to-exclude.html"&gt;http://nor-98.blogspot.com/2009/11/usda-and-oie-collaborate-to-exclude.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Friday, February 11, 2011 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Atypical/Nor98 Scrapie Infectivity in Sheep Peripheral Tissues &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://nor-98.blogspot.com/2011/02/atypicalnor98-scrapie-infectivity-in.html"&gt;http://nor-98.blogspot.com/2011/02/atypicalnor98-scrapie-infectivity-in.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, December 12, 2010 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;EFSA reviews BSE/TSE infectivity in small ruminant tissues News Story 2 December 2010 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/efsa-reviews-bsetse-infectivity-in.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/efsa-reviews-bsetse-infectivity-in.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, January 18, 2012 &lt;br /&gt;&lt;br /&gt;Selection of Distinct Strain Phenotypes in Mice Infected by Ovine Natural Scrapie Isolates Similar to CH1641 Experimental Scrapie &lt;br /&gt;&lt;br /&gt;Journal of Neuropathology &amp;amp; Experimental Neurology: February 2012 - Volume 71 - Issue 2 - p 140–147 &lt;br /&gt;&lt;br /&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/selection-of-distinct-strain-phenotypes.html &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, July 14, 2011 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Histopathological Studies of "CH1641-Like" Scrapie Sources Versus Classical Scrapie and BSE Transmitted to Ovine Transgenic Mice (TgOvPrP4) &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/07/histopathological-studies-of-ch1641.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/07/histopathological-studies-of-ch1641.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, January 18, 2012&lt;br /&gt;&lt;br /&gt;BSE IN GOATS CAN BE MISTAKEN FOR SCRAPIE &lt;br /&gt;&lt;br /&gt;February 1, 2012 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/bse-in-goats-can-be-mistaken-for.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/bse-in-goats-can-be-mistaken-for.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, December 23, 2010 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Molecular Typing of Protease-Resistant Prion Protein in Transmissible Spongiform Encephalopathies of Small Ruminants, France, 2002-2009 &lt;br /&gt;&lt;br /&gt;Volume 17, Number 1 January 2011 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/molecular-typing-of-protease-resistant.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/molecular-typing-of-protease-resistant.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, November 18, 2010 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy following passage in sheep &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://bse-atypical.blogspot.com/2010/11/increased-susceptibility-of-human-prp.html"&gt;http://bse-atypical.blogspot.com/2010/11/increased-susceptibility-of-human-prp.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;hmmm, no I ponder why some of these sporadic CJD cases, are now being linked to a genetic TSE, that has NO link to the family ?&lt;br /&gt;&lt;br /&gt;hmmm, could it be these atypical TSE in animals, that are linked to the human TSE in the USA, and also, these animals have been fed back and forth to each other ?&lt;br /&gt;&lt;br /&gt;hmmm, why no link there $$$&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;P03.141&lt;br /&gt;&lt;br /&gt;Aspects of the Cerebellar Neuropathology in Nor98&lt;br /&gt;&lt;br /&gt;Gavier-Widén, D1; Benestad, SL2; Ottander, L1; Westergren, E1 1National Veterinary Insitute, Sweden; 2National Veterinary Institute,&lt;br /&gt;&lt;br /&gt;Norway Nor98 is a prion disease of old sheep and goats. This atypical form of scrapie was first described in Norway in 1998. Several features of Nor98 were shown to be different from classical scrapie including the distribution of disease associated prion protein (PrPd) accumulation in the brain. The cerebellum is generally the most affected brain area in Nor98. The study here presented aimed at adding information on the neuropathology in the cerebellum of Nor98 naturally affected sheep of various genotypes in Sweden and Norway. A panel of histochemical and immunohistochemical (IHC) stainings such as IHC for PrPd, synaptophysin, glial fibrillary acidic protein, amyloid, and cell markers for phagocytic cells were conducted. The type of histological lesions and tissue reactions were evaluated. The types of PrPd deposition were characterized. The cerebellar cortex was regularly affected, even though there was a variation in the severity of the lesions from case to case. Neuropil vacuolation was more marked in the molecular layer, but affected also the granular cell layer. There was a loss of granule cells. Punctate deposition of PrPd was characteristic. It was morphologically and in distribution identical with that of synaptophysin, suggesting that PrPd accumulates in the synaptic structures. PrPd was also observed in the granule cell layer and in the white matter. The pathology features of Nor98 in the cerebellum of the affected sheep showed similarities with those of sporadic Creutzfeldt-Jakob disease in humans.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;***The pathology features of Nor98 in the cerebellum of the affected sheep showed similarities with those of sporadic Creutzfeldt-Jakob disease in humans.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf"&gt;http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;PR-26&lt;br /&gt;&lt;br /&gt;NOR98 SHOWS MOLECULAR FEATURES REMINISCENT OF GSS&lt;br /&gt;&lt;br /&gt;R. Nonno1, E. Esposito1, G. Vaccari1, E. Bandino2, M. Conte1, B. Chiappini1, S. Marcon1, M. Di Bari1, S.L. Benestad3, U. Agrimi1 1 Istituto Superiore di Sanità, Department of Food Safety and Veterinary Public Health, Rome, Italy (romolo.nonno@iss.it); 2 Istituto Zooprofilattico della Sardegna, Sassari, Italy; 3 National Veterinary Institute, Department of Pathology, Oslo, Norway&lt;br /&gt;&lt;br /&gt;Molecular variants of PrPSc are being increasingly investigated in sheep scrapie and are generally referred to as "atypical" scrapie, as opposed to "classical scrapie". Among the atypical group, Nor98 seems to be the best identified. We studied the molecular properties of Italian and Norwegian Nor98 samples by WB analysis of brain homogenates, either untreated, digested with different concentrations of proteinase K, or subjected to enzymatic deglycosylation. The identity of PrP fragments was inferred by means of antibodies spanning the full PrP sequence. We found that undigested brain homogenates contain a Nor98-specific PrP fragment migrating at 11 kDa (PrP11), truncated at both the C-terminus and the N-terminus, and not N-glycosylated. After mild PK digestion, Nor98 displayed full-length PrP (FL-PrP) and N-glycosylated C-terminal fragments (CTF), along with increased levels of PrP11. Proteinase K digestion curves (0,006-6,4 mg/ml) showed that FL-PrP and CTF are mainly digested above 0,01 mg/ml, while PrP11 is not entirely digested even at the highest concentrations, similarly to PrP27-30 associated with classical scrapie. Above 0,2 mg/ml PK, most Nor98 samples showed only PrP11 and a fragment of 17 kDa with the same properties of PrP11, that was tentatively identified as a dimer of PrP11. Detergent solubility studies showed that PrP11 is insoluble in 2% sodium laurylsorcosine and is mainly produced from detergentsoluble, full-length PrPSc. Furthermore, among Italian scrapie isolates, we found that a sample with molecular and pathological properties consistent with Nor98 showed plaque-like deposits of PrPSc in the thalamus when the brain was analysed by PrPSc immunohistochemistry. Taken together, our results show that the distinctive pathological feature of Nor98 is a PrP fragment spanning amino acids ~ 90-155. This fragment is produced by successive N-terminal and C-terminal cleavages from a full-length and largely detergent-soluble PrPSc, is produced in vivo and is extremely resistant to PK digestion.&lt;br /&gt;&lt;br /&gt;*** Intriguingly, these conclusions suggest that some pathological features of Nor98 are reminiscent of Gerstmann-Sträussler-Scheinker disease. &lt;br /&gt;&lt;br /&gt;119&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.neuroprion.com/pdf_docs/conferences/prion2006/abstract_book.pdf"&gt;http://www.neuroprion.com/pdf_docs/conferences/prion2006/abstract_book.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes &lt;br /&gt;&lt;br /&gt;Annick Le Dur*,?, Vincent Béringue*,?, Olivier Andréoletti?, Fabienne Reine*, Thanh Lan Laï*, Thierry Baron§, Bjørn Bratberg¶, Jean-Luc Vilotte?, Pierre Sarradin**, Sylvie L. Benestad¶, and Hubert Laude*,? +Author Affiliations&lt;br /&gt;&lt;br /&gt;*Virologie Immunologie Moléculaires and ?Génétique Biochimique et Cytogénétique, Institut National de la Recherche Agronomique, 78350 Jouy-en-Josas, France; ?Unité Mixte de Recherche, Institut National de la Recherche Agronomique-Ecole Nationale Vétérinaire de Toulouse, Interactions Hôte Agent Pathogène, 31066 Toulouse, France; §Agence Française de Sécurité Sanitaire des Aliments, Unité Agents Transmissibles Non Conventionnels, 69364 Lyon, France; **Pathologie Infectieuse et Immunologie, Institut National de la Recherche Agronomique, 37380 Nouzilly, France; and ¶Department of Pathology, National Veterinary Institute, 0033 Oslo, Norway&lt;br /&gt;&lt;br /&gt;***Edited by Stanley B. Prusiner, University of California, San Francisco, CA (received for review March 21, 2005)&lt;br /&gt;&lt;br /&gt;Abstract Scrapie in small ruminants belongs to transmissible spongiform encephalopathies (TSEs), or prion diseases, a family of fatal neurodegenerative disorders that affect humans and animals and can transmit within and between species by ingestion or inoculation. Conversion of the host-encoded prion protein (PrP), normal cellular PrP (PrPc), into a misfolded form, abnormal PrP (PrPSc), plays a key role in TSE transmission and pathogenesis. The intensified surveillance of scrapie in the European Union, together with the improvement of PrPSc detection techniques, has led to the discovery of a growing number of so-called atypical scrapie cases. These include clinical Nor98 cases first identified in Norwegian sheep on the basis of unusual pathological and PrPSc molecular features and "cases" that produced discordant responses in the rapid tests currently applied to the large-scale random screening of slaughtered or fallen animals. Worryingly, a substantial proportion of such cases involved sheep with PrP genotypes known until now to confer natural resistance to conventional scrapie. Here we report that both Nor98 and discordant cases, including three sheep homozygous for the resistant PrPARR allele (A136R154R171), efficiently transmitted the disease to transgenic mice expressing ovine PrP, and that they shared unique biological and biochemical features upon propagation in mice. *** These observations support the view that a truly infectious TSE agent, unrecognized until recently, infects sheep and goat flocks and may have important implications in terms of scrapie control and public health.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pnas.org/content/102/44/16031.abstract"&gt;http://www.pnas.org/content/102/44/16031.abstract&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, December 1, 2008&lt;br /&gt;&lt;br /&gt;When Atypical Scrapie cross species barriers&lt;br /&gt;&lt;br /&gt;Authors&lt;br /&gt;&lt;br /&gt;Andreoletti O., Herva M. H., Cassard H., Espinosa J. C., Lacroux C., Simon S., Padilla D., Benestad S. L., Lantier F., Schelcher F., Grassi J., Torres, J. M., UMR INRA ENVT 1225, Ecole Nationale Veterinaire de Toulouse.France; ICISA-INlA, Madrid, Spain; CEA, IBiTec-5, DSV, CEA/Saclay, Gif sur Yvette cedex, France; National Veterinary Institute, Postboks 750 Sentrum, 0106 Oslo, Norway, INRA IASP, Centre INRA de Tours, 3738O Nouzilly, France.&lt;br /&gt;&lt;br /&gt;Content&lt;br /&gt;&lt;br /&gt;Atypical scrapie is a TSE occurring in small ruminants and harbouring peculiar clinical, epidemiological and biochemical properties. Currently this form of disease is identified in a large number of countries. In this study we report the transmission of an atypical scrapie isolate through different species barriers as modeled by transgenic mice (Tg) expressing different species PRP sequence.&lt;br /&gt;&lt;br /&gt;The donor isolate was collected in 1995 in a French commercial sheep flock. inoculation into AHQ/AHQ sheep induced a disease which had all neuro-pathological and biochemical characteristics of atypical scrapie. Transmitted into Transgenic mice expressing either ovine or PrPc, the isolate retained all the described characteristics of atypical scrapie.&lt;br /&gt;&lt;br /&gt;Surprisingly the TSE agent characteristics were dramatically different v/hen passaged into Tg bovine mice. The recovered TSE agent had biological and biochemical characteristics similar to those of atypical BSE L in the same mouse model. Moreover, whereas no other TSE agent than BSE were shown to transmit into Tg porcine mice, atypical scrapie was able to develop into this model, albeit with low attack rate on first passage.&lt;br /&gt;&lt;br /&gt;Furthermore, after adaptation in the porcine mouse model this prion showed similar biological and biochemical characteristics than BSE adapted to this porcine mouse model. Altogether these data indicate.&lt;br /&gt;&lt;br /&gt;(i) the unsuspected potential abilities of atypical scrapie to cross species barriers&lt;br /&gt;&lt;br /&gt;(ii) the possible capacity of this agent to acquire new characteristics when crossing species barrier&lt;br /&gt;&lt;br /&gt;These findings raise some interrogation on the concept of TSE strain and on the origin of the diversity of the TSE agents and could have consequences on field TSE control measures. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.neuroprion.org/resources/pdf_docs/conferences/prion2008/abstract-book-prion2008.pdf"&gt;http://www.neuroprion.org/resources/pdf_docs/conferences/prion2008/abstract-book-prion2008.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, January 26, 2012 &lt;br /&gt;&lt;br /&gt;Facilitated Cross-Species Transmission of Prions in Extraneural Tissue &lt;br /&gt;&lt;br /&gt;Science 27 January 2012: Vol. 335 no. 6067 pp. 472-475 DOI: 10.1126/science.1215659 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/facilitated-cross-species-transmission.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/facilitated-cross-species-transmission.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Saturday, February 11, 2012&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Prion cross-species transmission efficacy is tissue dependent &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/prion-cross-species-transmission.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/prion-cross-species-transmission.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, January 26, 2012 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;The Risk of Prion Zoonoses &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Science 27 January 2012: Vol. 335 no. 6067 pp. 411-413 DOI: 10.1126/science.1218167 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/risk-of-prion-zoonoses.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/risk-of-prion-zoonoses.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;1: J Infect Dis 1980 Aug;142(2):205-8 &lt;br /&gt;&lt;br /&gt;Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates. &lt;br /&gt;&lt;br /&gt;Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC. &lt;br /&gt;&lt;br /&gt;Kuru and Creutzfeldt-Jakob disease of humans and scrapie disease of sheep and goats were transmitted to squirrel monkeys (Saimiri sciureus) that were exposed to the infectious agents only by their nonforced consumption of known infectious tissues. The asymptomatic incubation period in the one monkey exposed to the virus of kuru was 36 months; that in the two monkeys exposed to the virus of Creutzfeldt-Jakob disease was 23 and 27 months, respectively; and that in the two monkeys exposed to the virus of scrapie was 25 and 32 months, respectively. Careful physical examination of the buccal cavities of all of the monkeys failed to reveal signs or oral lesions. One additional monkey similarly exposed to kuru has remained asymptomatic during the 39 months that it has been under observation. &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;The successful transmission of kuru, Creutzfeldt-Jakob disease, and scrapie by natural feeding to squirrel monkeys that we have reported provides further grounds for concern that scrapie-infected meat may occasionally give rise in humans to Creutzfeldt-Jakob disease.&lt;br /&gt;&lt;br /&gt;PMID: 6997404 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=6997404&amp;amp;dopt=Abstract"&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=6997404&amp;amp;dopt=Abstract&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;12/10/76&lt;br /&gt;&lt;br /&gt;AGRICULTURAL RESEARCH COUNCIL REPORT OF THE ADVISORY COMMITTE ON SCRAPIE&lt;br /&gt;&lt;br /&gt;Office Note CHAIRMAN: PROFESSOR PETER WILDY&lt;br /&gt;&lt;br /&gt;snip...&lt;br /&gt;&lt;br /&gt;A The Present Position with respect to Scrapie A] The Problem Scrapie is a natural disease of sheep and goats. It is a slow and inexorably progressive degenerative disorder of the nervous system and it ia fatal. It is enzootic in the United Kingdom but not in all countries. The field problem has been reviewed by a MAFF working group (ARC 35/77). It is difficult to assess the incidence in Britain for a variety of reasons but the disease causes serious financial loss; it is estimated that it cost Swaledale breeders alone $l.7 M during the five years 1971-1975. A further inestimable loss arises from the closure of certain export markets, in particular those of the United States, to British sheep. It is clear that scrapie in sheep is important commercially and for that reason alone effective measures to control it should be devised as quickly as possible. Recently the question has again been brought up as to whether scrapie is transmissible to man. This has followed reports that the disease has been transmitted to primates. &lt;br /&gt;&lt;br /&gt;One particularly lurid speculation (Gajdusek 1977) conjectures that the agents of scrapie, kuru, Creutzfeldt-Jakob disease and transmissible encephalopathy of mink are varieties of a single "virus". The U.S. Department of Agriculture concluded that it could "no longer justify or permit scrapie-blood line and scrapie-exposed sheep and goats to be processed for human or animal food at slaughter or rendering plants" (ARC 84/77)" The problem is emphasised by the finding that some strains of scrapie produce lesions identical to the once which characterise the human dementias" Whether true or not. the hypothesis that these agents might be transmissible to man raises two considerations. First, the safety of laboratory personnel requires prompt attention. Second, action such as the "scorched meat" policy of USDA makes the solution of the acrapie problem urgent if the sheep industry is not to suffer grievously. &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;76/10.12/4.6 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://web.archive.org/web/20010305223125/www.bseinquiry.gov.uk/files/yb/1976/10/12004001.pdf"&gt;http://web.archive.org/web/20010305223125/www.bseinquiry.gov.uk/files/yb/1976/10/12004001.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Nature. 1972 Mar 10;236(5341):73-4. &lt;br /&gt;&lt;br /&gt;Transmission of scrapie to the cynomolgus monkey (Macaca fascicularis). &lt;br /&gt;&lt;br /&gt;Gibbs CJ Jr, Gajdusek DC. Nature 236, 73 - 74 (10 March 1972); doi:10.1038/236073a0 &lt;br /&gt;&lt;br /&gt;Transmission of Scrapie to the Cynomolgus Monkey (Macaca fascicularis) &lt;br /&gt;&lt;br /&gt;C. J. GIBBS jun. ; D. C. GAJDUSEK National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland &lt;br /&gt;&lt;br /&gt;SCRAPIE has been transmitted to the cynomolgus, or crab-eating, monkey (Macaca fascicularis) with an incubation period of more than 5 yr from the time of intracerebral inoculation of scrapie-infected mouse brain. The animal developed a chronic central nervous system degeneration, with ataxia, tremor and myoclonus with associated severe scrapie-like pathology of intensive astroglial hypertrophy and proliferation, neuronal vacuolation and status spongiosus of grey matter. The strain of scrapie virus used was the eighth passage in Swiss mice (NIH) of a Compton strain of scrapie obtained as ninth intracerebral passage of the agent in goat brain, from Dr R. L. Chandler (ARC, Compton, Berkshire). &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nature.com/nature/journal/v236/n5341/abs/236073a0.html"&gt;http://www.nature.com/nature/journal/v236/n5341/abs/236073a0.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Nature. 1972 Mar 10;236(5341):73-4. &lt;br /&gt;&lt;br /&gt;Transmission of scrapie to the cynomolgus monkey (Macaca fascicularis). &lt;br /&gt;&lt;br /&gt;Gibbs CJ Jr, Gajdusek DC. Nature 236, 73 - 74 (10 March 1972); doi:10.1038/236073a0 &lt;br /&gt;&lt;br /&gt;Transmission of Scrapie to the Cynomolgus Monkey (Macaca fascicularis) &lt;br /&gt;&lt;br /&gt;C. J. GIBBS jun. &amp;amp;; D. C. GAJDUSEK National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland &lt;br /&gt;&lt;br /&gt;SCRAPIE has been transmitted to the cynomolgus, or crab-eating, monkey (Macaca fascicularis) with an incubation period of more than 5 yr from the time of intracerebral inoculation of scrapie-infected mouse brain. The animal developed a chronic central nervous system degeneration, with ataxia, tremor and myoclonus with associated severe scrapie-like pathology of intensive astroglial hypertrophy and proliferation, neuronal vacuolation and status spongiosus of grey matter. The strain of scrapie virus used was the eighth passage in Swiss mice (NIH) of a Compton strain of scrapie obtained as ninth intracerebral passage of the agent in goat brain, from Dr R. L. Chandler (ARC, Compton, Berkshire). &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nature.com/nature/journal/v236/n5341/abs/236073a0.html"&gt;http://www.nature.com/nature/journal/v236/n5341/abs/236073a0.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, February 16, 2011&lt;br /&gt;&lt;br /&gt;IN CONFIDENCE&lt;br /&gt;&lt;br /&gt;SCRAPIE TRANSMISSION TO CHIMPANZEES&lt;br /&gt;&lt;br /&gt;IN CONFIDENCE&lt;br /&gt;&lt;br /&gt;&lt;a href="http://scrapie-usa.blogspot.com/2011/02/in-confidence-scrapie-transmission-to.html"&gt;http://scrapie-usa.blogspot.com/2011/02/in-confidence-scrapie-transmission-to.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;why do we not want to do TSE transmission studies on chimpanzees $ &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;5. A positive result from a chimpanzee challenged severly would likely create alarm in some circles even if the result could not be interpreted for man. I have a view that all these agents could be transmitted provided a large enough dose by appropriate routes was given and the animals kept long enough. Until the mechanisms of the species barrier are more clearly understood it might be best to retain that hypothesis. &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;R. BRADLEY &lt;br /&gt;&lt;br /&gt;&lt;a href="http://collections.europarchive.org/tna/20080102222950/http://www.bseinquiry.gov.uk/files/yb/1990/09/23001001.pdf"&gt;http://collections.europarchive.org/tna/20080102222950/http://www.bseinquiry.gov.uk/files/yb/1990/09/23001001.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Friday, February 11, 2011&lt;br /&gt;&lt;br /&gt;Atypical/Nor98 Scrapie Infectivity in Sheep Peripheral Tissues&lt;br /&gt;&lt;br /&gt;&lt;a href="http://nor-98.blogspot.com/2011/02/atypicalnor98-scrapie-infectivity-in.html"&gt;http://nor-98.blogspot.com/2011/02/atypicalnor98-scrapie-infectivity-in.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, April 25, 2011&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Experimental Oral Transmission of Atypical Scrapie to Sheep&lt;br /&gt;&lt;br /&gt;Volume 17, Number 5-May 2011&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://nor-98.blogspot.com/2011/04/experimental-oral-transmission-of.html"&gt;http://nor-98.blogspot.com/2011/04/experimental-oral-transmission-of.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, April 18, 2010&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;SCRAPIE AND ATYPICAL SCRAPIE TRANSMISSION STUDIES A REVIEW 2010 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://scrapie-usa.blogspot.com/2010/04/scrapie-and-atypical-scrapie.html"&gt;http://scrapie-usa.blogspot.com/2010/04/scrapie-and-atypical-scrapie.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, November 18, 2010 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy following passage in sheep &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://bse-atypical.blogspot.com/2010/11/increased-susceptibility-of-human-prp.html"&gt;http://bse-atypical.blogspot.com/2010/11/increased-susceptibility-of-human-prp.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, January 19, 2011&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;EFSA and ECDC review scientific evidence on possible links between TSEs in animals and humans Webnachricht 19 Januar 2011 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/01/efsa-and-ecdc-review-scientific.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/01/efsa-and-ecdc-review-scientific.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, June 27, 2011&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Comparison of Sheep Nor98 with Human Variably Protease-Sensitive Prionopathy and Gerstmann-Sträussler-Scheinker Disease&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://prionopathy.blogspot.com/2011/06/comparison-of-sheep-nor98-with-human.html"&gt;http://prionopathy.blogspot.com/2011/06/comparison-of-sheep-nor98-with-human.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Archive Number 20100312.0803 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Published Date 12-MAR-2010 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Subject PRO/AH/EDR; Scrapie, atypical, ovine - Australia: (WA) susp&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;SCRAPIE, ATYPICAL, OVINE - AUSTRALIA: (WESTERN AUSTRALIA) SUSPECTED&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;*******************************************************************&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;A ProMED-mail post&lt;br /&gt;&lt;br /&gt;ProMED-mail is a program of the International Society for Infectious Diseases&lt;br /&gt;&lt;br /&gt;[1] Date: Fri 12 Mar 2010 Source: The Australian [edited]&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;A West Australian sheep has been found to have signs characteristic of the fatal brain disease atypical scrapie. It comes as Australia faces growing anger from its trade partners over the Rudd government's surprise decision to extend a ban on the importation of beef from countries exposed to mad cow disease for a further 2 years.&lt;br /&gt;&lt;br /&gt;Australia's chief veterinarian, Andy Carroll, told the ABC an indicative case of the atypical scrapie had been confirmed but said it posed no risk to human or animal health or the safety of eating meat and animal products.&lt;br /&gt;&lt;br /&gt;Nor does atypical scrapie carry the dire trade consequences associated with classical scrapie.&lt;br /&gt;&lt;br /&gt;Classical scrapie is in the same transmissible spongiform encephalopathies (TSE) family as BSE, better known as mad cow disease, from which humans can be fatally infected.&lt;br /&gt;&lt;br /&gt;Dr Carroll said samples from the sheep's brain were being sent to the World Reference Laboratory in Britain.&lt;br /&gt;&lt;br /&gt;Neither atypical scrapie nor classical scrapie has been seen in Australia before, but a sheep in New Zealand tested positive to the atypical form last year [2009].&lt;br /&gt;&lt;br /&gt;Atypical scrapie is a relatively recently discovered disease and the common scientific view is that it occurs spontaneously or naturally in very small numbers of older sheep in countries all over the world.&lt;br /&gt;&lt;br /&gt;[Byline: Jodie Minus]&lt;br /&gt;&lt;br /&gt;-- Communicated by: Sabine Zentis Castleview Pedigree English Longhorns Gut Laach 52385 Nideggen Germany&lt;br /&gt;&lt;br /&gt;****** [2] Date: Wed 10 Mar 2010 Source: ABC News (Australian Broadcasting Corporation) [edited]&lt;br /&gt;&lt;br /&gt;Animal health authorities are testing a sheep's brain for what could be Australia's 1st case of the disease atypical scrapie.&lt;br /&gt;&lt;br /&gt;Although not confirmed, the sheep is thought to be from Western Australia.&lt;br /&gt;&lt;br /&gt;This type of scrapie is described as a sporadic degenerative brain condition affecting older sheep, and is not contagious.&lt;br /&gt;&lt;br /&gt;Ed Klim, from national advisory group SafeMeat, says a 2nd round of testing is now taking place. "We've been made aware that the Australian Animal Health Laboratory is conducting further routine testing on a sheep sample," he says.&lt;br /&gt;&lt;br /&gt;"The disease isn't considered a health risk nor should have any impact on food safety or export markets for sheep meat of live sheep."&lt;br /&gt;&lt;br /&gt;Australia's chief veterinarian and WA's Department of Agriculture of Food are both aware of the testing but will not comment.&lt;br /&gt;&lt;br /&gt;-- Communicated by: Terry S Singeltary Sr&lt;br /&gt;&lt;br /&gt;[Although atypical scrapie is not yet ruled out, it is important to realize this is a type of scrapie that thus far has only tended to appear as a sporadic condition in older animals. Currently it has not been shown to follow the same genetic tendencies for propagation as the usual scrapie.&lt;br /&gt;&lt;br /&gt;However, the atypical phenotypic appearance has been shown to be preserved on experimental passage.&lt;br /&gt;&lt;br /&gt;Atypical scrapie was first identified in Norwegian sheep in 1998 and has subsequently been identified in many countries, as Australia may join that list. It is likely that this case will be sent to the UK for definitive conformation.&lt;br /&gt;&lt;br /&gt;[Ref: M Simmons, T Konold, L Thurston, et al. BMC Veterinary Research 2010, 6:14 [provisional abstract available at ]&lt;br /&gt;&lt;br /&gt;"Background ----------- "Retrospective studies have identified cases predating the initial identification of this form of scrapie, and epidemiological studies have indicated that it does not conform to the behaviour of an infectious disease, giving rise to the hypothesis that it represents spontaneous disease. However, atypical scrapie isolates have been shown to be infectious experimentally, through intracerebral inoculation in transgenic mice and sheep. [Many of the neurological diseases can be transmitted by intracerebral inoculation, which causes this moderator to approach intracerebral studies as a tool for study, but not necessarily as a direct indication of transmissibility of natural diseases. - Mod.TG]&lt;br /&gt;&lt;br /&gt;"The 1st successful challenge of a sheep with 'field' atypical scrapie from an homologous donor sheep was reported in 2007.&lt;br /&gt;&lt;br /&gt;"Results -------- "This study demonstrates that atypical scrapie has distinct clinical, pathological, and biochemical characteristics which are maintained on transmission and sub-passage, and which are distinct from other strains of transmissible spongiform encephalopathies in the same host genotype.&lt;br /&gt;&lt;br /&gt;"Conclusions ------------ Atypical scrapie is consistently transmissible within AHQ homozygous sheep, and the disease phenotype is preserved on sub-passage."&lt;br /&gt;&lt;br /&gt;Lastly, this moderator wishes to thank Terry Singletary for some of his behind the scenes work of providing citations and references for this posting. - Mod.TG]&lt;br /&gt;&lt;br /&gt;The HealthMap/ProMED-mail interactive map of Australia is available at . - Sr.Tech.Ed.MJ]&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.promedmail.org/direct.php?id=20100312.0803"&gt;http://www.promedmail.org/direct.php?id=20100312.0803&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;UPDATE ATYPICAL SCRAPIE AUSTRALIA CONFIRMED &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;First occurrence of atypical scrapie&lt;br /&gt;&lt;br /&gt;Australia is free of scrapie, also known as ‘classical’ scrapie, and has been assessed as a ‘negligible bovine spongiform encephalopathy (BSE) risk’ (the lowest risk) by the World Organisation for Animal Health (OIE). Both diseases belong to a group of diseases termed transmissible spongiform encephalopathies (TSEs) or ‘prion diseases’.&lt;br /&gt;&lt;br /&gt;Active surveillance occurs to validate Australia’s status for both diseases, through the National Transmissible Spongiform Encephalopathies Surveillance Program (NTSESP), consistent with OIE recommendations. Results are routinely reported in Animal Health Surveillance Quarterly.&lt;br /&gt;&lt;br /&gt;The first case of atypical scrapie (another TSE) in Australia has been confirmed in a single sheep, through the NTSESP. This is not a surprising finding. Atypical scrapie is a rare, sporadic, degenerative brain condition that spontaneously occurs in a very small proportion of older sheep and, less commonly, in goats. Most countries that test large numbers of sheep for scrapie have found one or more cases of atypical scrapie.&lt;br /&gt;&lt;br /&gt;Testing on samples from the affected sheep at the CSIRO Australian Animal Health Laboratory in March 2010 showed preliminary results consistent with atypical scrapie. The results were confirmed by the Veterinary Laboratory Agencies at Weybridge in the United Kingdom, an OIE reference laboratory.&lt;br /&gt;&lt;br /&gt;Atypical scrapie is clinically, pathologically, biochemically and epidemiologically unrelated to classical scrapie, and has been recognised as a distinct disease of sheep and goats for about a decade. During this time, the disease has been diagnosed in more than 20 countries worldwide. It does not pose a risk to human health or to the productivity of the Australian sheep flock. There is evidence that it is not naturally spread to other animals. It is not known to have any causal relationship to other TSEs, including BSE in cattle, chronic wasting disease in deer, or any form of Creutzfeldt–Jakob disease in people.&lt;br /&gt;&lt;br /&gt;As atypical scrapie is a different disease to classical scrapie, Australia’s internationally recognised status as free from scrapie will not change as a result of this case. Contributed by Reg Butler, Biosecurity Services Group, Australian Government Department of Agriculture, Fisheries and Forestry &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.animalhealthaustralia.com.au/fms/Animal%20Health%20Australia/ADSP/AHSQ/AHSQ%20Q1%202010.pdf"&gt;http://www.animalhealthaustralia.com.au/fms/Animal%20Health%20Australia/ADSP/AHSQ/AHSQ%20Q1%202010.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Scrapie &lt;br /&gt;&lt;br /&gt;Scrapie has been recognised in sheep for more than 250 years, and occurs at a low annual incidence in many countries, but is not present in Australia or New Zealand.&lt;br /&gt;&lt;br /&gt;Atypical scrapie In 2009, atypical/Nor98 scrapie was detected in one sheep brain from a consignment of sheep and goat brains sent from New Zealand to the European Union, for use as negative control materials for evaluating rapid tests for BSE and scrapie.50 In 2010, a case of atypical/Nor98 scrapie was diagnosed in a sheep in Australia. &lt;br /&gt;&lt;br /&gt;Australian and New Zealand Standard Diagnostic Procedure, August 2010. Page 7 of 27 &lt;br /&gt;&lt;br /&gt;http://www.animalhealthaustralia.com.au/wp-content/uploads/2011/03/Australia-and-New-Zealand-Standard-Diagnostic-Protocols-for-TSE.pdf &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;The first case of atypical scrapie in Australia was recently detected through the active surveillance program for transmissible spongiform encephalopathies (TSEs). Atypical scrapie is a rare, degenerative brain condition that occurs spontaneously in a very small proportion of older sheep and goats. It is a different disease to classical scrapie and other known TSEs. Australia remains free from scrapie. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.animalhealthaustralia.com.au/wp-content/uploads/2011/05/AHSQ-Q1-2010.pdf"&gt;http://www.animalhealthaustralia.com.au/wp-content/uploads/2011/05/AHSQ-Q1-2010.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.animalhealthaustralia.com.au/"&gt;http://www.animalhealthaustralia.com.au/&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, October 7, 2010&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Australia first documented case of atypical scrapie confirmed First occurrence of atypical scrapie&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://nor-98.blogspot.com/2010/10/australia-first-documented-case-of.html"&gt;http://nor-98.blogspot.com/2010/10/australia-first-documented-case-of.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;RESEARCH&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 5, May 2011&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Experimental Oral Transmission of Atypical Scrapie to Sheep &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Marion M. Simmons, S. Jo Moore,1 Timm Konold, Lisa Thurston, Linda A. Terry, Leigh Thorne, Richard Lockey, Chris Vickery, Stephen A.C. Hawkins, Melanie J. Chaplin, and John Spiropoulos&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;To investigate the possibility of oral transmission of atypical scrapie in sheep and determine the distribution of infectivity in the animals’ peripheral tissues, we challenged neonatal lambs orally with atypical scrapie; they were then killed at 12 or 24 months. Screening test results were negative for disease-specifi c prion protein in all but 2 recipients; they had positive results for examination of brain, but negative for peripheral tissues. Infectivity of brain, distal ileum, and spleen from all animals was assessed in mouse bioassays; positive results were obtained from tissues that had negative results on screening. These fi ndings demonstrate that atypical scrapie can be transmitted orally and indicate that it has the potential for natural transmission and iatrogenic spread through animal feed. Detection of infectivity in tissues negative by current surveillance methods indicates that diagnostic sensitivity is suboptimal for atypical scrapie, and potentially infectious material may be able to pass into the human food chain.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;SNIP...&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Although we do not have epidemiologic evidence that supports the effi cient spread of disease in the fi eld, these data imply that disease is potentially transmissible under fi eld situations and that spread through animal feed may be possible if the current feed restrictions were to be relaxed. Additionally, almost no data are available on the potential for atypical scrapie to transmit to other food animal species, certainly by the oral route. However, work with transgenic mice has demonstrated the potential susceptibility of pigs, with the disturbing fi nding that the biochemical properties of the resulting PrPSc have changed on transmission (40). The implications of this observation for subsequent transmission and host target range are currently unknown.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;How reassuring is this absence of detectable PrPSc from a public health perspective? The bioassays performed in this study are not titrations, so the infectious load of the positive gut tissues cannot be quantifi ed, although infectivity has been shown unequivocally. No experimental data are currently available on the zoonotic potential of atypical scrapie, either through experimental challenge of humanized mice or any meaningful epidemiologic correlation with human forms of TSE. However, the detection of infectivity in the distal ileum of animals as young as 12 months, in which all the tissues tested were negative for PrPSc by the currently available screening and confi rmatory diagnostic tests, indicates that the diagnostic sensitivity of current surveillance methods is suboptimal for detecting atypical scrapie and that potentially infectious material may be able to pass into the human food chain undetected.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 5, May 2011&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://wwwnc.cdc.gov/eid/article/17/5/pdfs/10-1654.pdf"&gt;http://wwwnc.cdc.gov/eid/article/17/5/pdfs/10-1654.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;OIE Scrapie Chapter Revision • Current draft recognizes Nor98-like scrapie as a separate disease from classical scrapie • USDA provided comments on the draft to OIE&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.animalagriculture.org/Solutions/Proceedings/Annual%20Meeting/2009/Sheep%20&amp;amp;%20Goat/Myers,%20Thomas.pdf"&gt;http://www.animalagriculture.org/Solutions/Proceedings/Annual%20Meeting/2009/Sheep%20&amp;amp;%20Goat/Myers,%20Thomas.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Atypical scrapie/Nor 98 October 2009&lt;br /&gt;&lt;br /&gt;Last year, after examining member country submissions and investigating rigorous scientific research, the World Organisation for Animal Health (OIE) decided that Nor 98 should not be listed in its Terrestrial Animal Health Code. The Code sets out trade recommendations or restrictions for listed diseases or conditions, and the OIE determined there was no need for such recommendations around Nor 98.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nzfsa.govt.nz/publications/ce-column/ce-web-nor98.htm"&gt;http://www.nzfsa.govt.nz/publications/ce-column/ce-web-nor98.htm&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.biosecurity.govt.nz/files/pests/atypical-scrapie/atypical-scrapie-faq-oct09.pdf"&gt;http://www.biosecurity.govt.nz/files/pests/atypical-scrapie/atypical-scrapie-faq-oct09.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sutton reported that USDA has urged the World Organization for Animal Health (OIE) to categorize Nor98-like scrapie as a separate disease from classical scrapie. Currently, the OIE has proposed a draft revision of their scrapie chapter that would exclude Nor98-like scrapie from the chapter. USDA will be submitting it's comments on this proposal soon.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.ohiosheep.org/Events/ScrapieNewsletterMarch09.pdf"&gt;http://www.ohiosheep.org/Events/ScrapieNewsletterMarch09.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;SCRAPIE&lt;br /&gt;&lt;br /&gt;The United States is unable to support the proposed new draft Code Chapter on Scrapie. The draft chapter, as written, departs significantly from the existing chapter, is confusing and is difficult to understand. This version of the scrapie chapter uses much of the same wording as the BSE chapter and is written as if the predominance of evidence revealed that scrapie was a food-borne disease similar to BSE in cattle which is inappropriate. Moreover, several of the new changes are not supported by current scientific evidence. As a result, detailed comments on individual articles would not meaningful at this time.&lt;br /&gt;&lt;br /&gt;The United States is not supportive of the proposed draft chapter for the following reasons: 1. Inclusion of “atypical” scrapie: The scientific evidence indicates that “atypical” scrapie, also referred to as Nor-98, Nor-98-like, or non-classical scrapie, is not the same disease as classical scrapie. Further, “atypical” scrapie does not meet the criteria for listing diseases of trade concern by the OIE, as described in Chapter 2.1.1 of the Code. The United States recommends that the scope of this chapter be limited to classical scrapie in sheep and goats. Further, the United States recommends that OIE clearly adopt the position that “atypical” scrapie represents a distinct disease entity from classical scrapie and that it not be a listed disease.&lt;br /&gt;&lt;br /&gt;• There is no evidence that “atypical” scrapie is a contagious disease. If it is contagious, available evidence suggests that it has a much lower transmission efficiency. (Hopp, et al, 2006; Green, et al, 2007; Benestad, et al 2008; McIntyre, et al, 2008)&lt;br /&gt;&lt;br /&gt;• The disease appears to be ubiquitous in that it has been found wherever sufficient surveillance has been conducted. (Buschmann et al, 2004; De Bosschere et al, 2004; Orge, et al, 2004; Everest et al, 2006; Arsac, 2007; Benestad, et al 2008; Fediaevsky, et al, 2008)&lt;br /&gt;&lt;br /&gt;• The disease does not appear to be economically significant in that the prevalence of clinical disease is low and it typically occurs in older animals. (Luhken, et al., 2007; Benestad, et al 2008).&lt;br /&gt;&lt;br /&gt;• The disease is as likely as not to be the result of a spontaneous conversion of normal prion protein. (Benestad, et al 2008, De Bosschere et al 2007)&lt;br /&gt;&lt;br /&gt;• Removal of exposed sheep is unlikely to reduce the prevalence of “atypical” scrapie infection and removing only those exposed sheep that are phenylalanine (F) at codon 141 is scientifically unsound since the disease is known to affect sheep of most other genotypes. Further, sheep with AHQ alleles have a similar risk of infection with “atypical” strains as sheep with F at codon 141. (Luhken, et al., 2007).&lt;br /&gt;&lt;br /&gt;• If “atypical” scrapie is included as a listed disease, the surveillance and diagnostic requirements which are needed to identify these cases should be described in detail in both this Chapter and the Manual of Diagnostic Tests and Vaccines for Terrestrial&lt;br /&gt;&lt;br /&gt;2&lt;br /&gt;&lt;br /&gt;Animals. Data from Europe illustrates that using the proper test(s) is essential for the identification of atypical scrapie (Fediaevsky et al., 2008).&lt;br /&gt;&lt;br /&gt;SNIP...&lt;br /&gt;&lt;br /&gt;6. Overemphasis on importation and use of bovine meat and bone meal as a route of scrapie transmission: Given that the draft Chapter is not intended to address risk mitigation for BSE in small ruminants, we believe there is an over-emphasis on this potential route of transmission in the current draft.&lt;br /&gt;&lt;br /&gt;The United States recommends that the requirements in this chapter be limited to the inclusion of products from sheep and goats (instead of from all ruminants) in feed or feed ingredients intended for consumption by animals.&lt;br /&gt;&lt;br /&gt;• The use of products from sheep and goats as feed or feed ingredients for ruminant or non-ruminant animals represent one possible route of transmission (Philippe, et al, 2005) and a source of environmental contamination with the classical scrapie agent. However, this is not the primary route of transmission for the scrapie agent.&lt;br /&gt;&lt;br /&gt;• The need for the exclusion of cattle-derived protein or other animal protein to mitigate BSE risk should be based on a country’s BSE risk status and should be addressed in Chapter 2.3.13 of the Code.&lt;br /&gt;&lt;br /&gt;SNIP...&lt;br /&gt;&lt;br /&gt;14. Failure to provide scientific justification for the list of permitted commodities in Item 1 of Article 2.4.8.1. .&lt;br /&gt;&lt;br /&gt;We recommend that the list be re-evaluated and those items that have not been substantiated as presenting no risk be excluded or those with some risk but where the intended use mitigates the risk the use be specified.&lt;br /&gt;&lt;br /&gt;• There is no known human health risk associated with scrapie. As such, if meat and meat products for human consumption are included in this list, sheep and/or goat milk intended for human consumption should also be added to the list of permitted commodities in Item 1 of Article 2.4.8.1.&lt;br /&gt;&lt;br /&gt;• In the vast majority of sheep infected with classical scrapie, actual infectivity or PrPres has been identified in most tissues including the lymphoreticular system (tonsils, spleen, lymph nodes), the gastrointestinal tract, brain, and spinal cord (Hadlow et. al. 1979; Hadlow et al., 1980; van Kuelen et al., 1996; van Kuelen et al., 1999, Andreoletti et al., 2000; Heggebø et al., 2002; Caplazi et al., 2004). Infectivity and/or PrPres has also been identified in the placenta (see Hourrigan et al., 1979; Onodera et al., 1993; Pattison et al., 1972; Pattison et al., 1974; Race et al., 1998), blood (Hunter et al., 2002; Houston et al. 2008); peripheral nerves (Groschup et al., 1996), muscle (Pattison and Millson, 1962; Andreoletti et al., 2004; Casalone et al., 2005), salivary gland (Hadlow et al., 1980; Vascellari et al., 2007), kidney (Siso et al., 2006), and skin ( Thomzig et al., 2007). In addition, recent work has shown milk and/or colostrum from scrapie infected ewes transmitted the disease to 17 of 18 lambs (Konold et al., 2008).&lt;br /&gt;&lt;br /&gt;• The data on the risk of low protein tallow made from scrapie infected tissues particularly for use in milk replacer is limited and some epidemiologic studies suggest an association of milk replacer use with scrapie risk. Taylor et al., 1997 examined the inactivation capacity of different rendering system in regards to scrapie. The presence of infectivity was determined by bioassay into mice. From the onset of this study, it was assumed that tallow was not the vehicle for the transmission of TSE. Hence only 2 tallow samples were examined.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.aphis.usda.gov/import_export/animals/oie/downloads/tahc_mar-sep08/tahc-scrapie-77-mar08_cmt.pdf"&gt;http://www.aphis.usda.gov/import_export/animals/oie/downloads/tahc_mar-sep08/tahc-scrapie-77-mar08_cmt.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;• Most critical is that atypical scrapie shows higher prevalence in so-called resistant ARR homozygote and heterozygote genotypes, compared with classical scrapie. • Atypical scrapie has not been found naturally in VRQ/VRQ sheep, although such sheep can be infected artificially. VRQ sheep are, in contrast, highly susceptible to classical scrapie. In the UK, one case of atypical scrapie has been found in VRQ heterozygote (AF141RQ/VRQ) sheep. It is important to ascertain whether or not VRQ-carrying sheep are significantly resistant to infection with atypical scrapie or whether the data might result from a failure to detect PrPres in atypical scrapie due to a different pattern of PrP distribution in tissues. • Increased incidence of atypical scrapie in sheep with PrP alleles carrying the variant phenylalanine (F) at position 141 (leucine(L)/phenylalanine) has also been observed compared with classical scrapie. • It will be important to clarify the genotype effect, particularly in relation to ARR and L141F in transmission studies. • In classical scrapie, there is clear evidence for a PrP genotype effect on tissue distribution patterns of PrPres. This might also be true for atypical scrapie although the data are less complete. 4. Transmission of atypical scrapie It has recently18 been demonstrated that atypical scrapie is experimentally transmissible to mice and sheep, primarily through intracerebral injection. There are some data suggesting that it may also be transmissible orally to sheep of different genotypes. The subgroup noted that challenge experiments with atypical scrapie in sheep were underway in the UK, with one successful intracerebral challenge to date. The subgroup was informed that positive transmission of infectivity from atypical scrapie isolated from sheep with a range of genotypes had been observed in mice. This included ovinised transgenic mice overexpressing the VRQ allele. Nor98 atypical scrapie had also transmitted to ARR ovinised mice, with transmission experiments in AF141RQ ovinised mice planned. Biochemical features of the isolates were maintained after transmission, and were distinct from BSE and classical scrapie. High infectivity titres were observed in brain tissue from atypical scrapie, including from ARR/ARR sheep. Brain transmission experiments in mice carrying the human PrP gene were at an early stage. 18 Le Dur A., Béringue V., Andréoletti O., Reine F., Laï T.H., Baron T., Bratberg B., Vilotte J.- L., Sarradin P., Benestad S.L. and Laude H.(2005) A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. PNAS 102, 16031-16036&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.seac.gov.uk/pdf/positionstatement-sheep-subgroup.pdf"&gt;http://www.seac.gov.uk/pdf/positionstatement-sheep-subgroup.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;BSE: TIME TO TAKE H.B. PARRY SERIOUSLY&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;If the scrapie agent is generated from ovine DNA and thence causes disease in other species, then perhaps, bearing in mind the possible role of scrapie in CJD of humans (Davinpour et al, 1985), scrapie and not BSE should be the notifiable disease. ... &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://collections.europarchive.org/tna/20090505194948/http://bseinquiry.gov.uk/files/yb/1988/06/08004001.pdf"&gt;http://collections.europarchive.org/tna/20090505194948/http://bseinquiry.gov.uk/files/yb/1988/06/08004001.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Tuesday, February 14, 2012&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;White House budget proposes cuts to ag programs including TSE PRION disease aka mad cow type disease&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/white-house-budget-proposes-cuts-to-ag.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/white-house-budget-proposes-cuts-to-ag.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, February 16, 2012 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Bovine Spongiform Encephalopathy BSE &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;31 USA SENATORS ASK PRESIDENT OBAMA TO HELP SPREAD MAD COW DISEASE 2012 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/bovine-spongiform-encephalopathy-bse-31.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/bovine-spongiform-encephalopathy-bse-31.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, February 23, 2012 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;EIGHT FORMER SECRETARIES OF AGRICULTURE SPEAKING AT USDA'S 2012 AGRICULTURE OUTLOOK FORUM INDUCTED INTO USA MAD COW HALL OF SHAME &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://madcowusda.blogspot.com/2012/02/eight-former-secretaries-of-agriculture.html"&gt;http://madcowusda.blogspot.com/2012/02/eight-former-secretaries-of-agriculture.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, November 30, 2009&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;USDA AND OIE COLLABORATE TO EXCLUDE ATYPICAL SCRAPIE NOR-98 ANIMAL HEALTH CODE&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://nor-98.blogspot.com/2009/11/usda-and-oie-collaborate-to-exclude.html"&gt;http://nor-98.blogspot.com/2009/11/usda-and-oie-collaborate-to-exclude.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;TSS&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2560706674003621546-1749668615517378025?l=transmissiblespongiformencephalopathy.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://transmissiblespongiformencephalopathy.blogspot.com/feeds/1749668615517378025/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/atypical-scrapie-nor-98-confirmed.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/1749668615517378025'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/1749668615517378025'/><link rel='alternate' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/atypical-scrapie-nor-98-confirmed.html' title='Atypical Scrapie NOR-98 confirmed Alberta Canada sheep January 2012'/><author><name>Terry S. Singeltary Sr.</name><uri>http://www.blogger.com/profile/06986622967539963260</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='22' src='http://bp2.blogger.com/_gwMAfd8g9xo/SHuerfBUR1I/AAAAAAAAAAM/nNI1xcLm_Z4/S220/scan0002.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2560706674003621546.post-3785874962370200416</id><published>2012-02-19T19:47:00.000-08:00</published><updated>2012-02-19T19:52:43.680-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='CWD TSE PRION ZOONOSIS ENVIRONMENT'/><title type='text'>CDC REPORT ON Occurrence, Transmission, and Zoonotic Potential of Chronic Wasting Disease CWD North America</title><content type='html'>***CDC REPORT ON CWD*** &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Saturday, February 18, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Occurrence, Transmission, and Zoonotic Potential of Chronic Wasting Disease  &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;CDC Volume 18, Number 3—March 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/occurrence-transmission-and-zoonotic.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/occurrence-transmission-and-zoonotic.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;50 GAME FARMS IN USA INFECTED WITH CHRONIC WASTING DISEASE CWD &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Tuesday, December 20, 2011 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;CHRONIC WASTING DISEASE CWD WISCONSIN Almond Deer (Buckhorn Flats) Farm  Update DECEMBER 2011 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&amp;gt;&amp;gt;&amp;gt; The CWD infection rate was nearly 80%, the highest ever in a  North American captive herd. &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Despite the five year premise plan and site decontamination, The WI DNR has  concerns over the bioavailability of infectious prions at this site to wild  white-tail deer should these fences be removed. Current research indicates that  prions can persist in soil for a minimum of 3 years. &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;However, Georgsson et al. (2006) concluded that prions that produced  scrapie disease in sheep remained bioavailable and infectious for at least 16  years in natural Icelandic environments, most likely in contaminated soil.  &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Additionally, the authors reported that from 1978-2004, scrapie recurred on  33 sheep farms, of which 9 recurrences occurred 14-21 years after initial  culling and subsequent restocking efforts; these findings further emphasize the  effect of environmental contamination on sustaining TSE infectivity and that  long-term persistence of prions in soils may be substantially greater than  previously thought. &amp;lt;&amp;lt;&amp;lt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://dnr.wi.gov/org/nrboard/2011/december/12-11-2b2.pdf"&gt;http://dnr.wi.gov/org/nrboard/2011/december/12-11-2b2.pdf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;SNIP...SEE FULL TEXT ; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2011/12/chronic-wasting-disease-cwd-wisconsin.html"&gt;http://chronic-wasting-disease.blogspot.com/2011/12/chronic-wasting-disease-cwd-wisconsin.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thursday, February 09, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;50 GAME FARMS IN USA INFECTED WITH CHRONIC WASTING DISEASE &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/50-game-farms-to-date-in-usa-infected.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/50-game-farms-to-date-in-usa-infected.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Friday, February 03, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Wisconsin Farm-Raised Deer Farms and CWD there from 2012 report Singeltary  et al &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-farm-raised-deer-farms-and.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-farm-raised-deer-farms-and.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Saturday, February 04, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Wisconsin 16 age limit on testing dead deer Game Farm CWD Testing Protocol  Needs To Be Revised &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-16-age-limit-on-testing-dead.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-16-age-limit-on-testing-dead.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thursday, February 09, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Colorado Farm-Raised Deer Farms and CWD there from 2012 report Singeltary  et al &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/colorado-farm-raised-deer-farms-and-cwd.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/colorado-farm-raised-deer-farms-and-cwd.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Tuesday, February 14, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Oppose Indiana House Bill 1265 game farming cervids &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/oppose-indiana-house-bill-1265-game.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/oppose-indiana-house-bill-1265-game.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Monday, February 13, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Stop White-tailed Deer Farming from Destroying Tennessee's Priceless Wild  Deer Herd oppose HB3164 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/stop-white-tailed-deer-farming-from.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/stop-white-tailed-deer-farming-from.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Wednesday, February 15, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;West Virginia Deer Farming Bill backed by deer farmers advances, why ? BE  WARNED CWD &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/west-virginia-deer-farming-bill-backed.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/west-virginia-deer-farming-bill-backed.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sunday, January 22, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Chronic Wasting Disease CWD cervids interspecies transmission &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: black;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/01/chronic-wasting-disease-cwd-cervids.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/01/chronic-wasting-disease-cwd-cervids.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Tuesday, February 14, 2012&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;White House budget proposes cuts to ag programs including TSE PRION disease  aka mad cow type disease &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/white-house-budget-proposes-cuts-to-ag.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/white-house-budget-proposes-cuts-to-ag.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thursday, February 16, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Bovine Spongiform Encephalopathy BSE &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;31 USA SENATORS ASK PRESIDENT OBAMA TO HELP SPREAD MAD COW DISEASE 2012  &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/bovine-spongiform-encephalopathy-bse-31.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/bovine-spongiform-encephalopathy-bse-31.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Africa in Texas&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;January 29, 2012 7:09 PM &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Can hunting endangered animals save the species?&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.cbsnews.com/video/watch/?id=7396832n&amp;amp;tag=contentMain;contentBody" title="http://www.cbsnews.com/video/watch/?id=7396832n&amp;amp;tag=contentMain;contentBody"&gt;http://www.cbsnews.com/video/watch/?id=7396832n&amp;amp;tag=contentMain;contentBody&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Lunacy is a kind word. conservation, sustaining a species is one thing,  saving a species, to hunt it as high dollar exotics, that’s not conservation. if  it makes you fell good, call it what you want. I weep. I’m sure God did not want  man to muck up the world so bad, calling it progress, while bringing species  after species to extinction, then pooling what’s left over in game farms and  calling it ‘exotic hunting’ for high dollar price $$$, and then calling it  conservation. call me stupid, I call it the end as we once knew it. I  weep.&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;with kind regards,&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;I am sincerely,&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Terry S. Singeltary Sr.&lt;/div&gt;&lt;br /&gt;&lt;div&gt;P.O. Box 42&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Bacliff, Texas USA 77518&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="wlmailhtml:{DF7DDD7C-C70A-41E4-A8B1-D5D27F4F623C}mid://00000676/!x-usc:mailto:flounder9@verizon.net"&gt;flounder9@verizon.net&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2560706674003621546-3785874962370200416?l=transmissiblespongiformencephalopathy.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://transmissiblespongiformencephalopathy.blogspot.com/feeds/3785874962370200416/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/cdc-report-on-occurrence-transmission.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/3785874962370200416'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/3785874962370200416'/><link rel='alternate' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/cdc-report-on-occurrence-transmission.html' title='CDC REPORT ON Occurrence, Transmission, and Zoonotic Potential of Chronic Wasting Disease CWD North America'/><author><name>Terry S. Singeltary Sr.</name><uri>http://www.blogger.com/profile/06986622967539963260</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='22' src='http://bp2.blogger.com/_gwMAfd8g9xo/SHuerfBUR1I/AAAAAAAAAAM/nNI1xcLm_Z4/S220/scan0002.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2560706674003621546.post-1172496982439922272</id><published>2012-02-16T09:31:00.000-08:00</published><updated>2012-02-16T11:35:14.310-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Bovine Spongiform Encephalopathy BSE 31 USA SENATORS ASK PRESIDENT OBAMA TO HELP SPREAD MAD COW DISEASE 2012'/><title type='text'>Bovine Spongiform Encephalopathy BSE 31 USA SENATORS ASK PRESIDENT OBAMA TO HELP SPREAD MAD COW DISEASE 2012</title><content type='html'>Bovine Spongiform Encephalopathy BSE 31 USA SENATORS ASK PRESIDENT OBAMA TO HELP SPREAD MAD COW DISEASE 2012 &lt;br /&gt;&lt;br /&gt;A bipartisan group of 31 senators are asking the Obama administration to move along with a comprehensive rule that would loosen restrictions on imported beef and, they contend, facilitate better trade opportunities... &lt;br /&gt;&lt;br /&gt;USDA OIE GBR MRR $$$ &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sens. Charles Grassley (R-Iowa) and Ben Nelson (D-Neb.) et al ; &lt;br /&gt;&lt;br /&gt;UNITED STATES SENATE &lt;br /&gt;&lt;br /&gt;WASHINGTON, DC 20510 &lt;br /&gt;&lt;br /&gt;February 13,2012 &lt;br /&gt;&lt;br /&gt;The Honorable Jeffrey Zients &lt;br /&gt;&lt;br /&gt;Acting Director &lt;br /&gt;&lt;br /&gt;Office of Management and Budget &lt;br /&gt;&lt;br /&gt;725 1 ill Street, NW &lt;br /&gt;&lt;br /&gt;Washington, D.C. 20503 &lt;br /&gt;&lt;br /&gt;Dr. Gregory Parham &lt;br /&gt;&lt;br /&gt;Administrator &lt;br /&gt;&lt;br /&gt;Animal Plant Health and Inspection Services &lt;br /&gt;&lt;br /&gt;U.S. Department of Agriculture &lt;br /&gt;&lt;br /&gt;1400 Independence Ave., SW &lt;br /&gt;&lt;br /&gt;Washington, D.C. 20250 &lt;br /&gt;&lt;br /&gt;Dear Acting Director Zients and Administrator Parham: &lt;br /&gt;&lt;br /&gt;On behalf of America's beef producers, we urge you to move forward and publish the comprehensive rule for BSE (bovine spongiform encephalopathy). Non-tariff trade barriers limit our ability to sell U.S. beef to consumers in other countries. Beef producers need our trade negotiators to significantly reduce or eliminate non-tariff trade barriers by requiring our trading partners to make science-based decisions regarding U.S. beef. By the same logic, it is also important for our government to take the necessary steps to properly address risks related to BSE by adopting a comprehensive rule. For the benefit of U.S. beef producers, APHIS and OMB must issue a comprehensive BSE rule as soon as possible. &lt;br /&gt;&lt;br /&gt;A prime example of where non-science based standards have significantly limited our ability to sell U.S. beef is in the country of Mexico. Since 2004, Mexico has not allowed the importation of U.S. cattle that are over 30 months of age. Mexico has traditionally been one of the top export markets for U.S. beef; however due to the 30 month age restriction, it is estimated U.S. beef producers are losing $100 million annually. &lt;br /&gt;&lt;br /&gt;The World Organization for Animal Health (OIE) has formally classified the United States and Mexico as controlled risk countries. According to the OIE's guidelines on BSE, this common classification reflects the fact that both countries have effective BSE risk mitigation measures in place. Moreover, the OIE guidelines establish that beef and beef products from cattle of all ages in either country can be safely traded and consumed once specified risk materials have been properly removed. &lt;br /&gt;&lt;br /&gt;The failure of Mexico to abide by the international guidelines on BSE represents a lost opportunity on at least two levels. First, it unduly restricts U.S. beef exports and results in ongoing financial losses for U.S. beef producers. Beyond its immediate commercial impact, Mexico's treatment of U.S. beef also has implications on our ability to negotiate beef market access agreements with other nations. &lt;br /&gt;&lt;br /&gt;By having a comprehensive BSE rule in place, the U.S. will show leadership on the global scale and will give USTR and USDA a stronger position to press other nations to follow the OIE's guidelines and adopt science-based BSE policies. As a result, when nations base their decisions on sound science, we are confident more markets will be expanded or opened to U.S. beef. &lt;br /&gt;&lt;br /&gt;In 2004, USDA announced its plans for developing a comprehensive BSE rule, a comprehensive rule the U.S. beef industry has requested for many years. Earlier this year, APHIS submitted a proposed comprehensive BSE rule to OMB, but it has yet to be printed in the "Federal Register" asking for public comment. During a June 23,2011 hearing on livestock before the Senate Committee on Agriculture, Nutrition, and Forestry, Administrator Parham stated he expected the comprehensive BSE rule to be released sometime in FY2012. &lt;br /&gt;&lt;br /&gt;We appreciate Administrator Parham's commitment; however, there is a lot of time left in fiscal year 2012. We urge you to release the rule as soon as possible. The sooner the rule is allowed to move through the required rule-making process, the sooner we will be able to give our international negotiators this important tool for pushing our trading partners to adopt similar science-based approaches. &lt;br /&gt;&lt;br /&gt;We appreciate your attention to this important matter. &lt;br /&gt;&lt;br /&gt;Sincerely, &lt;br /&gt;&lt;br /&gt;Sens. Charles Grassley (R-Iowa) and Ben Nelson (D-Neb. &lt;br /&gt;&lt;br /&gt;and &lt;br /&gt;&lt;br /&gt;A bipartisan group of 31 senators are asking the Obama administration to move along with a comprehensive rule that would loosen restrictions on imported beef and, they contend, facilitate better trade opportunities... &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.grassley.senate.gov/news/upload/Agriculture-Trade-02-14-12-BSE-Letter-with-Nelson.pdf"&gt;http://www.grassley.senate.gov/news/upload/Agriculture-Trade-02-14-12-BSE-Letter-with-Nelson.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;McCaskill: Lift Limits on U.S. Beef Exports &lt;br /&gt;&lt;br /&gt;USAgNet - 02/15/2012 &lt;br /&gt;&lt;br /&gt;U.S. Senator Claire McCaskill is urging the U.S. Department of Agriculture (USDA) to finally move forward and establish a rule that will pave the way for increased exports of U.S. beef products.&lt;br /&gt;&lt;br /&gt;In a letter on behalf of America's beef producers, McCaskill--along with Senators Chuck Grassley (R-Ia.) and Ben Nelson (D-Neb.)--asked the USDA to move forward and publish the long-awaited comprehensive rule for Bovine Spongiform Encephalopathy (BSE), commonly referred to as "Mad-Cow Disease." The rule is expected to enhance the ability of U.S. beef producers to access foreign export markets for their products.&lt;br /&gt;&lt;br /&gt;In current trade negotiations, beef producers have urged compliance with the science-based International Organization for Animal Health guidelines on BSE. However, the U.S. has yet to adopt a comprehensive rule that would allow producers to look for opportunities to expand overseas, and also allow the government to take necessary steps to properly address risks related to BSE.&lt;br /&gt;&lt;br /&gt;The Senators also reiterated that by adding a science-based comprehensive BSE rule, the U.S. would show leadership and put the USDA in a stronger position to press other nations to follow the guidelines from the International Organization for Animal Health and adopt similar policies. When other countries make science-based decisions, they are far more likely to expand or open their markets to U.S. beef, enhancing the industry's competitive position in global markets.&lt;br /&gt;&lt;br /&gt;In 2004, the USDA announced its plans to develop a comprehensive BSE rule at the request of the U.S. beef industry. Despite promises from the USDA that the rule would be released for FY2012, no rule has yet been released. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.usagnet.com/story-national.php?Id=360&amp;amp;yr=2012"&gt;http://www.usagnet.com/story-national.php?Id=360&amp;amp;yr=2012&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;WHAT a bunch of hipocrits i.e. Washington. for almost 25 years, the USDA, OIE,  et al, went by the OIE guidelines like they were something Biblical, wrote on  stone tablets, even though every country that went by these terribly flawed BSE  TSE Prion OIE USDA et al industry friendly regulations, every country that went  by these flawed OIE USDA guidelines all went down with BSE TSE prion disease.  these Biblical tablets that the OIE and USDA went by, the mad cow surveillance  tablets claim that testing 400 animals out of about 1,000,000 animals, is good  enough for them to find said disease i.e. TSE PRION mad cow type disease. really  ? it does not get any better than this when it comes to a totally flawed and  corrupt system. has been for decades. red, white, right, left, republican, or  democrat, they all have a hand in this corporate corruption, i.e. BSe, bull sh!t  encephalopathy, i.e. corporate and political science $$$ just because the  incubation period is long, not enough _DOCUMENTED_ body bags, sporadic CJD, TSE,  Prion disease victims are expendable, for trade. now if it were a fast acting  disease like e-coli, listeria or any other fast acting fatal disease, things  would be different. but our best bet now, is to die from something else before  the TSE prion disease get’s us. because if your not a teenager, and a TSE prion  disease kills you, even though now science has linked up sporadic CJD with  atypical BSE and atypical Scrapie, both of which are here in the USA, it just  not matter, politics and industry have made you expendable, and even all those  that are exposed and die from friendly fire there from i.e. iatrogenic CJD.  because all that is is sporadic CJD, until source is proven. there ya go. keep  it all sporadic CJD. problem solved. we have all been exposed one way or the  other. only by Gods grace have we not all gone clinical. continue to roll the  dice, as these TSE prion disease mutates, they become more virulent, continue to  roll the dice, it might not be so pretty. times catching up, the TSE prion  disease have mutating. the cover up continues i.e. sporadic FFI and sporadic  GSS, and &lt;span style="font-family: Times New Roman;"&gt;VPSPr &lt;/span&gt;type BSe. continue to ignore  the science, continue to roll the dice, just for trade, God will make the  ultimate decision, and God, or whom ever you worship, are neither red nor blue.  &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sadly, once again, sound science will NOT play a part in any sound policy decision making in matters relating to Bovine Spongiform Encephalopathy BSE either typical or atypical. YOU can thank the OIE and the USDA for doing away with sound science long ago, with the BSE MRR policy, when they bypassed the BSE GBR for each country. It was a legal tool to make TSE prion disease a legal trading commodity, and they did just that with atypical TSE, which is now a legal trading commodity thanks to the OIE USDA BSE MRR i.e. minimal risk region. the USDA, FSIS, APHIS, FDA, have all failed terribly with the surveillance and eradication efforts of all strains of the TSE Prion disease in livestock and wild animals. BSE mad cow type disease and countries there from were all banned from the USA, until the USA accidently ran across and had to document 3 cases of mad cow disease. Texas successfully covered up one case of mad cow disease, and almost cover-up a second case, if not for the OIG and the Honorable Phyllis Fong. That Texas mad cow sat on a shelf and not tested for 7 months, so the BSE MRR policy could get set in place and ratified. it’s all about money folks, human and animal health went out the door long ago $$$ &lt;br /&gt;&lt;br /&gt;science has now linked atypical BSE and atypical Scrapie to some cases of sporadic CJD in humans, also, TSE Prion scientist around the globe are very concerned about the potential for CWD in deer and elk to be a zoonosis disease, especially now since mutating into a second strain, documented, to date, i.e. the Wisconsin CWD strain. All of these TSEs have been documented in North America, traded between Mexico, USA, and Canada, like two lovers swapping spit. all these TSE prion disease in different species have been rendered up and fed to food producing animals for humans and livestock for over a decade (please see 2012 BSE mad cow feed ban report below), the August 4, 1997 partial and voluntary mad cow feed ban was nothing but ink on paper, where some 10,000,000 MILLION POUNDS OF BLOOD LACED MEAD AND BONE MEAL went out into commerce, to be fed out, as late as one decade, post partial and voluntary mad cow feed ban, as late as 2007. &lt;br /&gt;&lt;br /&gt;ALL the USA has done, with this BSE MRR minimal risk region was what the U.K. did when they poisoned the globe, except now it’s been made legal with the BSE MRR policy. &lt;br /&gt;&lt;br /&gt;WHAT these senators are asking, is to just throw in the towel, the TSE Prion disease have one, let’s just trade them now around the globe. &lt;br /&gt;&lt;br /&gt;THAT SHOULD NOT BE ACCEPTABLE, under any circumstances $$$ &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Geographical BSE risk assessment and its impact on disease detection and dissemination &lt;br /&gt;&lt;br /&gt;Original Research Article&lt;br /&gt;&lt;br /&gt;Preventive Veterinary Medicine, Available online 1 February 2012, &lt;br /&gt;&lt;br /&gt;Mo Salman, Vittorio Silano, Dagmar Heim, Joachim Kreysa &lt;br /&gt;&lt;br /&gt;Preventive Veterinary Medicine&lt;br /&gt;&lt;br /&gt;1 February 2012 &lt;br /&gt;&lt;br /&gt;Geographical BSE risk assessment and its impact on disease detection and dissemination&lt;br /&gt;&lt;br /&gt;Salman M, Silano V, Heim D, Kreysa J.&lt;br /&gt;&lt;br /&gt;Source&lt;br /&gt;&lt;br /&gt;Campus Stop 1644, Animal Population Health Institute, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1644, USA. &lt;br /&gt;&lt;br /&gt;Abstract &lt;br /&gt;&lt;br /&gt;Bovine Spongiform Encephalopathy (BSE) rapidly evolved into an issue of major public concern particularly when, in 1996, evidence was provided that this disease had crossed the species barrier and infected humans in the UK with what has become known as "variant Creutzfeldt Jakob Disease" (vCJD). The aim of this paper is to describe the European Geographical BSE risk assessment (GBR) that was successfully used for assessing the qualitative likelihood that BSE could be present in a country where it was not yet officially recognized. It also discusses how this can lead to risk-based and therefore preventive management of BSE at national and international levels. The basic assumption of the GBR method is that the BSE agent is initially introduced into a country's domestic cattle production system through the importation of contaminated feedstuffs or live cattle. This is referred to as an "external challenge". The ability of the system to cope with such a challenge is, in turn, referred to as its "stability": a stable system will not allow the BSE agent to propagate and amplify following its introduction, while an unstable system will. The BSE-status of a country assessed by this system was used by the European Commission as the basis for trade legislation rules for cattle and their products. The GBR was an invaluable tool in evaluating the potential global spread of BSE as it demonstrated how a disease could be transferred through international trade. This was shown to be a critical factor to address in reducing the spread and amplification of BSE throughout the world. Furthermore, GBR resulted in the implementation of additional measures and management activities both to improve surveillance and to prevent transmission within the cattle population. &lt;br /&gt;&lt;br /&gt;Copyright © 2012 Elsevier B.V. All rights reserved. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.sciencedirect.com/science/article/pii/S0167587712000244"&gt;http://www.sciencedirect.com/science/article/pii/S0167587712000244&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, October 10, 2011 &lt;br /&gt;&lt;br /&gt;EFSA Journal 2011 The European Response to BSE: A Success Story &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;EFSA and the European Centre for Disease Prevention and Control (ECDC) recently delivered a scientific opinion on any possible epidemiological or molecular association between TSEs in animals and humans (EFSA Panel on Biological Hazards (BIOHAZ) and ECDC, 2011). This opinion confirmed Classical BSE prions as the only TSE agents demonstrated to be zoonotic so far but the possibility that a small proportion of human cases so far classified as "sporadic" CJD are of zoonotic origin could not be excluded. Moreover, transmission experiments to non-human primates suggest that some TSE agents in addition to Classical BSE prions in cattle (namely L-type Atypical BSE, Classical BSE in sheep, transmissible mink encephalopathy (TME) and chronic wasting disease (CWD) agents) might have zoonotic potential. &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1"&gt;http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf"&gt;http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;see follow-up here about North America BSE Mad Cow TSE prion risk factors, and the ever emerging strains of Transmissible Spongiform Encephalopathy in many species here in the USA, including humans ; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, August 12, 2010 &lt;br /&gt;&lt;br /&gt;Seven main threats for the future linked to prions &lt;br /&gt;&lt;br /&gt;First threat &lt;br /&gt;&lt;br /&gt;The TSE road map defining the evolution of European policy for protection against prion diseases is based on a certain numbers of hypotheses some of which may turn out to be erroneous. In particular, a form of BSE (called atypical Bovine Spongiform Encephalopathy), recently identified by systematic testing in aged cattle without clinical signs, may be the origin of classical BSE and thus potentially constitute a reservoir, which may be impossible to eradicate if a sporadic origin is confirmed. &lt;br /&gt;&lt;br /&gt;***Also, a link is suspected between atypical BSE and some apparently sporadic cases of Creutzfeldt-Jakob disease in humans. These atypical BSE cases constitute an unforeseen first threat that could sharply modify the European approach to prion diseases. &lt;br /&gt;&lt;br /&gt;Second threat &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.neuroprion.org/en/np-neuroprion.html"&gt;http://www.neuroprion.org/en/np-neuroprion.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Rural and Regional Affairs and Transport References Committee&lt;br /&gt;&lt;br /&gt;The possible impacts and consequences for public health, trade and agriculture of the Government's decision to relax import restrictions on beef Final report June 2010&lt;br /&gt;&lt;br /&gt;2.65 At its hearing on 14 May 2010, the committee heard evidence from Dr Alan Fahey who has recently submitted a thesis on the clinical neuropsychiatric, epidemiological and diagnostic features of Creutzfeldt-Jakob disease.48 Dr Fahey told the committee of his concerns regarding the lengthy incubation period for transmissible spongiform encephalopathies, the inadequacy of current tests and the limited nature of our current understanding of this group of diseases.49&lt;br /&gt;&lt;br /&gt;2.66 Dr Fahey also told the committee that in the last two years a link has been established between forms of atypical CJD and atypical BSE. Dr Fahey said that: They now believe that those atypical BSEs overseas are in fact causing sporadic Creutzfeldt-Jakob disease. They were not sure if it was due to mad sheep disease or a different form. If you look in the textbooks it looks like this is just arising by itself. But in my research I have a summary of a document which states that there has never been any proof that sporadic Creutzfeldt-Jakob disease has arisen de novo-has arisen of itself. There is no proof of that. The recent research is that in fact it is due to atypical forms of mad cow disease which have been found across Europe, have been found in America and have been found in Asia. These atypical forms of mad cow disease typically have even longer incubation periods than the classical mad cow disease.50 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.aph.gov.au/senate/committee/rrat_ctte/mad_cows/report/report.pdf"&gt;http://www.aph.gov.au/senate/committee/rrat_ctte/mad_cows/report/report.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Atypical BSE in Cattle &lt;br /&gt;&lt;br /&gt;To date the OIE/WAHO assumes that the human and animal health standards set out in the BSE chapter for classical BSE (C-Type) applies to all forms of BSE which include the H-type and L-type atypical forms. This assumption is scientifically not completely justified and accumulating evidence suggests that this may in fact not be the case. Molecular characterization and the spatial distribution pattern of histopathologic lesions and immunohistochemistry (IHC) signals are used to identify and characterize atypical BSE. Both the L-type and H-type atypical cases display significant differences in the conformation and spatial accumulation of the disease associated prion protein (PrPSc) in brains of afflicted cattle. Transmission studies in bovine transgenic and wild type mouse models support that the atypical BSE types might be unique strains because they have different incubation times and lesion profiles when compared to C-type BSE. When L-type BSE was inoculated into ovine transgenic mice and Syrian hamster the resulting molecular fingerprint had changed, either in the first or a subsequent passage, from L-type into C-type BSE. &lt;br /&gt;&lt;br /&gt;In addition, non-human primates are specifically susceptible for atypical BSE as demonstrated by an approximately 50% shortened incubation time for L-type BSE as compared to C-type. Considering the current scientific information available, it cannot be assumed that these different BSE types pose the same human health risks as C-type BSE or that these risks are mitigated by the same protective measures. &lt;br /&gt;&lt;br /&gt;This study will contribute to a correct definition of specified risk material (SRM) in atypical BSE. The incumbent of this position will develop new and transfer existing, ultra-sensitive methods for the detection of atypical BSE in tissue of experimentally infected cattle. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2"&gt;http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;When L-type BSE was inoculated into ovine transgenic mice and Syrian hamster the resulting molecular fingerprint had changed, either in the first or a subsequent passage, from L-type into C-type BSE. In addition, non-human primates are specifically susceptible for atypical BSE as demonstrated by an approximately 50% shortened incubation time for L-type BSE as compared to C-type. Considering the current scientific information available, it cannot be assumed that these different BSE types pose the same human health risks as C-type BSE or that these risks are mitigated by the same protective measures. &lt;br /&gt;&lt;br /&gt;This study will contribute to a correct definition of specified risk material (SRM) in atypical BSE. The incumbent of this position will develop new and transfer existing, ultra-sensitive methods for the detection of atypical BSE in tissue of experimentally infected cattle. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2"&gt;http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;The conclusions state that, at present, the only TSE agent demonstrated to be zoonotic is the classical BSE agent. Active screening has allowed the identification of 3 new forms of animal TSEs (H-type atypical BSE, L-type atypical BSE, and atypical scrapie), but the information obtained has major limitations due to the unknown sensitivity of the current monitoring system for these TSEs. There is no epidemiological evidence to suggest that classical scrapie is zoonotic. The epidemiological data are too limited to conclude whether the atypical scrapie agent has a zoonotic potential. Transmission experiments to human PrP transgenic mice or primates suggest that some TSE agents other than the classical BSE agent in cattle (namely L-type atypical BSE, classical BSE in sheep, TME, CWD agents) might have zoonotic potential and indicate that that of the L-type atypical BSE agent appears similar or even higher than that of the classical BSE agent. A single study reported efficient transmission of a natural sheep classical scrapie isolate to primates. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.promedmail.org/direct.php?id=20110607.1736"&gt;http://www.promedmail.org/direct.php?id=20110607.1736&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, January 18, 2012&lt;br /&gt;&lt;br /&gt;BSE IN GOATS CAN BE MISTAKEN FOR SCRAPIE &lt;br /&gt;&lt;br /&gt;February 1, 2012 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/bse-in-goats-can-be-mistaken-for.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/bse-in-goats-can-be-mistaken-for.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Owens, Julie&lt;br /&gt;&lt;br /&gt;From: Terry S. Singeltary Sr. [flounder9@verizon.net]&lt;br /&gt;&lt;br /&gt;Sent: Monday, July 24, 2006 1:09 PM&lt;br /&gt;&lt;br /&gt;To: FSIS RegulationsComments&lt;br /&gt;&lt;br /&gt;Subject: [Docket No. FSIS-2006-0011] FSIS Harvard Risk Assessment of Bovine Spongiform Encephalopathy (BSE)&lt;br /&gt;&lt;br /&gt;Page 1 of 98 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/OPPDE/Comments/2006-0011/2006-0011-1.pdf"&gt;http://www.fsis.usda.gov/OPPDE/Comments/2006-0011/2006-0011-1.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;FSIS RFEPLY TO TSS ; &lt;br /&gt;&lt;br /&gt;Harvard Risk Assessment of Bovine Spongiform Encephalopathy Update, October 31, 2005 INTRODUCTION The United States Department of Agriculture’s Food Safety and Inspection Service (FSIS) held a public meeting on July 25, 2006 in Washington, D.C. to present findings from the Harvard Risk Assessment of Bovine Spongiform Encephalopathy Update, October 31, 2005 (report and model located on the FSIS website: &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/Science/Risk_Assessments/index.asp"&gt;http://www.fsis.usda.gov/Science/Risk_Assessments/index.asp&lt;/a&gt;). &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Comments on technical aspects of the risk assessment were then submitted to FSIS. &lt;br /&gt;&lt;br /&gt;Comments were received from Food and Water Watch, Food Animal Concerns Trust (FACT), Farm Sanctuary, R-CALF USA, Linda A Detwiler, and Terry S. Singeltary. &lt;br /&gt;&lt;br /&gt;This document provides itemized replies to the public comments received on the 2005 updated Harvard BSE risk assessment. Please bear the following points in mind: &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/PDF/BSE_Risk_Assess_Response_Public_Comments.pdf"&gt;http://www.fsis.usda.gov/PDF/BSE_Risk_Assess_Response_Public_Comments.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;The most recent assessments (and reassessments) were published in June 2005 (Table I; 18), and included the categorisation of Canada, the USA, and Mexico as GBR III. Although only Canada and the USA have reported cases, the historically open system of trade in North America suggests that it is likely that BSE is present also in Mexico. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.oie.int/boutique/extrait/06heim937950.pdf"&gt;http://www.oie.int/boutique/extrait/06heim937950.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, February 08, 2012 &lt;br /&gt;&lt;br /&gt;Scrapie, Israel via OIE 02/02/2012 &lt;br /&gt;&lt;br /&gt;From: Terry S. Singeltary Sr. &lt;br /&gt;&lt;br /&gt;Sent: Wednesday, February 08, 2012 10:28 AM &lt;br /&gt;&lt;br /&gt;To: BSE-L BSE-L &lt;br /&gt;&lt;br /&gt;Cc: hmb-central@icba.org.il ; delegation-israel@eeas.europa.eu ; Cvo_vsah@moag.gov.il ; galonn@moag.gov.il ; CJDVOICE CJDVOICE ; bloodcjd bloodcjd &lt;br /&gt;&lt;br /&gt;Subject: Scrapie, Israel via OIE 02/02/2012 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://scrapie-usa.blogspot.com/2012/02/scrapie-israel-via-oie-02022012.html"&gt;http://scrapie-usa.blogspot.com/2012/02/scrapie-israel-via-oie-02022012.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, May 25, 2011 &lt;br /&gt;&lt;br /&gt;O.I.E. Terrestrial Animal Health Standards Commission and prion (TSE) disease reporting 2011 &lt;br /&gt;&lt;br /&gt;----- Original Message ----- &lt;br /&gt;&lt;br /&gt;From: Terry S. Singeltary Sr. &lt;br /&gt;&lt;br /&gt;To: BSE-L@LISTS.AEGEE.ORG &lt;br /&gt;&lt;br /&gt;Cc: trade@oie.int ; oie@oie.int ; f.diaz@oie.int ; scientific.dept@oie.int ; cjdvoice@yahoogroups.com ; BLOODCJD@YAHOOGROUPS.COM &lt;br /&gt;&lt;br /&gt;Sent: Tuesday, May 24, 2011 2:24 PM &lt;br /&gt;&lt;br /&gt;Subject: O.I.E. Terrestrial Animal Health Standards Commission and prion (TSE) disease reporting 2011 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://ec.europa.eu/food/international/organisations/docs/eu_position_oie_tahsc_en.pdf"&gt;http://ec.europa.eu/food/international/organisations/docs/eu_position_oie_tahsc_en.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Greetings OIE et al, &lt;br /&gt;&lt;br /&gt;I think that the OIE et al, should explain to the lay public, as to why the OIE post TSE prion disease reports and incidence there from different species on their disease reporting reports via email and or on their news feed web site, daily and or weekly, for just a chosen few Countries, yet other Countries seem to be exempt from this reporting to the public. WHY is this ? &lt;br /&gt;&lt;br /&gt;For instance, Japan just reported another incidence of scrapie, this time in goat. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://web.oie.int/wahis/public.php?page=single_report&amp;amp;pop=1&amp;amp;reportid=10624"&gt;http://web.oie.int/wahis/public.php?page=single_report&amp;amp;pop=1&amp;amp;reportid=10624&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;however, the USA (Michigan), is awash in scrapie in goat cases, to a point of epidemic, however, the OIE does not report this, WHY is this ? &lt;br /&gt;&lt;br /&gt;the USA and Canada Nor-98 scrapie cases are mounting. NO reports from the OIE. WHY is this ? &lt;br /&gt;&lt;br /&gt;we the lay public deserve an answer. i have ask this question before. i have ask it about CWD to the OIE a decade ago. &lt;br /&gt;&lt;br /&gt;WHY do some Countries get their TSE prion reports posted, and the USA does not, the USA is exempt from this Global embarrassment? &lt;br /&gt;&lt;br /&gt;i am confused. &lt;br /&gt;&lt;br /&gt;IF the OIE is going to be a reputable global disease control reporting agency, then the OIE needs to be honest and trust worthy and equal reporting for all Countries, not just a chosen few, while others are exempt. This weakens the animal disease reporting system, and really in all reality, seems to enhance fraud, and undermines reporting of actual disease, thus, defeats the very purpose of the O.I.E., thus undermines the very reason the OIE was suppose to be set up for. &lt;br /&gt;&lt;br /&gt;If countries can choose and pick whether or not their different animal disease are reported, and or NOT reported, then what's the point of the O.I.E. $$$ &lt;br /&gt;&lt;br /&gt;MY personal opinion, if a country is going to belong to the OIE, and or boast about OIE regulations they go by, then they should be made to report animal disease just as any other country does to the OIE, or they should not be a part of this OIE, and should not be allowed to be boasting that they go by OIE guidelines. ... &lt;br /&gt;&lt;br /&gt;with sincere regards, terry &lt;br /&gt;&lt;br /&gt;snip...see full text ; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/05/oie-terrestrial-animal-health-standards.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/05/oie-terrestrial-animal-health-standards.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;IN SHORT, AND IN A NUT SHELL ; &lt;br /&gt;&lt;br /&gt;(Adopted by the International Committee of the OIE on 23 May 2006) &lt;br /&gt;&lt;br /&gt;11. Information published by the OIE is derived from appropriate declarations made by the official Veterinary Services of Member Countries. The OIE is not responsible for inaccurate publication of country disease status based on inaccurate information or changes in epidemiological status or other significant events that were not promptly reported to the Central Bureau, &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.oie.int/eng/Session2007/RF2006.pdf"&gt;http://www.oie.int/eng/Session2007/RF2006.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Saturday, December 18, 2010 &lt;br /&gt;&lt;br /&gt;OIE Global Conference on Wildlife Animal Health and Biodiversity - Preparing for the Future (TSE AND PRIONS) Paris (France), 23-25 February 2011 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/oie-global-conference-on-wildlife.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/oie-global-conference-on-wildlife.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;I see again that the OIE has done little to help eradicate all animal TSE from the globe, and in fact in my opinion, have help enhance the spread of BSE and other animal TSE globally by their industry friendly regulations. I tried to warn the OIE in 2002 about CWD and the potential, but very real threat of CWD to humans. I was told that they were seriously considering this. what happened ? NOW, the OIE and the USDA collaborate to make legal the trading of all strains of atypical BSE legal, and in fact have done so with the atypical scrapie, when science has made perfectly clear the risk factors to humans and other species. I have said it once (see below), and i will say again ; &lt;br /&gt;&lt;br /&gt;"THE OIE has now shown they are nothing more than a National Trading Brokerage for all strains of animal TSE. AS i said before, OIE should hang up there jock strap now, since it appears they will buckle every time a country makes some political hay about trade protocol, commodities and futures. IF they are not going to be science based, they should do everyone a favor and dissolve there organization." &lt;br /&gt;&lt;br /&gt;NOW, some history on the failed OIE BSE/TSE policy, and why the OIE allowed BSE and other TSE to spread around the globe $$$ &lt;br /&gt;&lt;br /&gt;snip...see full text ; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/oie-global-conference-on-wildlife.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/oie-global-conference-on-wildlife.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Docket APHIS-2006-0026 Docket Title Bovine Spongiform Encephalopathy; Animal Identification and Importation of Commodities Docket Type Rulemaking Document APHIS-2006-0026-0001 Document Title Bovine Spongiform Encephalopathy; Minimal-Risk Regions, Identification of Ruminants and Processing and Importation of Commodities Public Submission APHIS-2006-0026-0012 Public Submission Title Comment from Terry S Singletary &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.regulations.gov/fdmspublic/component/main?main=DocumentDetail&amp;amp;o=09000064801e47e1"&gt;http://www.regulations.gov/fdmspublic/component/main?main=DocumentDetail&amp;amp;o=09000064801e47e1&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Docket APHIS-2006-0041 Docket Title Bovine Spongiform Encephalopathy; Minimal-Risk Regions; Importation of Live Bovines and Products Derived from Bovines Commodities Docket Type Rulemaking Document APHIS-2006-0041-0001 Document Title Bovine Spongiform Encephalopathy; Minimal-Risk Regions; Importation of Live Bovines and Products Derived From Bovines Public Submission APHIS-2006-0041-0028 Public Submission Title Comment from Terry S Singletary&lt;br /&gt;&lt;br /&gt;Comment 2006-2007 USA AND OIE POISONING GLOBE WITH BSE MRR POLICY&lt;br /&gt;&lt;br /&gt;THE USA is in a most unique situation, one of unknown circumstances with human and animal TSE. THE USA has the most documented TSE in different species to date, with substrains growing in those species (BSE/BASE in cattle and CWD in deer and elk, there is evidence here with different strains), and we know that sheep scrapie has over 20 strains of the typical scrapie with atypical scrapie documented and also BSE is very likely to have passed to sheep. all of which have been rendered and fed back to animals for human and animal consumption, a frightening scenario. WE do not know the outcome, and to play with human life around the globe with the very likely TSE tainted products from the USA, in my opinion is like playing Russian roulette, of long duration, with potential long and enduring consequences, of which once done, cannot be undone. These are the facts as I have come to know through daily and extensive research of TSE over 9 years, since 12/14/97. I do not pretend to have all the answers, but i do know to continue to believe in the ukbsenvcjd only theory of transmission to humans of only this one strain from only this one TSE from only this one part of the globe, will only lead to further failures, and needless exposure to humans from all strains of TSE, and possibly many more needless deaths from TSE via a multitude of proven routes and sources via many studies with primates and rodents and other species.&lt;br /&gt;&lt;br /&gt;MY personal belief, since you ask, is that not only the Canadian border, but the USA border, and the Mexican border should be sealed up tighter than a drum for exporting there TSE tainted products, until a validated, 100% sensitive test is available, and all animals for human and animal consumption are tested. all we are doing is the exact same thing the UK did with there mad cow poisoning when they exported it all over the globe, all the while knowing what they were doing. this BSE MRR policy is nothing more than a legal tool to do just exactly what the UK did... &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.regulations.gov/fdmspublic/component/main?main=DocumentDetail&amp;amp;o=09000064801f8151"&gt;http://www.regulations.gov/fdmspublic/component/main?main=DocumentDetail&amp;amp;o=09000064801f8151&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Docket APHIS-2006-0041 Docket Title Bovine Spongiform Encephalopathy; Minimal-Risk Regions; Importation of Live Bovines and Products Derived from Bovines Commodities Docket Type Rulemaking Document APHIS-2006-0041-0001 Document Title Bovine Spongiform Encephalopathy; Minimal-Risk Regions; Importation of Live Bovines and Products Derived From Bovines Public Submission APHIS-2006-0041-0028.1 Public Submission Title Attachment to Singletary comment&lt;br /&gt;&lt;br /&gt;January 28, 2007&lt;br /&gt;&lt;br /&gt;Greetings APHIS,&lt;br /&gt;&lt;br /&gt;I would kindly like to submit the following to ;&lt;br /&gt;&lt;br /&gt;BSE; MRR; IMPORTATION OF LIVE BOVINES AND PRODUCTS DERIVED FROM BOVINES [Docket No. APHIS-2006-0041] RIN 0579-AC01 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.regulations.gov/fdmspublic/ContentViewer?objectId=09000064801f8152&amp;amp;disposition=attachment&amp;amp;contentType=msw8"&gt;http://www.regulations.gov/fdmspublic/ContentViewer?objectId=09000064801f8152&amp;amp;disposition=attachment&amp;amp;contentType=msw8&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Saturday, April 10, 2010 &lt;br /&gt;&lt;br /&gt;TOYOTA VS MAD COW DISEASE USA OIE BSE MRR IMPORT AND EXPORT TRADE WARS &lt;br /&gt;&lt;br /&gt;&lt;a href="http://usdameatexport.blogspot.com/2010/04/toyota-vs-mad-cow-disease-usa-oie-bse.html"&gt;http://usdameatexport.blogspot.com/2010/04/toyota-vs-mad-cow-disease-usa-oie-bse.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Friday, December 23, 2011 &lt;br /&gt;&lt;br /&gt;Oral Transmission of L-type Bovine Spongiform Encephalopathy in Primate Model &lt;br /&gt;&lt;br /&gt;Volume 18, Number 1—January 2012 Dispatch &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/12/oral-transmission-of-l-type-bovine.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/12/oral-transmission-of-l-type-bovine.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Saturday, June 25, 2011&lt;br /&gt;&lt;br /&gt;Transmissibility of BSE-L and Cattle-Adapted TME Prion Strain to Cynomolgus Macaque &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;"BSE-L in North America may have existed for decades" &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/transmissibility-of-bse-l-and-cattle.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/transmissibility-of-bse-l-and-cattle.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Over the next 8-10 weeks, approximately 40% of all the adult mink on the farm died from TME. &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;The rancher was a ''dead stock'' feeder using mostly (&amp;gt;95%) downer or dead dairy cattle... &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://web.archive.org/web/20030516051623/http://www.bseinquiry.gov.uk/files/mb/m09/tab05.pdf"&gt;http://web.archive.org/web/20030516051623/http://www.bseinquiry.gov.uk/files/mb/m09/tab05.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, February 5, 2012 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;February 2012 Update on Feed Enforcement Activities to Limit the Spread of BSE&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/february-2012-update-on-feed.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/february-2012-update-on-feed.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;EFSA Scientific Report on the Assessment of the Geographical BSE-Risk (GBR) of the United States of America (USA)&lt;br /&gt;&lt;br /&gt;Summary of the Scientific Report&lt;br /&gt;&lt;br /&gt;The European Food Safety Authority and its Scientific Expert Working Group on the Assessment of the Geographical Bovine Spongiform Encephalopathy (BSE) Risk (GBR) were asked by the European Commission (EC) to provide an up-to-date scientific report on the GBR in the United States of America, i.e. the likelihood of the presence of one or more cattle being infected with BSE, pre-clinically as well as clinically, in USA. This scientific report addresses the GBR of USA as assessed in 2004 based on data covering the period 1980-2003.&lt;br /&gt;&lt;br /&gt;The BSE agent was probably imported into USA and could have reached domestic cattle in the middle of the eighties. These cattle imported in the mid eighties could have been rendered in the late eighties and therefore led to an internal challenge in the early nineties. It is possible that imported meat and bone meal (MBM) into the USA reached domestic cattle and leads to an internal challenge in the early nineties.&lt;br /&gt;&lt;br /&gt;A processing risk developed in the late 80s/early 90s when cattle imports from BSE risk countries were slaughtered or died and were processed (partly) into feed, together with some imports of MBM. This risk continued to exist, and grew significantly in the mid 90's when domestic cattle, infected by imported MBM, reached processing. Given the low stability of the system, the risk increased over the years with continued imports of cattle and MBM from BSE risk countries.&lt;br /&gt;&lt;br /&gt;EFSA concludes that the current GBR level of USA is III, i.e. it is likely but not confirmed that domestic cattle are (clinically or pre-clinically) infected with the BSE-agent. As long as there are no significant changes in rendering or feeding, the stability remains extremely/very unstable. Thus, the probability of cattle to be (pre-clinically or clinically) infected with the BSE-agent persistently increases. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/en/efsajournal/pub/3r.htm"&gt;http://www.efsa.europa.eu/en/efsajournal/pub/3r.htm&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;see full text ; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/en/efsajournal/doc/3r.pdf"&gt;http://www.efsa.europa.eu/en/efsajournal/doc/3r.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Scientific Report of the European Food Safety Authority on the Assessment of the Geographical BSE Risk (GBR) of the United States of America (USA) Question number: EFSA-Q-2003-083 Adopted date: 1 July 2004 Summary (0.1Mb)&lt;br /&gt;&lt;br /&gt;Document (0.2Mb)&lt;br /&gt;&lt;br /&gt;Summary&lt;br /&gt;&lt;br /&gt;The European Food Safety Authority and its Scientific Expert Working Group on the Assessment of the Geographical Bovine Spongiform Encephalopathy (BSE) Risk (GBR) were asked by the European Commission (EC) to provide an up-to-date scientific report on the GBR in the United States of America, i.e. the likelihood of the presence of one or more cattle being infected with BSE, pre-clinically as well as clinically, in USA. This scientific report addresses the GBR of USA as assessed in 2004 based on data covering the period 1980-2003.&lt;br /&gt;&lt;br /&gt;The BSE agent was probably imported into USA and could have reached domestic cattle in the middle of the eighties. These cattle imported in the mid eighties could have been rendered in the late eighties and therefore led to an internal challenge in the early nineties. It is possible that imported meat and bone meal (MBM) into the USA reached domestic cattle and leads to an internal challenge in the early nineties.&lt;br /&gt;&lt;br /&gt;A processing risk developed in the late 80s/early 90s when cattle imports from BSE risk countries were slaughtered or died and were processed (partly) into feed, together with some imports of MBM. This risk continued to exist, and grew significantly in the mid 90’s when domestic cattle, infected by imported MBM, reached processing. Given the low stability of the system, the risk increased over the years with continued imports of cattle and MBM from BSE risk countries.&lt;br /&gt;&lt;br /&gt;EFSA concludes that the current GBR level of USA is III, i.e. it is likely but not confirmed that domestic cattle are (clinically or pre-clinically) infected with the BSE-agent. As long as there are no significant changes in rendering or feeding, the stability remains extremely/very unstable. Thus, the probability of cattle to be (pre-clinically or clinically) infected with the BSE-agent persistently increases. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178620779461.htm"&gt;http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178620779461.htm&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/EFSA/Scientific_Document/sr03_biohaz02_usa_report_annex_en1.pdf?ssbinary=true"&gt;http://www.efsa.europa.eu/EFSA/Scientific_Document/sr03_biohaz02_usa_report_annex_en1.pdf?ssbinary=true&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/EFSA/Scientific_Document/sr03_biohaz02_usa_report_v2_en1.pdf?ssbinary=true"&gt;http://www.efsa.europa.eu/EFSA/Scientific_Document/sr03_biohaz02_usa_report_v2_en1.pdf?ssbinary=true&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/EFSA/Scientific_Document/sr03_biohaz02_usa_report_summary_en1.pdf?ssbinary=true"&gt;http://www.efsa.europa.eu/EFSA/Scientific_Document/sr03_biohaz02_usa_report_summary_en1.pdf?ssbinary=true&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;10,000,000+ LBS. of PROHIBITED BANNED MAD COW FEED I.E. BLOOD LACED MBM IN COMMERCE USA 2007&lt;br /&gt;&lt;br /&gt;Date: March 21, 2007 at 2:27 pm PST&lt;br /&gt;&lt;br /&gt;RECALLS AND FIELD CORRECTIONS: VETERINARY MEDICINES -- CLASS II &lt;br /&gt;&lt;br /&gt;___________________________________ &lt;br /&gt;&lt;br /&gt;PRODUCT&lt;br /&gt;&lt;br /&gt;Bulk cattle feed made with recalled Darling's 85% Blood Meal, Flash Dried, Recall # V-024-2007&lt;br /&gt;&lt;br /&gt;CODE&lt;br /&gt;&lt;br /&gt;Cattle feed delivered between 01/12/2007 and 01/26/2007&lt;br /&gt;&lt;br /&gt;RECALLING FIRM/MANUFACTURER&lt;br /&gt;&lt;br /&gt;Pfeiffer, Arno, Inc, Greenbush, WI. by conversation on February 5, 2007.&lt;br /&gt;&lt;br /&gt;Firm initiated recall is ongoing.&lt;br /&gt;&lt;br /&gt;REASON&lt;br /&gt;&lt;br /&gt;Blood meal used to make cattle feed was recalled because it was cross-contaminated with prohibited bovine meat and bone meal that had been manufactured on common equipment and labeling did not bear cautionary BSE statement.&lt;br /&gt;&lt;br /&gt;VOLUME OF PRODUCT IN COMMERCE&lt;br /&gt;&lt;br /&gt;42,090 lbs.&lt;br /&gt;&lt;br /&gt;DISTRIBUTION&lt;br /&gt;&lt;br /&gt;WI&lt;br /&gt;&lt;br /&gt;___________________________________&lt;br /&gt;&lt;br /&gt;PRODUCT&lt;br /&gt;&lt;br /&gt;Custom dairy premix products: MNM ALL PURPOSE Pellet, HILLSIDE/CDL Prot-Buffer Meal, LEE, M.-CLOSE UP PX Pellet, HIGH DESERT/ GHC LACT Meal, TATARKA, M CUST PROT Meal, SUNRIDGE/CDL PROTEIN Blend, LOURENZO, K PVM DAIRY Meal, DOUBLE B DAIRY/GHC LAC Mineral, WEST PIONT/GHC CLOSEUP Mineral, WEST POINT/GHC LACT Meal, JENKS, J/COMPASS PROTEIN Meal, COPPINI - 8# SPECIAL DAIRY Mix, GULICK, L-LACT Meal (Bulk), TRIPLE J - PROTEIN/LACTATION, ROCK CREEK/GHC MILK Mineral, BETTENCOURT/GHC S.SIDE MK-MN, BETTENCOURT #1/GHC MILK MINR, V&amp;amp;C DAIRY/GHC LACT Meal, VEENSTRA, F/GHC LACT Meal, SMUTNY, A-BYPASS ML W/SMARTA, Recall # V-025-2007&lt;br /&gt;&lt;br /&gt;CODE&lt;br /&gt;&lt;br /&gt;The firm does not utilize a code - only shipping documentation with commodity and weights identified.&lt;br /&gt;&lt;br /&gt;RECALLING FIRM/MANUFACTURER&lt;br /&gt;&lt;br /&gt;Rangen, Inc, Buhl, ID, by letters on February 13 and 14, 2007. Firm initiated recall is complete.&lt;br /&gt;&lt;br /&gt;REASON&lt;br /&gt;&lt;br /&gt;Products manufactured from bulk feed containing blood meal that was cross contaminated with prohibited meat and bone meal and the labeling did not bear cautionary BSE statement.&lt;br /&gt;&lt;br /&gt;VOLUME OF PRODUCT IN COMMERCE&lt;br /&gt;&lt;br /&gt;9,997,976 lbs.&lt;br /&gt;&lt;br /&gt;DISTRIBUTION&lt;br /&gt;&lt;br /&gt;ID and NV&lt;br /&gt;&lt;br /&gt;END OF ENFORCEMENT REPORT FOR MARCH 21, 2007 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fda.gov/bbs/topics/enforce/2007/ENF00996.html"&gt;http://www.fda.gov/bbs/topics/enforce/2007/ENF00996.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, March 19, 2009&lt;br /&gt;&lt;br /&gt;MILLIONS AND MILLIONS OF POUNDS OF MAD COW FEED IN COMMERCE USA WITH ONGOING 12 YEARS OF DENIAL NOW, WHY IN THE WORLD DO WE TO TALK ABOUT THIS ANYMORE $$$ &lt;br /&gt;&lt;br /&gt;&lt;a href="http://madcowfeed.blogspot.com/2009/03/millions-and-millions-of-pounds-of-mad.html"&gt;http://madcowfeed.blogspot.com/2009/03/millions-and-millions-of-pounds-of-mad.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Owner and Corporation Plead Guilty to Defrauding Bovine Spongiform Encephalopathy (BSE) Surveillance Program&lt;br /&gt;&lt;br /&gt;An Arizona meat processing company and its owner pled guilty in February 2007 to charges of theft of Government funds, mail fraud, and wire fraud. The owner and his company defrauded the BSE Surveillance Program when they falsified BSE Surveillance Data Collection Forms and then submitted payment requests to USDA for the services. In addition to the targeted sample population (those cattle that were more than 30 months old or had other risk factors for BSE), the owner submitted to USDA, or caused to be submitted, BSE obex (brain stem) samples from healthy USDA-inspected cattle. As a result, the owner fraudulently received approximately $390,000. Sentencing is scheduled for May 2007.&lt;br /&gt;&lt;br /&gt;snip...&lt;br /&gt;&lt;br /&gt;Topics that will be covered in ongoing or planned reviews under Goal 1 include:&lt;br /&gt;&lt;br /&gt;soundness of BSE maintenance sampling (APHIS),&lt;br /&gt;&lt;br /&gt;implementation of Performance-Based Inspection System enhancements for specified risk material (SRM) violations and improved inspection controls over SRMs (FSIS and APHIS),&lt;br /&gt;&lt;br /&gt;snip...&lt;br /&gt;&lt;br /&gt;The findings and recommendations from these efforts will be covered in future semiannual reports as the relevant audits and investigations are completed.&lt;br /&gt;&lt;br /&gt;4 USDA OIG SEMIANNUAL REPORT TO CONGRESS FY 2007 1st Half &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.usda.gov/oig/webdocs/sarc070619.pdf"&gt;http://www.usda.gov/oig/webdocs/sarc070619.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;-MORE Office of the United States Attorney District of Arizona FOR IMMEDIATE RELEASE For Information Contact Public Affairs February 16, 2007 WYN HORNBUCKLE Telephone: (602) 514-7625 Cell: (602) 525-2681&lt;br /&gt;&lt;br /&gt;CORPORATION AND ITS PRESIDENT PLEAD GUILTY TO DEFRAUDING GOVERNMENT'S MAD COW DISEASE SURVEILLANCE PROGRAM&lt;br /&gt;&lt;br /&gt;PHOENIX -- Farm Fresh Meats, Inc. and Roland Emerson Farabee, 55, of Maricopa, Arizona, pleaded guilty to stealing $390,000 in government funds, mail fraud and wire fraud, in federal district court in Phoenix. U.S. Attorney Daniel Knauss stated, "The integrity of the system that tests for mad cow disease relies upon the honest cooperation of enterprises like Farm Fresh Meats. Without that honest cooperation, consumers both in the U.S. and internationally are at risk. We want to thank the USDA's Office of Inspector General for their continuing efforts to safeguard the public health and enforce the law." Farm Fresh Meats and Farabee were charged by Information with theft of government funds, mail fraud and wire fraud. According to the Information, on June 7, 2004, Farabee, on behalf of Farm Fresh Meats, signed a contract with the U.S. Department of Agriculture (the "USDA Agreement") to collect obex samples from cattle at high risk of mad cow disease (the "Targeted Cattle Population"). The Targeted Cattle Population consisted of the following cattle: cattle over thirty months of age; nonambulatory cattle; cattle exhibiting signs of central nervous system disorders; cattle exhibiting signs of mad cow disease; and dead cattle. Pursuant to the USDA Agreement, the USDA agreed to pay Farm Fresh Meats $150 per obex sample for collecting obex samples from cattle within the Targeted Cattle Population, and submitting the obex samples to a USDA laboratory for mad cow disease testing. Farm Fresh Meats further agreed to maintain in cold storage the sampled cattle carcasses and heads until the test results were received by Farm Fresh Meats.&lt;br /&gt;&lt;br /&gt;Evidence uncovered during the government's investigation established that Farm Fresh Meats and Farabee submitted samples from cattle outside the Targeted Cattle Population. Specifically, Farm Fresh Meats and Farabee submitted, or caused to be submitted, obex samples from healthy, USDA inspected cattle, in order to steal government moneys.&lt;br /&gt;&lt;br /&gt;Evidence collected also demonstrated that Farm Fresh Meats and Farabee failed to maintain cattle carcasses and heads pending test results and falsified corporate books and records to conceal their malfeasance. Such actions, to the extent an obex sample tested positive (fortunately, none did), could have jeopardized the USDA's ability to identify the diseased animal and pinpoint its place of origin. On Wednesday, February 14, 2007, Farm Fresh Meats and Farabee pleaded guilty to stealing government funds and using the mails and wires to effect the scheme. According to their guilty pleas:&lt;br /&gt;&lt;br /&gt;(a) Farm Fresh Meats collected, and Farabee directed others to collect, obex samples from cattle outside the Targeted Cattle Population, which were not subject to payment by the USDA;&lt;br /&gt;&lt;br /&gt;(b) Farm Fresh Meats 2 and Farabee caused to be submitted payment requests to the USDA knowing that the requests were based on obex samples that were not subject to payment under the USDA Agreement;&lt;br /&gt;&lt;br /&gt;(c) Farm Fresh Meats completed and submitted, and Farabee directed others to complete and submit, BSE Surveillance Data Collection Forms to the USDA's testing laboratory that were false and misleading;&lt;br /&gt;&lt;br /&gt;(d) Farm Fresh Meats completed and submitted, and Farabee directed others to complete and submit, BSE Surveillance Submission Forms filed with the USDA that were false and misleading;&lt;br /&gt;&lt;br /&gt;(e) Farm Fresh Meats falsified, and Farabee directed others to falsify, internal Farm Fresh Meats documents to conceal the fact that Farm Fresh Meats was seeking and obtaining payment from the USDA for obex samples obtained from cattle outside the Targeted Cattle Population; and&lt;br /&gt;&lt;br /&gt;(f) Farm Fresh Meats failed to comply with, and Farabee directed others to fail to comply with, the USDA Agreement by discarding cattle carcasses and heads prior to receiving BSE test results. A conviction for theft of government funds carries a maximum penalty of 10 years imprisonment. Mail fraud and wire fraud convictions carry a maximum penalty of 20 years imprisonment. Convictions for the above referenced violations also carry a maximum fine of $250,000 for individuals and $500,000 for organizations. In determining an actual sentence, Judge Earl H. Carroll will consult the U.S. Sentencing Guidelines, which provide appropriate sentencing ranges. The judge, however, is not bound by those guidelines in determining a sentence.&lt;br /&gt;&lt;br /&gt;Sentencing is set before Judge Earl H. Carroll on May 14, 2007. The investigation in this case was conducted by Assistant Special Agent in Charge Alejandro Quintero, United States Department of Agriculture, Office of Inspector General. The prosecution is being handled by Robert Long, Assistant U.S. Attorney, District of Arizona, Phoenix. CASE NUMBER: CR-07-00160-PHX-EHC RELEASE NUMBER: 2007-051(Farabee) # # # &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.usdoj.gov/usao/az/press_releases/2007/2007-051(Farabee).pdf"&gt;http://www.usdoj.gov/usao/az/press_releases/2007/2007-051(Farabee).pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;IN my opinion, the OIE lost all it's credibility when they went with the Bush administration on the BSE MRR policy. Science was not involved in that policy, only trade. IT did nothing but make legal, the trading of all strains of TSE globally, and set back the eradication of mad cow disease, to the beginning of the epidemic. with the atypical mad cow cases showing up, it will be interesting how this plays out in the years, and decades to come.&lt;br /&gt;&lt;br /&gt;IN my opinion, the USA should be classified as undetermined risk, because these are the hard cold facts, they have absolutely no idea, and neither does anyone else. ... &lt;br /&gt;&lt;br /&gt;TSS &lt;br /&gt;&lt;br /&gt;Friday, March 6, 2009&lt;br /&gt;&lt;br /&gt;Risk of Introduction of BSE into Japan by the Historical Importation of Live Cattle from the United Kingdom &lt;br /&gt;&lt;br /&gt;&lt;a href="http://bseusa.blogspot.com/2009/03/risk-of-introduction-of-bse-into-japan.html"&gt;http://bseusa.blogspot.com/2009/03/risk-of-introduction-of-bse-into-japan.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, May 10, 2009&lt;br /&gt;&lt;br /&gt;Identification and characterization of bovine spongiform encephalopathy cases diagnosed and not diagnosed in the United States &lt;br /&gt;&lt;br /&gt;&lt;a href="http://bse-atypical.blogspot.com/2009/05/identification-and-characterization-of.html"&gt;http://bse-atypical.blogspot.com/2009/05/identification-and-characterization-of.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Saturday, November 19, 2011 &lt;br /&gt;&lt;br /&gt;Novel Prion Protein in BSE-affected Cattle, Switzerland &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/11/novel-prion-protein-in-bse-affected.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/11/novel-prion-protein-in-bse-affected.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Increased Atypical Scrapie Detections&lt;br /&gt;&lt;br /&gt;Press reports indicate that increased surveillance is catching what otherwise would have been unreported findings of atypical scrapie in sheep. In 2009, five new cases have been reported in Quebec, Ontario, Alberta, and Saskatchewan. With the exception of Quebec, all cases have been diagnosed as being the atypical form found in older animals. Canada encourages producers to join its voluntary surveillance program in order to gain scrapie-free status. The World Animal Health will not classify Canada as scrapie-free until no new cases are reported for seven years. The Canadian Sheep Federation is calling on the government to fund a wider surveillance program in order to establish the level of prevalence prior to setting an eradication date. Besides long-term testing, industry is calling for a compensation program for farmers who report unusual deaths in their flocks.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://gain.fas.usda.gov/Recent%20GAIN%20Publications/This%20Week%20in%20Canadian%20Agriculture%20%20%20%20%20Issue%2028_Ottawa_Canada_11-6-2009.pdf"&gt;http://gain.fas.usda.gov/Recent%20GAIN%20Publications/This%20Week%20in%20Canadian%20Agriculture%20%20%20%20%20Issue%2028_Ottawa_Canada_11-6-2009.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;J Vet Diagn Invest 21:454-463 (2009) &lt;br /&gt;&lt;br /&gt;Nor98 scrapie identified in the United States &lt;br /&gt;&lt;br /&gt;Christie M. Loiacono,' Bruce V. Thomsen, S. Mark Hall, Matti Kiupe!, Diane Sutton, Katherine O'Rourke, Bradd Barr, Lucy Anthenill, Deiwyn Keane &lt;br /&gt;&lt;br /&gt;Abstract. &lt;br /&gt;&lt;br /&gt;A distinct strain of scrapic identified in sheep of Norway in 1998 has since been identified in numerous countries throughout Europe. The disease is known as Nor98 or Not-98-like scrapic. among other names. Distinctions between classic scrapie and Nor98 scrapie are made based on histopathologv and immunodiagnostic results. There are also differences in the epidemiology, typical signalment, and likelihood of clinical signs being observed. In addition, sheep that have genotypes associated with resistance to classic scrapie are not spared from Nor98 disease. The various differences between classic and Nor98 scrapie have been consistently reported in the vast majority of cases described across Europe. The current study describes in detail the patholo gic changes and diagnostic results of the first 6 cases of' Nor98 scrapic disease diagnosed in sheep of the United States. &lt;br /&gt;&lt;br /&gt;Key words: Hisiopathology: Nor98: PrP imniunolabeling; scrapie: sheep. &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;Results &lt;br /&gt;&lt;br /&gt;Case I &lt;br /&gt;&lt;br /&gt;The first case identified as consistent with Nor98 scrapie had nonclassic PrP distribution in brain tissue, no PrPSC in lymph tissue, and nonclassic migration of protein bands on a Western blot test. The animal was an aged, mottled-faced ewe that was traced back to a commercial flock in Wyoming. ... &lt;br /&gt;&lt;br /&gt;Case 2 &lt;br /&gt;&lt;br /&gt;The second case was a clinically normal 8-year-old Suffolk ewe that had been in a quarantined flock for 5 years at a USDA facility in Iowa. &lt;br /&gt;&lt;br /&gt;Case 3 &lt;br /&gt;&lt;br /&gt;A 16-year-old, white-faced, cross-bred wether was born to a black-faced ewe. He lived his entire life as a pet on a farm in California. &lt;br /&gt;&lt;br /&gt;Case 4 &lt;br /&gt;&lt;br /&gt;The fourth case of Nor98 scrapie was identified in an approximately 8-year-old Dorset ewe that was born into a flock of approximately 20 ewes in Indiana. &lt;br /&gt;&lt;br /&gt;Case 5 &lt;br /&gt;&lt;br /&gt;The fifth case was a clinically normal, approximately 3-year-old, white-faced, cross-bred ewe from an approximately 400 head commercial flock in Minnesota. &lt;br /&gt;&lt;br /&gt;Case 6 &lt;br /&gt;&lt;br /&gt;The sixth case of Nor98 scrapie was identified in a 4-year-old, white-faced ewe that was purchased and added to a commercial flock in Pennsylvania &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;see full text ; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://ddr.nal.usda.gov/bitstream/10113/33943/1/IND44241920.pdf"&gt;http://ddr.nal.usda.gov/bitstream/10113/33943/1/IND44241920.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://scrapie-usa.blogspot.com/"&gt;http://scrapie-usa.blogspot.com/&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, November 30, 2009 &lt;br /&gt;&lt;br /&gt;USDA AND OIE COLLABORATE TO EXCLUDE ATYPICAL SCRAPIE NOR-98 ANIMAL HEALTH CODE &lt;br /&gt;&lt;br /&gt;&lt;a href="http://nor-98.blogspot.com/2009/11/usda-and-oie-collaborate-to-exclude.html"&gt;http://nor-98.blogspot.com/2009/11/usda-and-oie-collaborate-to-exclude.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Friday, February 11, 2011 &lt;br /&gt;&lt;br /&gt;Atypical/Nor98 Scrapie Infectivity in Sheep Peripheral Tissues &lt;br /&gt;&lt;br /&gt;&lt;a href="http://nor-98.blogspot.com/2011/02/atypicalnor98-scrapie-infectivity-in.html"&gt;http://nor-98.blogspot.com/2011/02/atypicalnor98-scrapie-infectivity-in.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, December 12, 2010 &lt;br /&gt;&lt;br /&gt;EFSA reviews BSE/TSE infectivity in small ruminant tissues News Story 2 December 2010 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/efsa-reviews-bsetse-infectivity-in.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/efsa-reviews-bsetse-infectivity-in.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, January 18, 2012 &lt;br /&gt;&lt;br /&gt;Selection of Distinct Strain Phenotypes in Mice Infected by Ovine Natural Scrapie Isolates Similar to CH1641 Experimental Scrapie &lt;br /&gt;&lt;br /&gt;Journal of Neuropathology &amp;amp; Experimental Neurology: February 2012 - Volume 71 - Issue 2 - p 140–147 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/selection-of-distinct-strain-phenotypes.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/selection-of-distinct-strain-phenotypes.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, July 14, 2011 &lt;br /&gt;&lt;br /&gt;Histopathological Studies of "CH1641-Like" Scrapie Sources Versus Classical Scrapie and BSE Transmitted to Ovine Transgenic Mice (TgOvPrP4) &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/07/histopathological-studies-of-ch1641.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/07/histopathological-studies-of-ch1641.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, December 23, 2010 &lt;br /&gt;&lt;br /&gt;Molecular Typing of Protease-Resistant Prion Protein in Transmissible Spongiform Encephalopathies of Small Ruminants, France, 2002-2009 &lt;br /&gt;&lt;br /&gt;Volume 17, Number 1 January 2011 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/molecular-typing-of-protease-resistant.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2010/12/molecular-typing-of-protease-resistant.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, November 18, 2010 &lt;br /&gt;&lt;br /&gt;Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy following passage in sheep &lt;br /&gt;&lt;br /&gt;&lt;a href="http://bse-atypical.blogspot.com/2010/11/increased-susceptibility-of-human-prp.html"&gt;http://bse-atypical.blogspot.com/2010/11/increased-susceptibility-of-human-prp.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;hmmm, no I ponder why some of these sporadic CJD cases, are now being linked to a genetic TSE, that has NO link to the family ?&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;hmmm, could it be these atypical TSE in animals, that are linked to the human TSE in the USA, and also, these animals have been fed back and forth to each other ?&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;hmmm, why no link there $$$ &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;P03.141&lt;br /&gt;&lt;br /&gt;Aspects of the Cerebellar Neuropathology in Nor98&lt;br /&gt;&lt;br /&gt;Gavier-Widén, D1; Benestad, SL2; Ottander, L1; Westergren, E1 1National Veterinary Insitute, Sweden; 2National Veterinary Institute,&lt;br /&gt;&lt;br /&gt;Norway Nor98 is a prion disease of old sheep and goats. This atypical form of scrapie was first described in Norway in 1998. Several features of Nor98 were shown to be different from classical scrapie including the distribution of disease associated prion protein (PrPd) accumulation in the brain. The cerebellum is generally the most affected brain area in Nor98. The study here presented aimed at adding information on the neuropathology in the cerebellum of Nor98 naturally affected sheep of various genotypes in Sweden and Norway. A panel of histochemical and immunohistochemical (IHC) stainings such as IHC for PrPd, synaptophysin, glial fibrillary acidic protein, amyloid, and cell markers for phagocytic cells were conducted. The type of histological lesions and tissue reactions were evaluated. The types of PrPd deposition were characterized. The cerebellar cortex was regularly affected, even though there was a variation in the severity of the lesions from case to case. Neuropil vacuolation was more marked in the molecular layer, but affected also the granular cell layer. There was a loss of granule cells. Punctate deposition of PrPd was characteristic. It was morphologically and in distribution identical with that of synaptophysin, suggesting that PrPd accumulates in the synaptic structures. PrPd was also observed in the granule cell layer and in the white matter. The pathology features of Nor98 in the cerebellum of the affected sheep showed similarities with those of sporadic Creutzfeldt-Jakob disease in humans. &lt;br /&gt;&lt;br /&gt;***The pathology features of Nor98 in the cerebellum of the affected sheep showed similarities with those of sporadic Creutzfeldt-Jakob disease in humans. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf"&gt;http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;PR-26&lt;br /&gt;&lt;br /&gt;NOR98 SHOWS MOLECULAR FEATURES REMINISCENT OF GSS&lt;br /&gt;&lt;br /&gt;R. Nonno1, E. Esposito1, G. Vaccari1, E. Bandino2, M. Conte1, B. Chiappini1, S. Marcon1, M. Di Bari1, S.L. Benestad3, U. Agrimi1 1 Istituto Superiore di Sanità, Department of Food Safety and Veterinary Public Health, Rome, Italy (romolo.nonno@iss.it); 2 Istituto Zooprofilattico della Sardegna, Sassari, Italy; 3 National Veterinary Institute, Department of Pathology, Oslo, Norway&lt;br /&gt;&lt;br /&gt;Molecular variants of PrPSc are being increasingly investigated in sheep scrapie and are generally referred to as "atypical" scrapie, as opposed to "classical scrapie". Among the atypical group, Nor98 seems to be the best identified. We studied the molecular properties of Italian and Norwegian Nor98 samples by WB analysis of brain homogenates, either untreated, digested with different concentrations of proteinase K, or subjected to enzymatic deglycosylation. The identity of PrP fragments was inferred by means of antibodies spanning the full PrP sequence. We found that undigested brain homogenates contain a Nor98-specific PrP fragment migrating at 11 kDa (PrP11), truncated at both the C-terminus and the N-terminus, and not N-glycosylated. After mild PK digestion, Nor98 displayed full-length PrP (FL-PrP) and N-glycosylated C-terminal fragments (CTF), along with increased levels of PrP11. Proteinase K digestion curves (0,006-6,4 mg/ml) showed that FL-PrP and CTF are mainly digested above 0,01 mg/ml, while PrP11 is not entirely digested even at the highest concentrations, similarly to PrP27-30 associated with classical scrapie. Above 0,2 mg/ml PK, most Nor98 samples showed only PrP11 and a fragment of 17 kDa with the same properties of PrP11, that was tentatively identified as a dimer of PrP11. Detergent solubility studies showed that PrP11 is insoluble in 2% sodium laurylsorcosine and is mainly produced from detergentsoluble, full-length PrPSc. Furthermore, among Italian scrapie isolates, we found that a sample with molecular and pathological properties consistent with Nor98 showed plaque-like deposits of PrPSc in the thalamus when the brain was analysed by PrPSc immunohistochemistry. Taken together, our results show that the distinctive pathological feature of Nor98 is a PrP fragment spanning amino acids ~ 90-155. This fragment is produced by successive N-terminal and C-terminal cleavages from a full-length and largely detergent-soluble PrPSc, is produced in vivo and is extremely resistant to PK digestion.&lt;br /&gt;&lt;br /&gt;*** Intriguingly, these conclusions suggest that some pathological features of Nor98 are reminiscent of Gerstmann-Sträussler-Scheinker disease. &lt;br /&gt;&lt;br /&gt;119 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.neuroprion.com/pdf_docs/conferences/prion2006/abstract_book.pdf"&gt;http://www.neuroprion.com/pdf_docs/conferences/prion2006/abstract_book.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes &lt;br /&gt;&lt;br /&gt;Annick Le Dur*,?, Vincent Béringue*,?, Olivier Andréoletti?, Fabienne Reine*, Thanh Lan Laï*, Thierry Baron§, Bjørn Bratberg¶, Jean-Luc Vilotte?, Pierre Sarradin**, Sylvie L. Benestad¶, and Hubert Laude*,? +Author Affiliations&lt;br /&gt;&lt;br /&gt;*Virologie Immunologie Moléculaires and ?Génétique Biochimique et Cytogénétique, Institut National de la Recherche Agronomique, 78350 Jouy-en-Josas, France; ?Unité Mixte de Recherche, Institut National de la Recherche Agronomique-Ecole Nationale Vétérinaire de Toulouse, Interactions Hôte Agent Pathogène, 31066 Toulouse, France; §Agence Française de Sécurité Sanitaire des Aliments, Unité Agents Transmissibles Non Conventionnels, 69364 Lyon, France; **Pathologie Infectieuse et Immunologie, Institut National de la Recherche Agronomique, 37380 Nouzilly, France; and ¶Department of Pathology, National Veterinary Institute, 0033 Oslo, Norway&lt;br /&gt;&lt;br /&gt;***Edited by Stanley B. Prusiner, University of California, San Francisco, CA (received for review March 21, 2005)&lt;br /&gt;&lt;br /&gt;Abstract Scrapie in small ruminants belongs to transmissible spongiform encephalopathies (TSEs), or prion diseases, a family of fatal neurodegenerative disorders that affect humans and animals and can transmit within and between species by ingestion or inoculation. Conversion of the host-encoded prion protein (PrP), normal cellular PrP (PrPc), into a misfolded form, abnormal PrP (PrPSc), plays a key role in TSE transmission and pathogenesis. The intensified surveillance of scrapie in the European Union, together with the improvement of PrPSc detection techniques, has led to the discovery of a growing number of so-called atypical scrapie cases. These include clinical Nor98 cases first identified in Norwegian sheep on the basis of unusual pathological and PrPSc molecular features and "cases" that produced discordant responses in the rapid tests currently applied to the large-scale random screening of slaughtered or fallen animals. Worryingly, a substantial proportion of such cases involved sheep with PrP genotypes known until now to confer natural resistance to conventional scrapie. Here we report that both Nor98 and discordant cases, including three sheep homozygous for the resistant PrPARR allele (A136R154R171), efficiently transmitted the disease to transgenic mice expressing ovine PrP, and that they shared unique biological and biochemical features upon propagation in mice. *** These observations support the view that a truly infectious TSE agent, unrecognized until recently, infects sheep and goat flocks and may have important implications in terms of scrapie control and public health. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pnas.org/content/102/44/16031.abstract"&gt;http://www.pnas.org/content/102/44/16031.abstract&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, December 1, 2008&lt;br /&gt;&lt;br /&gt;When Atypical Scrapie cross species barriers&lt;br /&gt;&lt;br /&gt;Authors&lt;br /&gt;&lt;br /&gt;Andreoletti O., Herva M. H., Cassard H., Espinosa J. C., Lacroux C., Simon S., Padilla D., Benestad S. L., Lantier F., Schelcher F., Grassi J., Torres, J. M., UMR INRA ENVT 1225, Ecole Nationale Veterinaire de Toulouse.France; ICISA-INlA, Madrid, Spain; CEA, IBiTec-5, DSV, CEA/Saclay, Gif sur Yvette cedex, France; National Veterinary Institute, Postboks 750 Sentrum, 0106 Oslo, Norway, INRA IASP, Centre INRA de Tours, 3738O Nouzilly, France.&lt;br /&gt;&lt;br /&gt;Content&lt;br /&gt;&lt;br /&gt;Atypical scrapie is a TSE occurring in small ruminants and harbouring peculiar clinical, epidemiological and biochemical properties. Currently this form of disease is identified in a large number of countries. In this study we report the transmission of an atypical scrapie isolate through different species barriers as modeled by transgenic mice (Tg) expressing different species PRP sequence.&lt;br /&gt;&lt;br /&gt;The donor isolate was collected in 1995 in a French commercial sheep flock. inoculation into AHQ/AHQ sheep induced a disease which had all neuro-pathological and biochemical characteristics of atypical scrapie. Transmitted into Transgenic mice expressing either ovine or PrPc, the isolate retained all the described characteristics of atypical scrapie.&lt;br /&gt;&lt;br /&gt;Surprisingly the TSE agent characteristics were dramatically different v/hen passaged into Tg bovine mice. The recovered TSE agent had biological and biochemical characteristics similar to those of atypical BSE L in the same mouse model. Moreover, whereas no other TSE agent than BSE were shown to transmit into Tg porcine mice, atypical scrapie was able to develop into this model, albeit with low attack rate on first passage.&lt;br /&gt;&lt;br /&gt;Furthermore, after adaptation in the porcine mouse model this prion showed similar biological and biochemical characteristics than BSE adapted to this porcine mouse model. Altogether these data indicate.&lt;br /&gt;&lt;br /&gt;(i) the unsuspected potential abilities of atypical scrapie to cross species barriers&lt;br /&gt;&lt;br /&gt;(ii) the possible capacity of this agent to acquire new characteristics when crossing species barrier&lt;br /&gt;&lt;br /&gt;These findings raise some interrogation on the concept of TSE strain and on the origin of the diversity of the TSE agents and could have consequences on field TSE control measures. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.neuroprion.org/resources/pdf_docs/conferences/prion2008/abstract-book-prion2008.pdf"&gt;http://www.neuroprion.org/resources/pdf_docs/conferences/prion2008/abstract-book-prion2008.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;LET'S take a closer look at this new prionpathy or prionopathy, and then let's look at the g-h-BSEalabama mad cow. &lt;br /&gt;&lt;br /&gt;This new prionopathy in humans? the genetic makeup is IDENTICAL to the g-h-BSEalabama mad cow, the only _documented_ mad cow in the world to date like this, ......wait, it get's better. this new prionpathy is killing young and old humans, with LONG DURATION from onset of symptoms to death, and the symptoms are very similar to nvCJD victims, OH, and the plaques are very similar in some cases too, bbbut, it's not related to the g-h-BSEalabama cow, WAIT NOW, it gets even better, the new human prionpathy that they claim is a genetic TSE, has no relation to any gene mutation in that family. daaa, ya think it could be related to that mad cow with the same genetic make-up ??? there were literally tons and tons of banned mad cow protein in Alabama in commerce, and none of it transmitted to cows, and the cows to humans there from ??? r i g h t $$$ &lt;br /&gt;&lt;br /&gt;ALABAMA MAD COW g-h-BSEalabama &lt;br /&gt;&lt;br /&gt;In this study, we identified a novel mutation in the bovine prion protein gene (Prnp), called E211K, of a confirmed BSE positive cow from Alabama, United States of America. This mutation is identical to the E200K pathogenic mutation found in humans with a genetic form of CJD. This finding represents the first report of a confirmed case of BSE with a potential pathogenic mutation within the bovine Prnp gene. We hypothesize that the bovine Prnp E211K mutation most likely has caused BSE in "the approximately 10-year-old cow" carrying the E221K mutation. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000156"&gt;http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000156&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.plospathogens.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.ppat.1000156&amp;amp;representation=PDF"&gt;http://www.plospathogens.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.ppat.1000156&amp;amp;representation=PDF&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Saturday, August 14, 2010&lt;br /&gt;&lt;br /&gt;BSE Case Associated with Prion Protein Gene Mutation (g-h-BSEalabama) and VPSPr PRIONPATHY&lt;br /&gt;&lt;br /&gt;(see mad cow feed in COMMERCE IN ALABAMA...TSS) &lt;br /&gt;&lt;br /&gt;&lt;a href="http://prionpathy.blogspot.com/2010/08/bse-case-associated-with-prion-protein.html"&gt;http://prionpathy.blogspot.com/2010/08/bse-case-associated-with-prion-protein.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;her healthy calf also carried the mutation (J. A. Richt and S. M. Hall PLoS Pathog. 4, e1000156; 2008).&lt;br /&gt;&lt;br /&gt;This raises the possibility that the disease could occasionally be genetic in origin. Indeed, the report of the UK BSE Inquiry in 2000 suggested that the UK epidemic had most likely originated from such a mutation and argued against the scrapierelated assumption. Such rare potential pathogenic PRNP mutations could occur in countries at present considered to be free of BSE, such as Australia and New Zealand. So it is important to maintain strict surveillance for BSE in cattle, with rigorous enforcement of the ruminant feed ban (many countries still feed ruminant proteins to pigs). Removal of specified risk material, such as brain and spinal cord, from cattle at slaughter prevents infected material from entering the human food chain. Routine genetic screening of cattle for PRNP mutations, which is now available, could provide additional data on the risk to the public. Because the point mutation identified in the Alabama animals is identical to that responsible for the commonest type of familial (genetic) CJD in humans, it is possible that the resulting infective prion protein might cross the bovine-human species barrier more easily. Patients with vCJD continue to be identified. The fact that this is happening less often should not lead to relaxation of the controls necessary to prevent future outbreaks.&lt;br /&gt;&lt;br /&gt;Malcolm A. Ferguson-Smith Cambridge University Department of Veterinary Medicine, Madingley Road, Cambridge CB3 0ES, UK e-mail: maf12@cam.ac.uk Jürgen A. Richt College of Veterinary Medicine, Kansas State University, K224B Mosier Hall, Manhattan, Kansas 66506-5601, USA&lt;br /&gt;&lt;br /&gt;NATURE|Vol 457|26 February 2009 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nature.com/nature/journal/v457/n7233/full/4571079b.html"&gt;http://www.nature.com/nature/journal/v457/n7233/full/4571079b.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, June 23, 2011&lt;br /&gt;&lt;br /&gt;Experimental H-type bovine spongiform encephalopathy characterized by plaques and glial- and stellate-type prion protein deposits &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/experimental-h-type-bovine-spongiform.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/experimental-h-type-bovine-spongiform.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, July 21, 2011&lt;br /&gt;&lt;br /&gt;A Second Case of Gerstmann-Sträussler-Scheinker Disease Linked to the G131V Mutation in the Prion Protein Gene in a Dutch Patient Journal of Neuropathology &amp;amp; Experimental Neurology:&lt;br /&gt;&lt;br /&gt;August 2011 - Volume 70 - Issue 8 - pp 698-702 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/07/second-case-of-gerstmann-straussler.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/07/second-case-of-gerstmann-straussler.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;2012 &lt;br /&gt;&lt;br /&gt;Tuesday, December 20, 2011 &lt;br /&gt;&lt;br /&gt;CHRONIC WASTING DISEASE CWD WISCONSIN Almond Deer (Buckhorn Flats) Farm Update DECEMBER 2011 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&amp;gt;&amp;nbsp;The CWD infection rate was nearly 80%, the highest ever in a North American captive herd. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Despite the five year premise plan and site decontamination, The WI DNR has concerns over the bioavailability of infectious prions at this site to wild white-tail deer should these fences be removed. Current research indicates that prions can persist in soil for a minimum of 3 years. &lt;br /&gt;&lt;br /&gt;However, Georgsson et al. (2006) concluded that prions that produced scrapie disease in sheep remained bioavailable and infectious for at least 16 years in natural Icelandic environments, most likely in contaminated soil. &lt;br /&gt;&lt;br /&gt;Additionally, the authors reported that from 1978-2004, scrapie recurred on 33 sheep farms, of which 9 recurrences occurred 14-21 years after initial culling and subsequent restocking efforts; these findings further emphasize the effect of environmental contamination on sustaining TSE infectivity and that long-term persistence of prions in soils may be substantially greater than previously thought. &amp;lt; &amp;lt; &amp;lt; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://dnr.wi.gov/org/nrboard/2011/december/12-11-2b2.pdf"&gt;http://dnr.wi.gov/org/nrboard/2011/december/12-11-2b2.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;SNIP...SEE FULL TEXT ; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2011/12/chronic-wasting-disease-cwd-wisconsin.html"&gt;http://chronic-wasting-disease.blogspot.com/2011/12/chronic-wasting-disease-cwd-wisconsin.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, February 09, 2012 &lt;br /&gt;&lt;br /&gt;50 GAME FARMS IN USA INFECTED WITH CHRONIC WASTING DISEASE&lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/50-game-farms-to-date-in-usa-infected.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/50-game-farms-to-date-in-usa-infected.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Friday, February 03, 2012 &lt;br /&gt;&lt;br /&gt;Wisconsin Farm-Raised Deer Farms and CWD there from 2012 report Singeltary et al &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-farm-raised-deer-farms-and.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-farm-raised-deer-farms-and.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Saturday, February 04, 2012 &lt;br /&gt;&lt;br /&gt;Wisconsin 16 age limit on testing dead deer Game Farm CWD Testing Protocol Needs To Be Revised &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-16-age-limit-on-testing-dead.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-16-age-limit-on-testing-dead.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, February 09, 2012&lt;br /&gt;&lt;br /&gt;Colorado Farm-Raised Deer Farms and CWD there from 2012 report Singeltary et al &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/colorado-farm-raised-deer-farms-and-cwd.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/colorado-farm-raised-deer-farms-and-cwd.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Tuesday, February 14, 2012 &lt;br /&gt;&lt;br /&gt;Oppose Indiana House Bill 1265 game farming cervids &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/oppose-indiana-house-bill-1265-game.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/oppose-indiana-house-bill-1265-game.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, February 13, 2012&lt;br /&gt;&lt;br /&gt;Stop White-tailed Deer Farming from Destroying Tennessee’s Priceless Wild Deer Herd oppose HB3164 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/stop-white-tailed-deer-farming-from.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/stop-white-tailed-deer-farming-from.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, February 15, 2012 &lt;br /&gt;&lt;br /&gt;West Virginia Deer Farming Bill backed by deer farmers advances, why ? BE WARNED CWD&lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/west-virginia-deer-farming-bill-backed.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/west-virginia-deer-farming-bill-backed.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, January 22, 2012&lt;br /&gt;&lt;br /&gt;Chronic Wasting Disease CWD cervids interspecies transmission &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/01/chronic-wasting-disease-cwd-cervids.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/01/chronic-wasting-disease-cwd-cervids.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, January 26, 2012 &lt;br /&gt;&lt;br /&gt;The Risk of Prion Zoonoses &lt;br /&gt;&lt;br /&gt;Science 27 January 2012: Vol. 335 no. 6067 pp. 411-413 DOI: 10.1126/science.1218167 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/risk-of-prion-zoonoses.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/risk-of-prion-zoonoses.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, January 26, 2012 &lt;br /&gt;&lt;br /&gt;Facilitated Cross-Species Transmission of Prions in Extraneural Tissue &lt;br /&gt;&lt;br /&gt;Science 27 January 2012: Vol. 335 no. 6067 pp. 472-475 DOI: 10.1126/science.1215659 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/facilitated-cross-species-transmission.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/facilitated-cross-species-transmission.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Saturday, February 11, 2012 &lt;br /&gt;&lt;br /&gt;Prion cross-species transmission efficacy is tissue dependent &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/prion-cross-species-transmission.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/prion-cross-species-transmission.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;PIG IN A POKE !!! &lt;br /&gt;&lt;br /&gt;Sunday, January 29, 2012 &lt;br /&gt;&lt;br /&gt;Prion Disease Risks in the 21st Century 2011 PDA European Virus-TSE Safety Dr. Detwiler &lt;br /&gt;&lt;br /&gt;Dr. Detwiler published Prion Disease Risks in the 21st Century 2011 PDA European Virus-TSE Safety Forum\Presentations TSE\ Page 33 and 34 of 44 ; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pda.org/"&gt;http://www.pda.org/&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/prion-disease-risks-in-21st-century.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/prion-disease-risks-in-21st-century.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, February 12, 2012 &lt;br /&gt;&lt;br /&gt;National Prion Disease Pathology Surveillance Center Cases Examined1 (August 19, 2011) including Texas &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/national-prion-disease-pathology.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/national-prion-disease-pathology.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Terry S. Singeltary Sr. on the Creutzfeldt-Jakob Disease Public Health Crisis &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.youtube.com/watch?v=zf3lfz9NrT4"&gt;http://www.youtube.com/watch?v=zf3lfz9NrT4&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.youtube.com/watch?v=c0tWkNvhO4g"&gt;http://www.youtube.com/watch?v=c0tWkNvhO4g&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.youtube.com/watch?v=zf3lfz9NrT4&amp;amp;feature=results_main&amp;amp;playnext=1&amp;amp;list=PL780BE2AF0B62A944"&gt;http://www.youtube.com/watch?v=zf3lfz9NrT4&amp;amp;feature=results_main&amp;amp;playnext=1&amp;amp;list=PL780BE2AF0B62A944&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;full text with source references ; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/08/terry-singeltary-sr-on-creutzfeldt.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/08/terry-singeltary-sr-on-creutzfeldt.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;THESE CUTS BY THE WHITE HOUSE TO TSE PRION FUNDING COULD NOT HAVE COME AT A WORSE TIME !!!&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Tuesday, February 14, 2012 &lt;br /&gt;&lt;br /&gt;White House budget proposes cuts to ag programs including TSE PRION disease aka mad cow type disease &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/white-house-budget-proposes-cuts-to-ag.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/white-house-budget-proposes-cuts-to-ag.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;layperson &lt;br /&gt;&lt;br /&gt;Terry S. Singeltary Sr.&lt;br /&gt;&lt;br /&gt;P.O. Box 42&lt;br /&gt;&lt;br /&gt;Bacliff, Texas USA 77518&lt;br /&gt;&lt;br /&gt;flounder9@verizon.net&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2560706674003621546-1172496982439922272?l=transmissiblespongiformencephalopathy.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://transmissiblespongiformencephalopathy.blogspot.com/feeds/1172496982439922272/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/bovine-spongiform-encephalopathy-bse-31.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/1172496982439922272'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/1172496982439922272'/><link rel='alternate' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/bovine-spongiform-encephalopathy-bse-31.html' title='Bovine Spongiform Encephalopathy BSE 31 USA SENATORS ASK PRESIDENT OBAMA TO HELP SPREAD MAD COW DISEASE 2012'/><author><name>Terry S. Singeltary Sr.</name><uri>http://www.blogger.com/profile/06986622967539963260</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='22' src='http://bp2.blogger.com/_gwMAfd8g9xo/SHuerfBUR1I/AAAAAAAAAAM/nNI1xcLm_Z4/S220/scan0002.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2560706674003621546.post-1117532174102119449</id><published>2012-02-14T09:57:00.000-08:00</published><updated>2012-02-17T07:12:33.228-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='White House budget proposes cuts to ag programs including TSE PRION disease aka mad cow type disease'/><title type='text'>White House budget proposes cuts to ag programs including TSE PRION disease aka mad cow type disease</title><content type='html'>White House budget proposes cuts to ag programs including TSE PRION disease aka mad cow type disease &lt;br /&gt;&lt;br /&gt;page 91 or 213 &lt;br /&gt;&lt;br /&gt;Justification &lt;br /&gt;&lt;br /&gt;The purpose of APHIS is to prevent the introduction and spread of pests and diseases that could affect agriculture and other resources. The Budget proposes to reduce or eliminate Federal support in programs that are no longer needed or may have limited impact in responding to an infestation (e.g., the infestation may no longer be able to be controlled). Examples of programs that are being reduced or eliminated are: Johne's Disease; Cotton Pest; and Chronic Wasting Disease programs. These reductions will allow the Department of Agriculture (USDA) to focus on areas where it can achieve success. In some cases, reductions assume additional support from State and local cooperators. Total reductions of $65 million in lower-priority pest and disease programs are partially offset by increases in higher-priority programs for a net reduction of $54 million. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.whitehouse.gov/sites/default/files/omb/budget/fy2013/assets/ccs.pdf"&gt;http://www.whitehouse.gov/sites/default/files/omb/budget/fy2013/assets/ccs.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, October 27, 2011&lt;br /&gt;&lt;br /&gt;CHRONIC WASTING DISEASE (CWD) funds disappearing &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2011/10/chronic-wasting-disease-cwd-funds.html"&gt;http://chronic-wasting-disease.blogspot.com/2011/10/chronic-wasting-disease-cwd-funds.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;PRION TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY RESEARCH FUNDING U.S.A. &lt;br /&gt;&lt;br /&gt;COMPARE TO USA PRION FUNDING 2011 &lt;br /&gt;&lt;br /&gt;"which includes the ___elimination___ of Prion activities ($5,473,000)," &lt;br /&gt;&lt;br /&gt;All Other Emerging and Zoonotic Infectious Diseases CDC‘s FY 2012 request of $52,658,000 for all other emerging and zoonotic infectious disease activities is a decrease of $13,607,000 below the FY 2010 level, which includes the elimination of Prion activities ($5,473,000), a reduction for other cross-cutting infectious disease activities, and administrative savings. These funds support a range of critical emerging and zoonotic infectious disease programs such Lyme Disease, Chronic Fatigue Syndrome, and Special Pathogens, as well as other activities described below. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.cdc.gov/fmo/topic/Budget%20Information/appropriations_budget_form_pdf/FY2012_CDC_CJ_Final.pdf"&gt;http://www.cdc.gov/fmo/topic/Budget%20Information/appropriations_budget_form_pdf/FY2012_CDC_CJ_Final.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Friday, April 15, 2011 &lt;br /&gt;&lt;br /&gt;PRION TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY PROJECTS, RESEARCH FUNDING, BSE VOLUNTARY TESTING UPDATE IN NORTH AMERICA 2011 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://prionunitusaupdate2008.blogspot.com/2011/04/prion-transmissible-spongiform.html"&gt;http://prionunitusaupdate2008.blogspot.com/2011/04/prion-transmissible-spongiform.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Greetings mad cow TSE Prion community et al ; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;this does NOT surprise me. the USDA, FSIS, APHIS, CDC, FDA, NIH et al gave up a long time ago on human and animal TSE prion disease aka mad cow type disease. they failed terribly on the surveillance, testing and eradication of the mad cow type agent in all species, and just gave up$ these TSE prion disease are mutating and spreading, espeically the CWD in deer, elk, who knows what other species. yep, they cannot stop it now. so they just throw in the towel. sporadic CJD has now been linked to atypical BSE, atypical Scrapie, and scientist around the globe are very concerned about the zoonosis of CWD. however, the feds know they have lost the fight, so why waste the money on it $$$ &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;STOP HOUSE BILLS Tennessee’s HB3164 and Indiana House Bill 1265 game farming cervids &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, February 13, 2012 &lt;br /&gt;&lt;br /&gt;Stop White-tailed Deer Farming from Destroying Tennessee’s Priceless Wild Deer Herd oppose HB3164 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/stop-white-tailed-deer-farming-from.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/stop-white-tailed-deer-farming-from.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Tuesday, February 14, 2012 &lt;br /&gt;&lt;br /&gt;Oppose Indiana House Bill 1265 game farming cervids &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/oppose-indiana-house-bill-1265-game.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/oppose-indiana-house-bill-1265-game.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, February 09, 2012 &lt;br /&gt;&lt;br /&gt;50 GAME FARMS IN USA INFECTED WITH CHRONIC WASTING DISEASE &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/50-game-farms-to-date-in-usa-infected.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/50-game-farms-to-date-in-usa-infected.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Friday, February 03, 2012 &lt;br /&gt;&lt;br /&gt;Wisconsin Farm-Raised Deer Farms and CWD there from 2012 report Singeltary et al &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-farm-raised-deer-farms-and.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-farm-raised-deer-farms-and.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Saturday, February 04, 2012 &lt;br /&gt;&lt;br /&gt;Wisconsin 16 age limit on testing dead deer Game Farm CWD Testing Protocol Needs To Be Revised &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-16-age-limit-on-testing-dead.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/wisconsin-16-age-limit-on-testing-dead.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, February 09, 2012 &lt;br /&gt;&lt;br /&gt;Colorado Farm-Raised Deer Farms and CWD there from 2012 report Singeltary et al &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/02/colorado-farm-raised-deer-farms-and-cwd.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/02/colorado-farm-raised-deer-farms-and-cwd.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Comment from Terry Singeltary&lt;br /&gt;&lt;br /&gt;Document ID: APHIS-2011-0032-0002Document Type: Public Submission &lt;br /&gt;&lt;br /&gt;This is comment on Notice: Agency Information Collection Activities; Proposals, Submissions, and Approvals: Chronic Wasting Disease Herd Certification Program&lt;br /&gt;&lt;br /&gt;Docket ID: APHIS-2011-0032RIN: &lt;br /&gt;&lt;br /&gt;Topics: No Topics associated with this document&lt;br /&gt;&lt;br /&gt;View Document:&lt;br /&gt;&lt;br /&gt;Show Details &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Document Subtype: Public Comment &lt;br /&gt;&lt;br /&gt;Status: Posted &lt;br /&gt;&lt;br /&gt;Received Date: January 24 2012, at 12:00 AM Eastern Standard Time  &lt;br /&gt;&lt;br /&gt;Date Posted: January 25 2012, at 12:00 AM Eastern Standard Time  &lt;br /&gt;&lt;br /&gt;Comment Start Date: January 24 2012, at 12:00 AM Eastern Standard Time  &lt;br /&gt;&lt;br /&gt;Comment Due Date: March 26 2012, at 11:59 PM Eastern Daylight Time  &lt;br /&gt;&lt;br /&gt;Tracking Number: xxxxxxx&lt;br /&gt;First Name: Terry &lt;br /&gt;Middle Name: S. &lt;br /&gt;Last Name: Singeltary &lt;br /&gt;City: Bacliff &lt;br /&gt;Country: United States &lt;br /&gt;State or Province: TX &lt;br /&gt;Organization Name: LAYPERSON &lt;br /&gt;Submitter's Representative: CJD TSE PRION VICTIMS &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Comment:&lt;br /&gt;&lt;br /&gt;Agency Information Collection Activities; Proposals, Submissions, and Approvals: Chronic Wasting Disease Herd Certification Program (Document ID APHIS-2011-0032-0001) I believe that any voluntary program for CWD free herd certification from game farms will be futile, as was the partial and voluntary mad cow feed ban of August 4, 1997. That failed terribly, with some 10,000,000 of banned blood laced MBM being fed out in 2007, a decade post August 4, 1997 partial and voluntary ban. Game farms are a petri dish for CWD TSE Prion disease, with Wisconsin having documented 9 CWD infected game farms, with one having the highest CWD infection rate in the world, 80% CWD infection rate. I believe that all game farms should be SHUT DOWN PERMANENTLY. CWD TSE prion disease survives ashing to 600 degrees celsius, that’s around 1112 degrees farenheit. you cannot cook the CWD TSE prion disease out of meat. you can take the ash and mix it with saline and inject that ash into a mouse, and the mouse will go down with TSE. Prion Infected Meat-and-Bone Meal Is Still Infectious after Biodiesel Production as well. the TSE prion agent also survives Simulated Wastewater Treatment Processes. IN fact, you should also know that the CWD TSE Prion agent will survive in the environment for years, if not decades. you can bury it and it will not go away. CWD TSE agent is capable of infected your water table i.e. Detection of protease-resistant cervid prion protein in water from a CWD-endemic area. it’s not your ordinary pathogen you can just cook it out and be done with. that’s what’s so worrisome about Iatrogenic mode of transmission, a simple autoclave will not kill this TSE prion agent. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Tuesday, December 20, 2011 CHRONIC WASTING DISEASE CWD WISCONSIN Almond Deer &lt;br /&gt;&lt;br /&gt;(Buckhorn Flats) Farm Update DECEMBER 2011 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://dnr.wi.gov/org/nrboard/2011/december/12-11-2b2.pdf"&gt;http://dnr.wi.gov/org/nrboard/2011/december/12-11-2b2.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/"&gt;http://chronic-wasting-disease.blogspot.com/&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;additional data submission ;&lt;br /&gt;&lt;br /&gt;Name: Terry S. Singeltary&lt;br /&gt;&lt;br /&gt;Address: &lt;br /&gt;Bacliff, TX, &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Submitter's Representative: CJD TSE PRION VICTIMS&lt;br /&gt;&lt;br /&gt;Organization: LAYPERSON&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;--------------------------------------------------------------------------------&lt;br /&gt;&lt;br /&gt;General Comment&lt;br /&gt;Agency Information Collection Activities; Proposals, Submissions, and Approvals: Chronic Wasting Disease Herd Certification Program (Document ID APHIS-2011-0032-0001)&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;I believe that any voluntary program for CWD free herd certification from game farms will be futile, as was the partial and voluntary mad cow feed ban of August 4, 1997. That failed terribly, with some 10,000,000 of banned blood laced MBM being fed out in 2007, a decade post August 4, 1997 partial and voluntary ban. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Game farms are a petri dish for CWD TSE Prion disease, with Wisconsin having documented 9 CWD infected game farms, with one having the highest CWD infection rate in the world, 80% CWD infection rate.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;I believe that all game farms should be SHUT DOWN PERMANENTLY.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;CWD TSE prion disease survives ashing to 600 degrees celsius, that’s around 1112 degrees farenheit. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;you cannot cook the CWD TSE prion disease out of meat. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;you can take the ash and mix it with saline and inject that ash into a mouse, and the mouse will go down with TSE. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Prion Infected Meat-and-Bone Meal Is Still Infectious after Biodiesel Production as well. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;the TSE prion agent also survives Simulated Wastewater Treatment Processes. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;IN fact, you should also know that the CWD TSE Prion agent will survive in the environment for years, if not decades. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;you can bury it and it will not go away. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;CWD TSE agent is capable of infected your water table i.e. Detection of protease-resistant cervid prion protein in water from a CWD-endemic area. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;it’s not your ordinary pathogen you can just cook it out and be done with. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;that’s what’s so worrisome about Iatrogenic mode of transmission, a simple autoclave will not kill this TSE prion agent. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Tuesday, December 20, 2011 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;CHRONIC WASTING DISEASE CWD WISCONSIN Almond Deer (Buckhorn Flats) Farm Update DECEMBER 2011 &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://dnr.wi.gov/org/nrboard/2011/december/12-11-2b2.pdf"&gt;http://dnr.wi.gov/org/nrboard/2011/december/12-11-2b2.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/"&gt;http://chronic-wasting-disease.blogspot.com/&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.regulations.gov/#!documentDetail;D=APHIS-2011-0032-0002"&gt;http://www.regulations.gov/#!documentDetail;D=APHIS-2011-0032-0002&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, January 22, 2012 &lt;br /&gt;&lt;br /&gt;Chronic Wasting Disease CWD cervids interspecies transmission &lt;br /&gt;&lt;br /&gt;&lt;a href="http://chronic-wasting-disease.blogspot.com/2012/01/chronic-wasting-disease-cwd-cervids.html"&gt;http://chronic-wasting-disease.blogspot.com/2012/01/chronic-wasting-disease-cwd-cervids.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, January 26, 2012 &lt;br /&gt;&lt;br /&gt;The Risk of Prion Zoonoses &lt;br /&gt;&lt;br /&gt;Science 27 January 2012: Vol. 335 no. 6067 pp. 411-413 DOI: 10.1126/science.1218167 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/risk-of-prion-zoonoses.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/risk-of-prion-zoonoses.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, January 26, 2012 &lt;br /&gt;&lt;br /&gt;Facilitated Cross-Species Transmission of Prions in Extraneural Tissue &lt;br /&gt;&lt;br /&gt;Science 27 January 2012: Vol. 335 no. 6067 pp. 472-475 DOI: 10.1126/science.1215659 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/facilitated-cross-species-transmission.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/facilitated-cross-species-transmission.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Monday, October 10, 2011 &lt;br /&gt;&lt;br /&gt;EFSA Journal 2011 The European Response to BSE: A Success Story &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;EFSA and the European Centre for Disease Prevention and Control (ECDC) recently delivered a scientific opinion on any possible epidemiological or molecular association between TSEs in animals and humans (EFSA Panel on Biological Hazards (BIOHAZ) and ECDC, 2011). This opinion confirmed Classical BSE prions as the only TSE agents demonstrated to be zoonotic so far but the possibility that a small proportion of human cases so far classified as "sporadic" CJD are of zoonotic origin could not be excluded. Moreover, transmission experiments to non-human primates suggest that some TSE agents in addition to Classical BSE prions in cattle (namely L-type Atypical BSE, Classical BSE in sheep, transmissible mink encephalopathy (TME) and chronic wasting disease (CWD) agents) might have zoonotic potential. &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1"&gt;http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf"&gt;http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;see follow-up here about North America BSE Mad Cow TSE prion risk factors, and the ever emerging strains of Transmissible Spongiform Encephalopathy in many species here in the USA, including humans ; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Thursday, August 12, 2010 &lt;br /&gt;&lt;br /&gt;Seven main threats for the future linked to prions &lt;br /&gt;&lt;br /&gt;First threat &lt;br /&gt;&lt;br /&gt;The TSE road map defining the evolution of European policy for protection against prion diseases is based on a certain numbers of hypotheses some of which may turn out to be erroneous. In particular, a form of BSE (called atypical Bovine Spongiform Encephalopathy), recently identified by systematic testing in aged cattle without clinical signs, may be the origin of classical BSE and thus potentially constitute a reservoir, which may be impossible to eradicate if a sporadic origin is confirmed. &lt;br /&gt;&lt;br /&gt;***Also, a link is suspected between atypical BSE and some apparently sporadic cases of Creutzfeldt-Jakob disease in humans. These atypical BSE cases constitute an unforeseen first threat that could sharply modify the European approach to prion diseases. &lt;br /&gt;&lt;br /&gt;Second threat &lt;br /&gt;&lt;br /&gt;snip... &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.neuroprion.org/en/np-neuroprion.html"&gt;http://www.neuroprion.org/en/np-neuroprion.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Rural and Regional Affairs and Transport References Committee&lt;br /&gt;&lt;br /&gt;The possible impacts and consequences for public health, trade and agriculture of the Government's decision to relax import restrictions on beef Final report June 2010&lt;br /&gt;&lt;br /&gt;2.65 At its hearing on 14 May 2010, the committee heard evidence from Dr Alan Fahey who has recently submitted a thesis on the clinical neuropsychiatric, epidemiological and diagnostic features of Creutzfeldt-Jakob disease.48 Dr Fahey told the committee of his concerns regarding the lengthy incubation period for transmissible spongiform encephalopathies, the inadequacy of current tests and the limited nature of our current understanding of this group of diseases.49&lt;br /&gt;&lt;br /&gt;2.66 Dr Fahey also told the committee that in the last two years a link has been established between forms of atypical CJD and atypical BSE. Dr Fahey said that: They now believe that those atypical BSEs overseas are in fact causing sporadic Creutzfeldt-Jakob disease. They were not sure if it was due to mad sheep disease or a different form. If you look in the textbooks it looks like this is just arising by itself. But in my research I have a summary of a document which states that there has never been any proof that sporadic Creutzfeldt-Jakob disease has arisen de novo-has arisen of itself. There is no proof of that. The recent research is that in fact it is due to atypical forms of mad cow disease which have been found across Europe, have been found in America and have been found in Asia. These atypical forms of mad cow disease typically have even longer incubation periods than the classical mad cow disease.50 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.aph.gov.au/senate/committee/rrat_ctte/mad_cows/report/report.pdf"&gt;http://www.aph.gov.au/senate/committee/rrat_ctte/mad_cows/report/report.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Atypical BSE in Cattle &lt;br /&gt;&lt;br /&gt;To date the OIE/WAHO assumes that the human and animal health standards set out in the BSE chapter for classical BSE (C-Type) applies to all forms of BSE which include the H-type and L-type atypical forms. This assumption is scientifically not completely justified and accumulating evidence suggests that this may in fact not be the case. Molecular characterization and the spatial distribution pattern of histopathologic lesions and immunohistochemistry (IHC) signals are used to identify and characterize atypical BSE. Both the L-type and H-type atypical cases display significant differences in the conformation and spatial accumulation of the disease associated prion protein (PrPSc) in brains of afflicted cattle. Transmission studies in bovine transgenic and wild type mouse models support that the atypical BSE types might be unique strains because they have different incubation times and lesion profiles when compared to C-type BSE. When L-type BSE was inoculated into ovine transgenic mice and Syrian hamster the resulting molecular fingerprint had changed, either in the first or a subsequent passage, from L-type into C-type BSE. &lt;br /&gt;&lt;br /&gt;In addition, non-human primates are specifically susceptible for atypical BSE as demonstrated by an approximately 50% shortened incubation time for L-type BSE as compared to C-type. Considering the current scientific information available, it cannot be assumed that these different BSE types pose the same human health risks as C-type BSE or that these risks are mitigated by the same protective measures. &lt;br /&gt;&lt;br /&gt;This study will contribute to a correct definition of specified risk material (SRM) in atypical BSE. The incumbent of this position will develop new and transfer existing, ultra-sensitive methods for the detection of atypical BSE in tissue of experimentally infected cattle. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2"&gt;http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;When L-type BSE was inoculated into ovine transgenic mice and Syrian hamster the resulting molecular fingerprint had changed, either in the first or a subsequent passage, from L-type into C-type BSE. In addition, non-human primates are specifically susceptible for atypical BSE as demonstrated by an approximately 50% shortened incubation time for L-type BSE as compared to C-type. Considering the current scientific information available, it cannot be assumed that these different BSE types pose the same human health risks as C-type BSE or that these risks are mitigated by the same protective measures. &lt;br /&gt;&lt;br /&gt;This study will contribute to a correct definition of specified risk material (SRM) in atypical BSE. The incumbent of this position will develop new and transfer existing, ultra-sensitive methods for the detection of atypical BSE in tissue of experimentally infected cattle. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2"&gt;http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;The conclusions state that, at present, the only TSE agent demonstrated to be zoonotic is the classical BSE agent. Active screening has allowed the identification of 3 new forms of animal TSEs (H-type atypical BSE, L-type atypical BSE, and atypical scrapie), but the information obtained has major limitations due to the unknown sensitivity of the current monitoring system for these TSEs. There is no epidemiological evidence to suggest that classical scrapie is zoonotic. The epidemiological data are too limited to conclude whether the atypical scrapie agent has a zoonotic potential. Transmission experiments to human PrP transgenic mice or primates suggest that some TSE agents other than the classical BSE agent in cattle (namely L-type atypical BSE, classical BSE in sheep, TME, CWD agents) might have zoonotic potential and indicate that that of the L-type atypical BSE agent appears similar or even higher than that of the classical BSE agent. A single study reported efficient transmission of a natural sheep classical scrapie isolate to primates. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.promedmail.org/direct.php?id=20110607.1736"&gt;http://www.promedmail.org/direct.php?id=20110607.1736&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, January 18, 2012&lt;br /&gt;&lt;br /&gt;BSE IN GOATS CAN BE MISTAKEN FOR SCRAPIE &lt;br /&gt;&lt;br /&gt;February 1, 2012 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/bse-in-goats-can-be-mistaken-for.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/bse-in-goats-can-be-mistaken-for.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Owens, Julie&lt;br /&gt;&lt;br /&gt;From: Terry S. Singeltary Sr. [flounder9@verizon.net]&lt;br /&gt;&lt;br /&gt;Sent: Monday, July 24, 2006 1:09 PM&lt;br /&gt;&lt;br /&gt;To: FSIS RegulationsComments&lt;br /&gt;&lt;br /&gt;Subject: [Docket No. FSIS-2006-0011] FSIS Harvard Risk Assessment of Bovine Spongiform Encephalopathy (BSE)&lt;br /&gt;&lt;br /&gt;Page 1 of 98 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/OPPDE/Comments/2006-0011/2006-0011-1.pdf"&gt;http://www.fsis.usda.gov/OPPDE/Comments/2006-0011/2006-0011-1.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;FSIS RFEPLY TO TSS ; &lt;br /&gt;&lt;br /&gt;Harvard Risk Assessment of Bovine Spongiform Encephalopathy Update, October 31, 2005 INTRODUCTION The United States Department of Agriculture’s Food Safety and Inspection Service (FSIS) held a public meeting on July 25, 2006 in Washington, D.C. to present findings from the Harvard Risk Assessment of Bovine Spongiform Encephalopathy Update, October 31, 2005 (report and model located on the FSIS website: &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/Science/Risk_Assessments/index.asp"&gt;http://www.fsis.usda.gov/Science/Risk_Assessments/index.asp&lt;/a&gt;). &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Comments on technical aspects of the risk assessment were then submitted to FSIS. &lt;br /&gt;&lt;br /&gt;Comments were received from Food and Water Watch, Food Animal Concerns Trust (FACT), Farm Sanctuary, R-CALF USA, Linda A Detwiler, and Terry S. Singeltary. &lt;br /&gt;&lt;br /&gt;This document provides itemized replies to the public comments received on the 2005 updated Harvard BSE risk assessment. Please bear the following points in mind: &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.fsis.usda.gov/PDF/BSE_Risk_Assess_Response_Public_Comments.pdf"&gt;http://www.fsis.usda.gov/PDF/BSE_Risk_Assess_Response_Public_Comments.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;THE steady rise of sporadic CJD cases in Canada AND USA, with many unusual cases of ''PENDING CLASSIFICATIONS" which have been pending now FOR 3 YEARS. HOW long can this cover-up continue $$$ &lt;br /&gt;&lt;br /&gt;The most recent assessments (and reassessments) were published in June 2005 (Table I; 18), and included the categorisation of Canada, the USA, and Mexico as GBR III. Although only Canada and the USA have reported cases, the historically open system of trade in North America suggests that it is likely that BSE is present also in Mexico. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.oie.int/boutique/extrait/06heim937950.pdf"&gt;http://www.oie.int/boutique/extrait/06heim937950.pdf&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;SEE FULL TEXT AND MORE HERE ; &lt;br /&gt;&lt;br /&gt;Saturday, March 5, 2011 &lt;br /&gt;&lt;br /&gt;MAD COW ATYPICAL CJD PRION TSE CASES WITH CLASSIFICATIONS PENDING ON THE RISE IN NORTH AMERICA &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/03/mad-cow-atypical-cjd-prion-tse-cases.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/03/mad-cow-atypical-cjd-prion-tse-cases.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;PIG AND A POKE !!! &lt;br /&gt;&lt;br /&gt;pharmaceuticals and porcine and TSE prion &lt;br /&gt;&lt;br /&gt;old concerns made new again. they had the science and risk factor there from 2 decades ago, political science won out $$$ i.e. TRADE $$$ thanks to the OIE and the USDA et al. ...TSS &lt;br /&gt;&lt;br /&gt;Sunday, January 29, 2012 &lt;br /&gt;&lt;br /&gt;Prion Disease Risks in the 21st Century 2011 PDA European Virus-TSE Safety Dr. Detwiler &lt;br /&gt;&lt;br /&gt;Dr. Detwiler published Prion Disease Risks in the 21st Century 2011 PDA European Virus-TSE Safety Forum\Presentations TSE\ Page 33 and 34 of 44 ; &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pda.org/"&gt;http://www.pda.org/&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/prion-disease-risks-in-21st-century.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/01/prion-disease-risks-in-21st-century.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, February 1, 2012 &lt;br /&gt;&lt;br /&gt;CJD and PLASMA / URINE PRODUCTS EMA Position Statements Alberto Ganan Jimenez, European Medicines Agency PDA TSE Safety Forum, 30 June 2011 &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/cjd-and-plasma-urine-products-ema.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/cjd-and-plasma-urine-products-ema.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Wednesday, February 1, 2012 &lt;br /&gt;&lt;br /&gt;Prion Disease Risks in the 21st Century 2011 PDA European Virus-TSE Safety Update on CJD and VCJD Transmission RG Will &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/prion-disease-risks-in-21st-century.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/prion-disease-risks-in-21st-century.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;WHAT ABOUT THAT partial and voluntary mad cow feed ban of August 4, 1997, you know the one, the one that was NOTHING BUT INK ON PAPER $$$ &lt;br /&gt;&lt;br /&gt;Sunday, February 5, 2012 &lt;br /&gt;&lt;br /&gt;February 2012 Update on Feed Enforcement Activities to Limit the Spread of BSE &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/february-2012-update-on-feed.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/february-2012-update-on-feed.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Friday, February 10, 2012 &lt;br /&gt;&lt;br /&gt;Creutzfeldt-Jakob disease (CJD) biannual update (2012/1) potential iatrogenic (healthcare-acquired) exposure to CJD, and on the National Anonymous Tonsil Archive &lt;br /&gt;&lt;br /&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2012/02/creutzfeldt-jakob-disease-cjd-biannual.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2012/02/creutzfeldt-jakob-disease-cjd-biannual.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sunday, February 12, 2012 &lt;br /&gt;&lt;br /&gt;National Prion Disease Pathology Surveillance Center Cases Examined1 (August 19, 2011) including Texas &lt;br /&gt;&lt;br /&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/national-prion-disease-pathology.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/national-prion-disease-pathology.html&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;layperson &lt;br /&gt;&lt;br /&gt;Terry S. Singeltary Sr. &lt;br /&gt;P.O. Box 42&lt;br /&gt;Bacliff, Texas USA 77518&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2560706674003621546-1117532174102119449?l=transmissiblespongiformencephalopathy.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://transmissiblespongiformencephalopathy.blogspot.com/feeds/1117532174102119449/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/white-house-budget-proposes-cuts-to-ag.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/1117532174102119449'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2560706674003621546/posts/default/1117532174102119449'/><link rel='alternate' type='text/html' href='http://transmissiblespongiformencephalopathy.blogspot.com/2012/02/white-house-budget-proposes-cuts-to-ag.html' title='White House budget proposes cuts to ag programs including TSE PRION disease aka mad cow type disease'/><author><name>Terry S. Singeltary Sr.</name><uri>http://www.blogger.com/profile/06986622967539963260</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='22' src='http://bp2.blogger.com/_gwMAfd8g9xo/SHuerfBUR1I/AAAAAAAAAAM/nNI1xcLm_Z4/S220/scan0002.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2560706674003621546.post-536815840888492447</id><published>2012-02-12T19:42:00.000-08:00</published><updated>2012-02-12T19:42:16.699-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='National Prion Disease Pathology Surveillance Center Cases Examined1 (August 19'/><category scheme='http://www.blogger.com/atom/ns#' term='2011) including Texas'/><title type='text'>National Prion Disease Pathology Surveillance Center Cases Examined1 (August 19, 2011) including Texas</title><content type='html'>&lt;div&gt;National Prion Disease Pathology Surveillance Center Cases Examined1  (August 19, 2011) including Texas&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;See where sporadic CJD on a steady increase, with unknown type pending  cases rising. also, notice the sporadic FFI cases in TEXAS of the very young,  with long duration. we have heard it all before. same old BSe $$$&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;See where sporadic CJD went from 33 cases in 1996 and before, to 68 cases  in 1997, and from there a steady increase until topping out at 215 cases in  2010. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2011 cases still pending so count not final yet. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;the UKBSEnvCJD only theory has got to be reevaluated. Sporadic CJD is  rising in the EU Countries as well. this sporadic FFI and sporadic GSS, no link  to any family gene? really? not related to any TSE prion disease in any species  documented in North America, and or friendly fire there from i.e. iCJD ???  c-BSE, h-BSE, L-BSE, scrapie (over 20 strains documented), atypical nor-98  scrapie, 2 strains documented in CWD, TME, all fed back to food producing  animals for humans and animals for decades. no human TSE prion disease there  from...really???&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;really???&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;National Prion Disease Pathology Surveillance Center Cases Examined1  (August 19, 2011)&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Year Total Referrals2 Prion Disease Sporadic Familial Iatrogenic vCJD&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;1996 &amp;amp; earlier 51 33 28 5 0 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;1997 114 68 59 9 0 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;1998 88 52 43 7 1 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;1999 122 74 65 8 1 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2000 145 103 89 14 0 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2001 210 120 110 10 0 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2002 248 149 125 22 2 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2003 274 176 137 39 0 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2004 325 186 164 21 0 13&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2005 344 194 157 36 1 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2006 382 196 166 28 0 24&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2007 376 212 186 26 0 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2008 396 232 206 26 0 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2009 423 256 213 43 0 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2010 412 256 215 41 0 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2011 216 134 105 21 0 0&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;TOTAL 41265 24416 2068 356 5 3&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;1 Listed based on the year of death or, if not available, on year of  referral; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2 Cases with suspected prion disease for which brain tissue and/or blood  (in familial cases) were submitted; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;3 Disease acquired in the United Kingdom; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;4 Disease was acquired in the United Kingdom in one case and in Saudi  Arabia in the other case; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;5 Includes 8 cases in which the diagnosis is pending, and 18 inconclusive  cases; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;6 Includes 9 (8 from 2011) cases with type determination pending in which  the diagnosis of vCJD has been excluded.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.cjdsurveillance.com/pdf/case-table.pdf" title="http://www.cjdsurveillance.com/pdf/case-table.pdf"&gt;http://www.cjdsurveillance.com/pdf/case-table.pdf&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="word-wrap: break-word;"&gt;&lt;span style="color: #997755; font-family: Arial;"&gt;&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Monday, September 26, 2011&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Singeltary et al &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionopathy.blogspot.com/2011/09/variably-protease-sensitive-prionopathy.html" style="word-wrap: break-word;"&gt;&lt;span style="color: #cc3300;"&gt;&lt;span style="font-family: Georgia; text-decoration: none;"&gt;&lt;span style="font-size: 22.5pt;"&gt;Variably Protease-Sensitive Prionopathy, Prionpathy,  Prionopathy, FFI, GSS, gCJD, hvCJD, sCJD, TSE, PRION, update  2011&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionopathy.blogspot.com/2011/09/variably-protease-sensitive-prionopathy.html" title="http://prionopathy.blogspot.com/2011/09/variably-protease-sensitive-prionopathy.html"&gt;http://prionopathy.blogspot.com/2011/09/variably-protease-sensitive-prionopathy.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sunday, November 28, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionopathy.blogspot.com/2010/11/variably-protease-sensitive-prionopathy.html" style="word-wrap: break-word;"&gt;&lt;span style="color: #cc3300;"&gt;&lt;span style="font-family: Georgia; text-decoration: none;"&gt;&lt;span style="font-size: 22.5pt;"&gt;Variably protease-sensitive prionopathy in a PRNP  codon 129 heterozygous UK patient with co-existing tau, a synuclein and AB  pathology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #333333; font-size: 22.5pt;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionopathy.blogspot.com/" title="http://prionopathy.blogspot.com/"&gt;http://prionopathy.blogspot.com/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Saturday, August 14, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionpathy.blogspot.com/2010/08/bse-case-associated-with-prion-protein.html" style="word-wrap: break-word;"&gt;&lt;span style="color: #cc3300;"&gt;&lt;span style="font-family: Georgia; text-decoration: none;"&gt;&lt;span style="font-size: 22.5pt;"&gt;BSE Case Associated with Prion Protein Gene Mutation  (g-h-BSEalabama) and VPSPr PRIONPATHY&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #333333; font-size: 22.5pt;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionpathy.blogspot.com/2010/08/bse-case-associated-with-prion-protein.html" title="http://prionpathy.blogspot.com/2010/08/bse-case-associated-with-prion-protein.html"&gt;http://prionpathy.blogspot.com/2010/08/bse-case-associated-with-prion-protein.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Saturday, August 14, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #333333; font-size: 22.5pt;"&gt;BSE Case  Associated with Prion Protein Gene Mutation (g-h-BSEalabama) and VPSPr  PRIONPATHY &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionpathy.blogspot.com/2010/08/bse-case-associated-with-prion-protein.html" title="http://prionpathy.blogspot.com/2010/08/bse-case-associated-with-prion-protein.html"&gt;http://prionpathy.blogspot.com/2010/08/bse-case-associated-with-prion-protein.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Tuesday, August 03, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Variably protease-sensitive prionopathy: A new sporadic disease of the  prion protein &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Here we go folks. AS predicted. THIS JUST OUT !&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;kind regards, terry&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Original Article&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Variably protease-sensitive prionopathy: A new sporadic disease of the  prion protein&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Wen-Quan Zou, MD, PhD 1 *, Gianfranco Puoti, MD, PhD 1, Xiangzhu Xiao, PhD  1, Jue Yuan, BA 1, Liuting Qing, PhD 1, Ignazio Cali, MSc 1, Miyuki Shimoji, PhD  1, Jan P.M. Langeveld, PhD 2, Rudy Castellani, MD 3, Silvio Notari, PhD 1,  Barbara Crain, MD 4, Robert E. Schmidt, MD 5, Michael Geschwind, MD 6, Stephen  J. DeArmond, MD, PhD 6, Nigel J. Cairns, MD 7, Dennis Dickson, MD 8, Lawrence  Honig, MD 9, Juan Maria Torres, PhD 10, James Mastrianni, MD, PhD 11, Sabina  Capellari, MD 12, Giorgio Giaccone, MD 13, Ermias D. Belay, MD 14, Lawrence B.  Schonberger, MD, MPH 14, Mark Cohen, MD 1, George Perry, PhD 15, Qingzhong Kong,  PhD 1, Piero Parchi, MD, PhD 12, Fabrizio Tagliavini, MD 13, Pierluigi Gambetti,  MD 1 * 1Department of Pathology, National Prion Disease Pathology Surveillance  Center, Case Western Reserve University, Cleveland, OH 2Central Veterinary  Institute of Wageningen, Lelystad, the Netherlands 3Department of  Neuropathology, University of Maryland Medical Center, Baltimore, MD 4Department  of Neuropathology, Johns Hopkins University, Baltimore, MD 5Department of  Neuropathology, Washington University, St. Louis, MO 6Department of Pathology,  University of California at San Francisco, San Francisco, CA 7Departments of  Neurology, Pathology, and Immunology, Washington University, St. Louis, MO  8Department of Neuropathology, Mayo Clinic-Jacksonville, Jacksonville, FL 9New  York Presbyterian Hospital, Columbia University, New York, NY 10Centro de  Investigación en Sanidad Animal, Madrid, Spain 11Department of Neurology,  University of Chicago, Chicago, IL 12Department of Neurological Sciences,  University of Bologna, Dipartimento di Scienze Neurologiche, Università di  Bologna, Bologna, Italy 13IRCCS Foundation, National Neurological Institute,  Instituto Nazionale Neurologico Carlo Besta, Milan, Italy 14Center of  Investigation on Animal Health, Centers for Disease Control and Prevention,  Atlanta, GA 15College of Science, University of Texas at San Antonio, San  Antonio, TX&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&amp;gt;&amp;gt;&amp;gt; Because 8 out of 10 patients had a positive family  history of dementia in the original study, a genetic cause was suspected.  Although all cases were homozygous for valine at codon 129 of the PrP gene, NO  mutations were detected.&amp;lt;&amp;lt;&amp;lt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2010/08/variably-protease-sensitive-prionopathy.html" title="http://creutzfeldt-jakob-disease.blogspot.com/2010/08/variably-protease-sensitive-prionopathy.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2010/08/variably-protease-sensitive-prionopathy.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;NOW, we have a new prion TSE disease in the USA in humans, in the very  young, with very long clinical durations, now they want to call it prionpathy or  prionopathy or what they are calling variably protease-sensitive prionopathy: A  new sporadic Disease of the Prion Protein, and I don’t think it’s new at all.  just another strain or phenotype of the same old Scrapie. I’m no scientist, but  I don’t believe today, nor did I believe 15 years ago, that 85%+ of all human  TSE prion disease i.e. sporadic CJD, just happens, a happenstance of bad luck, a  protein that either twisted too good, or too bad, and that none of it is related  either directly or indirectly to the livestock and or wild animals we eat that  have TSE prion disease. a new genetic TSE prion disease sFFI or sGSS, but yet  not be tied to any family member??? could it be a iatrogenic genetic TSE???  blame it on that I guess instead of the livestock/wild animals with TSE prion  disease, and or friendly fire there from. that’s probably what they should do to  keep the obvious from the public domain. ...really...TSS&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Report from Gambetti et al USA Prion Unit National Prion Disease Pathology  Surveillance Center Cases Examined 1 (April 28, 2011)&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.cjdfoundation.org/presentations/13.pdf" title="http://www.cjdfoundation.org/presentations/13.pdf"&gt;http://www.cjdfoundation.org/presentations/13.pdf&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; g-h-BSEalabama &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;BSE Case Associated with Prion Protein Gene Mutation&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Bovine spongiform encephalopathy (BSE) is a transmissible spongiform  encephalopathy (TSE) of cattle and was first detected in 1986 in the United  Kingdom. It is the most likely cause of variant Creutzfeldt-Jakob disease (CJD)  in humans. The origin of BSE remains an enigma. Here we report an H-type BSE  case associated with the novel mutation E211K within the prion protein gene  (Prnp). Sequence analysis revealed that the animal with H-type BSE was  heterozygous at Prnp nucleotides 631 through 633. An identical pathogenic  mutation at the homologous codon position (E200K) in the human Prnp has been  described as the most common cause of genetic CJD. This finding represents the  first report of a confirmed case of BSE with a potential pathogenic mutation  within the bovine Prnp gene. A recent epidemiological study revealed that the  K211 allele was not detected in 6062 cattle from commercial beef processing  plants and 42 cattle breeds, indicating an extremely low prevalence of the E211K  variant (less than 1 in 2000) in cattle.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Author Summary Top&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Bovine spongiform encephalopathy (BSE or Mad Cow Disease), a transmissible  spongiform encephalopathy (TSE) or prion disease of cattle, was first discovered  in the United Kingdom in 1986. BSE is most likely the cause of a human prion  disease known as variant Creutzfeldt Jakob Disease (vCJD). In this study, we  identified a novel mutation in the bovine prion protein gene (Prnp), called  E211K, of a confirmed BSE positive cow from Alabama, United States of America.  This mutation is identical to the E200K pathogenic mutation found in humans with  a genetic form of CJD. This finding represents the first report of a confirmed  case of BSE with a potential pathogenic mutation within the bovine Prnp gene. We  hypothesize that the bovine Prnp E211K mutation most likely has caused BSE in  “the approximately 10-year-old cow” carrying the E221K mutation. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000156"&gt;http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000156&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.plospathogens.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.ppat.1000156&amp;amp;representation=PDF"&gt;http://www.plospathogens.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.ppat.1000156&amp;amp;representation=PDF&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Wednesday, July 9, 2008&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;10 people killed by new CJD-like disease USA&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://cjdmadcowbaseoct2007.blogspot.com/2008/07/10-people-killed-by-new-cjd-like.html"&gt;http://cjdmadcowbaseoct2007.blogspot.com/2008/07/10-people-killed-by-new-cjd-like.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thursday, July 10, 2008&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;A Novel Human Disease with Abnormal Prion Protein Sensitive to Protease  update July 10, 2008&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://cjdmadcowbaseoct2007.blogspot.com/2008/07/novel-human-disease-with-abnormal-prion.html"&gt;http://cjdmadcowbaseoct2007.blogspot.com/2008/07/novel-human-disease-with-abnormal-prion.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thursday, July 10, 2008&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;A New Prionopathy update July 10, 2008&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://cjdmadcowbaseoct2007.blogspot.com/2008/07/new-prionopathy-update-july-10-2008.html"&gt;http://cjdmadcowbaseoct2007.blogspot.com/2008/07/new-prionopathy-update-july-10-2008.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sunday, August 10, 2008&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;A New Prionopathy OR more of the same old BSe and sporadic CJD&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2008/08/new-prionopathy-or-more-of-same-old-bse.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2008/08/new-prionopathy-or-more-of-same-old-bse.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thursday, August 12, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #333333; font-size: 22.5pt;"&gt;Seven main  threats for the future linked to prions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #333333; font-family: Georgia;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionpathy.blogspot.com/2010/08/seven-main-threats-for-future-linked-to.html" title="http://prionpathy.blogspot.com/2010/08/seven-main-threats-for-future-linked-to.html"&gt;http://prionpathy.blogspot.com/2010/08/seven-main-threats-for-future-linked-to.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionpathy.blogspot.com/" title="http://prionpathy.blogspot.com/"&gt;http://prionpathy.blogspot.com/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;sporadic FFI and sporadic GSS ???&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; O.10.5&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;A novel human prion disease affecting subjects with the three prion protein  codon 129 genotypes: could it be the sporadic form of  Gerstmann-Straussler?&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Pierluigi Gambetti Case Western Reserve University, USA&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Background: We recently described a novel prion disease, named  protease-sensitive prionopathy or PSPr, characterized by the presence of an  abnormal prion protein (PrP) that was 60 fold less protease resistant than that  of sporadic Creutzfeldt-Jakob disease (sCJD) and on immunoblot generated a  distinct ladder-like profile. All affected subjects where homozygous for valine  at codon 129 (VV) and had no mutation in the PrP gene.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Methods: We have characterized several new cases in our surveillance and  received from Europe.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Results:&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;1) A disease overall similar to that reported in the 129VV subjects also  affects subjects that are methionine/valine heterozygous (MV) and methionine  homozygous (MM) at codon 129 and have no PrP gene mutation;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2) The clinical and histopathological features of the new MV and MM PSPr  cases are similar but distinguishable from those of the original VV cases; 3)  The electrophoretic profiles generated by the abnormal PrP isoforms associated  with the MV and MM cases are similar to VV cases but show increasing levels of  proteaseresistance; 3) abnormal tau is present in all three genotypic forms of  PSPr with features apparently similar to those of primary tauopathies placing  PSPr at the intersection of tauopathies and prion diseases.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Discussion: Will focus on: 1) the features of the abnormal PrP in the newly  discovered 129MV and 129MM PSPr; 2) the effect of the 129 polymorphism on PSPr  compared to that on sCJD; 3) the relationship of PSPr with tauopathies; 4)  whether PSPr now with the three 129 genotypic forms is the long sought sporadic  form of GSS. (Supported by NIH AG-14359, NS052319, CDC UR8/CCU515004). &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.neuroprion.org/resources/pdf_docs/conferences/prion2009/prion2009_bookofabstracts.pdf"&gt;http://www.neuroprion.org/resources/pdf_docs/conferences/prion2009/prion2009_bookofabstracts.pdf&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://sporadicffi.blogspot.com/2008/08/sporadic-fatal-insomnia-with-unusual.html" title="http://sporadicffi.blogspot.com/2008/08/sporadic-fatal-insomnia-with-unusual.html"&gt;http://sporadicffi.blogspot.com/2008/08/sporadic-fatal-insomnia-with-unusual.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sunday, August 24, 2008 Sporadic Fatal Insomnia with Unusual Biochemical  and Neuropathological Findings&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;P03.121&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sporadic Fatal Insomnia with Unusual Biochemical and Neuropathological  Findings&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Giaccone, G1; Mangieri, M1; Priano, L2; Limido, L1; Brioschi, A2; Albani,  G2; Pradotto, L2; Fociani, P3; Orsi, L4; Mortara, P4; Tagliavini, F1; Mauro, A2  1Fondazione IRCCS Istituto Neurologico Carlo Besta, Italy; 2IRCCS Istituto  Auxologico Italiano, Italy; 3Università di Milano, Ospedale Luigi Sacco, Italy;  4Università di Torino, Dipartimento di Neuroscienze, Italy&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sporadic fatal insomnia (SFI) is a rare subtype of human prion disease,  whose clinical and neuropathological phenotype is very similar to familial fatal  insomnia (FFI). SFI patients reported until now were all homozygous for  methionine at codon 129 of PRNP with deposition of type 2 PrPres (Parchi  classification) in the brain. Here we describe a 56-year-old woman who died  after a 10-month illness characterized by progressive drowsiness, cognitive  deterioration, autonomic impairment and myoclonus. Polysomnography demonstrated  a pattern similar to that described in FFI cases with loss of circadian pattern  of sleep-wake cycle. A remarkable finding was that 20 years before the onset of  symptoms, the patient had undergone surgery for a colloid cyst of the third  ventricle, and two ventricular shunts were placed, one correctly in the left  ventricle, while the second ended in the right thalamus. The PRNP gene showed no  mutation and methionine homozygosity at codon 129. The neuropathologic  examination revealed neuronal loss, gliosis, and spongiosis that were mild in  the cerebral cortex, while relevant in the caudate nucleus, putamen, thalamus,  hypothalamus and inferior olives. In the thalamus, the mediodorsal nuclei were  more severely affected than the ventral ones. PrPres immunoreactivity was  consistent in the striatum, thalamus and hypothalamus, patchy and of low  intensity in the cerebral cortex and absent in the cerebellum. Western blot  analysis confirmed this topographic distribution of PrPres. The bands  corresponding to di- glycosylated, monoglycosylated and non-glycosylated PrPres  were equally represented. The nonglycosylated PrPres band had an electrophoretic  mobility identical to that of type 1 by Parchi classification, in the multiple  cortical and subcortical regions examined. These findings demonstrate the  existence of further rare molecular subtypes of human prion diseases, whose  characterization may provide clues for the elucidation of the relation between  biochemical characteristics of PrPres and clinico-pathological features of these  disorders.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.neuroprion.com/pdf_docs/conferences/prion2007/abstract_book.pdf"&gt;http://www.neuroprion.com/pdf_docs/conferences/prion2007/abstract_book.pdf&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; Greetings,&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;IT could also be that this sFFI is just another case of iCJD (via friendly  fire from the surgery for a colloid cyst of the third ventricle, and two  ventricular shunts were placed, one correctly in the left ventricle, while the  second ended in the right thalamus), some 20 years before the onset of symptoms  of this so called sFFI case, from some sub-type of sporadic CJD, now called  sporadic FFI ???&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;I believe it was Gambetti et al that coined this term sporadic FFI, from  some conspicuous sub-type of sporadic CJD possibly? seems they could not tie it  to a true FFI by diagnostic standards to date, so it was then termed a sFFI,  confusing matters even worse ;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;A subtype of sporadic prion disease mimicking fatal familial insomnia&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.neurology.org/cgi/content/abstract/52/9/1757?ck=nck"&gt;http://www.neurology.org/cgi/content/abstract/52/9/1757?ck=nck&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; THIS seems to raise more questions than answers, confusing the TSEs even  worse.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;WHAT is sporadic CJD, and how many sub-types and atypical strains,  phenotypes etc. will there be, arising from nothing. a spontaneous happening of  sorts??? &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://sporadicffi.blogspot.com/2008/08/sporadic-fatal-insomnia-with-unusual.html"&gt;http://sporadicffi.blogspot.com/2008/08/sporadic-fatal-insomnia-with-unusual.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; August 19, 2008, Publish Ahead of Print:&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;First Report of Creutzfeldt-Jakob Disease Occurring in 2 Siblings  Unexplained by PRNP Mutation.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Original Article&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Journal of Neuropathology &amp;amp; Experimental Neurology. POST EDITOR  CORRECTIONS, 19 August 2008 Webb, Thomas E.F. MRCP; Pal, Suvankar MRCP;  Siddique, Durrenajaf MRCP; Heaney, Dominic C. MRCP; Linehan, Jacqueline M. BSc;  Wadsworth, Jonathan D.F. PhD; Joiner, Susan BSc; Beck, Jon BSc; Wroe, Stephen J.  FRCP; Stevenson, Valerie MRCP; Brandner, Sebastian MRCPath; Mead, Simon PhD;  Collinge, John FRS&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Abstract: Sibling concurrence of pathologically confirmed prion disease has  only been reported in association with pathogenic mutation of the prion protein  gene (PRNP). Here, we report 2 siblings with classic neuropathologic features of  sporadic Creutzfeldt-Jakob disease unexplained by PRNP mutation or known risk  factors for iatrogenic transmission of prion infection. Possible explanations  include coincidental occurrence, common exposure to an unidentified  environmental source of prions, horizontal transmission of disease, or the  presence of unknown shared genetic predisposition.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;(C) 2008 American Association of Neurop&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.jneuropath.com/pt/re/jnen/abstract.00005072-900000000-99931.htm"&gt;http://www.jneuropath.com/pt/re/jnen/abstract.00005072-900000000-99931.htm&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;GEN-07&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;SPORADIC FATAL INSOMNIA IN A FATAL FAMILIAL INSOMNIA PEDIGREE&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;S. Capellari1a, P. Cortelli1, P. Avoni1, G.P. Casadei2, A. Baruzzi1, E.  Lugaresi1, M. Pocchiari3, P. Gambetti4, P. Montagna1, P. Parchi1. 1Department of  Neurological Sciences, University of Bologna, Bologna, Italy; 2Department of  Cell Biology and Neurosciences, ISS, Roma, Italy; 3Servizio di Anatomia  Patologica, Ospedale Maggiore, Bologna, Italy, 4Division of Neuropathology,  CWRU, Cleveland, OH, USA. a  mhtml:%7B33B38F65-8D2E-434D-8F9B-8BDCD77D3066%7Dmid://00000208/!x-usc:mailto:capellari@neuro.unibo.it&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;We describe a case of sporadic fatal insomnia (sFI) occurring in a family  in which several members carried the D178N mutation in the PRNP gene and died of  fatal familial insomnia (FFI). A 43-year-old woman presented with an 11-month  history of diplopia, withdrawal, confusion, memory loss, unsteady gait and  inability to sleep with episodes of agitation and dream enactment. After a  progressive course characterized by cognitive impairment, marked gait ataxia,  signs of autonomic hyperactivity, and myoclonus the patient died 24 months after  the onset of symptoms. The patient did not have any personal contact with FFI  affected relatives and her closest one was a paternal uncle, the son of her  grand-grand mother. Analyses of DNA from various tissues of endo- ecto- and  meso-dermal origin, including 5 different regions of the CNS revealed no  pathogenic mutations and methionine homozygosity at codon 129 of PRNP. Brain  histopathology and PrPSc typing showed typical features of FI such as thalamic  and olivary atrophy, focal spongiform degeneration limited to the cerebral  cortex, relative sparing of basal ganglia and cerebellum, and relatively low  amount of PrPSc type 2A accumulation. sFI represents the rarest among the  sporadic human TSE subtypes described to date with less than twenty cases  described worldwide and only three cases diagnosed in Italy since the  establishment of TSE surveillance. Similarly, only six unrelated FFI families  have been observed in Italy to date, making the probability of a chance  association between sFI and FFI in the same family extremely low. Thus, we  believe that our observation emphasizes the importance of undiscovered factors  modulating the susceptibility to human prion diseases. Supported by the EU  Network of Excellence "NeuroPrion" (FOOD-CT-2004-506579). &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;a href="http://www.neuroprion.com/pdf_docs/conferences/prion2006/abstract_book.pdf"&gt;http://www.neuroprion.com/pdf_docs/conferences/prion2006/abstract_book.pdf&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;a href="http://sporadicffi.blogspot.com/2008/08/sporadic-fatal-insomnia-with-unusual.html"&gt;http://sporadicffi.blogspot.com/2008/08/sporadic-fatal-insomnia-with-unusual.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sunday, August 24, 2008&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sporadic Fatal Insomnia with Unusual Biochemical and Neuropathological  Findings P03.121&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;snip...&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;for those interested, please see ; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://sporadicffi.blogspot.com/2008/08/sporadic-fatal-insomnia-with-unusual.html"&gt;http://sporadicffi.blogspot.com/2008/08/sporadic-fatal-insomnia-with-unusual.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2010/08/variably-protease-sensitive-prionopathy.html" title="http://creutzfeldt-jakob-disease.blogspot.com/2010/08/variably-protease-sensitive-prionopathy.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2010/08/variably-protease-sensitive-prionopathy.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://sporadicffi.blogspot.com/" title="http://sporadicffi.blogspot.com/"&gt;http://sporadicffi.blogspot.com/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionunitusaupdate2008.blogspot.com/" title="http://prionunitusaupdate2008.blogspot.com/"&gt;http://prionunitusaupdate2008.blogspot.com/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;=========================TEXAS===========PRION=============DISEASE===================&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;CREUTZFELDT JAKOB DISEASE CJD PRION DISEASE CASES IN TEXAS BY YEAR  (2000-2010)&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" class="topicheader" style="color: black;"&gt;&lt;tbody&gt;&lt;tr&gt; &lt;td align="left" bgcolor="#f5f5f5" class="table" valign="top"&gt; &lt;h3&gt;CREUTZFELDT JAKOB DISEASE CJD PRION DISEASE CASES IN TEXAS BY YEAR  (2000-2010)&lt;/h3&gt;&lt;h3&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/h3&gt;&lt;h3&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/h3&gt;&lt;h3&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/h3&gt;&lt;h3&gt;&lt;span style="font-family: Times New Roman;"&gt;Creutzfeldt-Jakob Disease (CJD)&lt;/span&gt;&lt;/h3&gt;&lt;div&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman; font-size: medium;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;h3&gt;&lt;br /&gt;&lt;/h3&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;ICD-9 046.1; ICD-10  A81.0 &lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt; &lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table align="center" border="0" cellpadding="0" cellspacing="0" class="table" id="print_no" style="color: black;" summary="."&gt;&lt;caption align="left" valign="top"&gt; &lt;strong&gt;&lt;/strong&gt;&lt;strong&gt; &lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Prion  Disease Cases in Texas by Year (2000-2010) &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/caption&gt; &lt;tbody&gt;&lt;tr height="20"&gt; &lt;td align="left" bgcolor="#f5f5f5" class="navbar" valign="middle"&gt;&lt;strong&gt;  &lt;br /&gt;&lt;table border="1" cellpadding="0" cellspacing="3" style="color: black; width: 598px;"&gt;&lt;tbody&gt;&lt;tr&gt; &lt;td nowrap="" valign="top" width="87"&gt; &lt;span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="40"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="43"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2001&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2002&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2003&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2004&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2005&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2006&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2007&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2008&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2009&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2010&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td colspan="12" nowrap="" valign="top" width="592"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Sporadic  CJD (sCJD)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td nowrap="" valign="top" width="87"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;confirmed&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="40"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;8&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="43"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;7&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;4&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;7&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;7&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;5&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;13&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;11&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;16&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td nowrap="" valign="top" width="87"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;probable&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="40"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;2&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="43"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;4&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;5&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;5&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;8&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;4&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;2&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;4&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;6&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;7&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td nowrap="" valign="top" width="87"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;possible&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="40"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;3&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="43"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;3&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;2&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td nowrap="" valign="top" width="87"&gt; &lt;span style="font-family: Times New Roman;"&gt;&lt;b&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt;Variant  &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style="font-size: 9pt;"&gt;&lt;b&gt;&lt;span&gt;CJD  &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt;(vCJD)&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="40"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="43"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td nowrap="" valign="top" width="87"&gt; &lt;span style="font-family: Times New Roman;"&gt;&lt;b&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt;Familial  CJD &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt;(fCJD)&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="40"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="43"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;2&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;2&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;2&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td nowrap="" valign="top" width="87"&gt; &lt;span style="font-family: Times New Roman;"&gt;&lt;b&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt;Iatrogenic  CJD &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt;(iCJD)&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="40"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="43"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td nowrap="" valign="top" width="87"&gt; &lt;span style="font-family: Times New Roman;"&gt;&lt;b&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt;Sporadic  fatal insomnia&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt;(sFI)&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="40"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="43"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td nowrap="" valign="top" width="87"&gt; &lt;span style="font-family: Times New Roman;"&gt;&lt;b&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt;Fatal  familial insomnia&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt;(FFI)&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="40"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="43"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;2&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td nowrap="" valign="top" width="87"&gt; &lt;b&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="40"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;13&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="43"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;14&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;7&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;15&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;13&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;18&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;11&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;14&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;19&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;21&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td nowrap="" valign="top" width="44"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 9pt;"&gt;27&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Creutzfeldt-Jakob  Disease in Texas&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt; &lt;br /&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr height="20"&gt; &lt;td align="left" bgcolor="#f5f5f5" class="navbar" valign="middle"&gt; &lt;h3&gt; &lt;table align="left" border="1" cellpadding="0" cellspacing="0" style="color: black;"&gt;&lt;tbody&gt;&lt;tr&gt; &lt;td align="left" valign="top"&gt; &lt;div align="left"&gt;&lt;span&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 13.6pt;"&gt;Type&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 13.6pt;"&gt;2009&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 13.6pt;"&gt;2010&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td colspan="3" valign="top" width="590"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;Sporadic&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td valign="top" width="197"&gt; &lt;span&gt;&lt;span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;confirmed&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;11&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;16&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td valign="top" width="197"&gt; &lt;span&gt;&lt;span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;probable&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;6&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;7&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td valign="top" width="197"&gt; &lt;span&gt;&lt;span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;possible&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;2&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;0&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td valign="top" width="197"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;Familial&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;2&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;4&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td valign="top" width="197"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;Total&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;21&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="197"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;strong&gt;&lt;span style="font-size: 13.6pt;"&gt;27&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/h3&gt;&lt;h3&gt;&lt;/h3&gt;&lt;h3&gt;&lt;/h3&gt;&lt;h3&gt;&lt;/h3&gt;&lt;h3&gt;&lt;/h3&gt;&lt;h3&gt;&lt;/h3&gt;&lt;h3&gt;&lt;/h3&gt;&lt;h3&gt;&lt;/h3&gt;&lt;h3&gt;&lt;/h3&gt;&lt;h3&gt;&lt;/h3&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr height="20"&gt; &lt;td align="left" bgcolor="#f5f5f5" class="navbar" valign="middle"&gt; &lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt; &lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt; &lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Creutzfeldt-Jakob Disease Surveillance Data for Reporting  Years 2000-2010 &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;A total of  172 people died from CJD during 2000-2010. Texas has had one variant CJD  case.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Investigators  have concluded that the patient was a former resident of the  UK&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;where  exposure was likely to have occurred. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/span&gt; &lt;br /&gt;&lt;span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr height="20"&gt; &lt;td align="left" bgcolor="#f5f5f5" class="navbar" valign="middle"&gt; &lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Cases of  CJD in Texas (2000-2010)&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;img alt="CJD graph" class="design_selected_field" src="http://www.dshs.state.tx.us/uploadedImages/Content/Prevention_and_Preparedness/IDCU/disease/creutzfeldt_jakob/CJD%20graph.4.jpg" title="CJD graph" /&gt;&lt;br /&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr height="20"&gt; &lt;td align="left" bgcolor="#f5f5f5" class="navbar" valign="middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr height="20"&gt; &lt;td align="left" bgcolor="#f5f5f5" class="navbar" valign="middle"&gt; &lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Texas&lt;/span&gt;&lt;span&gt;&lt;span style="font-size: 9pt;"&gt; CJD Cases  by Age and Gender 2000-2010&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span&gt;&lt;/span&gt; &lt;br /&gt;&lt;span&gt;&lt;/span&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr height="20"&gt; &lt;td align="left" bgcolor="#f5f5f5" class="navbar" valign="middle"&gt;  &lt;br /&gt;&lt;table border="1" cellpadding="0" cellspacing="0" style="color: black;"&gt;&lt;tbody&gt;&lt;tr&gt; &lt;td&gt; &lt;span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2001&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2002&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2003&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2004&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2005&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2006&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2007&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2008&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2009&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="51"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2010&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="53"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Total&lt;/span&gt;&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td colspan="12" valign="top" width="627"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Age&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="54"&gt; &lt;span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td valign="top" width="70"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;&amp;lt;  55&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="53"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td valign="top" width="70"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;≥  55&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="53"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;137&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td colspan="12" valign="top" width="627"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Gender&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td valign="top" width="54"&gt; &lt;span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td valign="top" width="70"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Male&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="53"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;88&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt; &lt;td valign="top" width="70"&gt; &lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;Female&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td width="51"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="top" width="53"&gt; &lt;div align="center"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;br /&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr height="20"&gt; &lt;td align="left" bgcolor="#f5f5f5" class="navbar" valign="middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr height="20"&gt; &lt;td align="left" bgcolor="#f5f5f5" class="navbar" valign="middle"&gt; &lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span style="font-size: 9pt;"&gt;CJD Cases  by County 2000-2010&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt; &lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;img alt="CJD county map(1)" height="382" src="http://www.dshs.state.tx.us/uploadedImages/Content/Prevention_and_Preparedness/IDCU/disease/creutzfeldt_jakob/cjd%20county%20map.1.JPG" title="CJD county map(1)" width="501" /&gt;&lt;br /&gt;&lt;br /&gt;&lt;hr /&gt; &lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="font-family: Times New Roman;"&gt;&lt;span class="lastUpdated" id="ctl00_ContentPlaceHolder1_UxLastUpdatedDate_UxLastUpdated"&gt;&lt;span style="font-size: 9pt;"&gt;Last updated &lt;/span&gt;&lt;/span&gt;&lt;span class="lastUpdatedDate"&gt;&lt;span style="font-size: 9pt;"&gt;October 06,  2011&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.dshs.state.tx.us/idcu/disease/creutzfeldt-jakob/data/" title="http://www.dshs.state.tx.us/idcu/disease/creutzfeldt-jakob/data/"&gt;http://www.dshs.state.tx.us/idcu/disease/creutzfeldt-jakob/data/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #333333;"&gt;Creutzfeldt-Jakob Disease in  Northeast Texas,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #333333;"&gt;&lt;span style="color: black; font-family: Calibri;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #333333;"&gt;&lt;span style="color: black; font-family: Calibri;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #333333;"&gt;&lt;span style="color: black; font-family: Calibri;"&gt;&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #333333;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #333333;"&gt;&lt;div&gt;&lt;br /&gt;&lt;br /&gt;J.A. Rawlings,*1 K.A. Hendricks1, O.M. Nuno1, D.A. Brown1, D.A.  Evans2, Texas Department of Health, 1Austin and 2Tyler, Texas&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;span style="color: black; font-family: Calibri;"&gt;&lt;/span&gt; &lt;br /&gt;&lt;div&gt;&lt;br /&gt;&lt;br /&gt;Creutzfeldt-Jacob Disease (CJD), a transmissible spongiform  encephalopathy, is caused by prions composed of proteinaceous material devoid of  nucleic acid. CJD occurs sporadically (generally 1 case/1,000,000 population per  year) in older patients (average age of 65) and is characterized by rapidly  progressive dementia, accompanied by severe muscle spasms and incoordination.  Death usually occurs within 3 to 12 months (average 7 months). CJD activity in  Texas, which has a population of nearly 19 million, appeared to be typical. The  statewide death rate for 1995 and 1996 was just under 1/1,000,000. In April of  1997, the Texas Department of Health became aware of an increased number of  possible CJD cases in a 23-county area of NE Texas with a population of just  over one million. After review of medical and pathology records, four patients  were identified with definite classic CJD and three were identified with  probable CJD. Dates of death for the eight patients were from April, 1996  through mid-July 1997. The patients were from 46 through 65 years of age; four  were male and three were female. A case-control study to identify risks for CJD  in NE Texas has been initiated.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: black; font-family: Calibri;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;/span&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;div&gt;&lt;a href="http://www.jifsan.umd.edu/tse/Rawlings.htm" style="line-height: 19.2pt;"&gt;&lt;span style="color: #668844; font-family: Georgia;"&gt;&lt;strong&gt;&lt;span style="text-decoration: none;"&gt;http://www.jifsan.umd.edu/tse/Rawlings.htm&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Wednesday, November 9, 2011&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;sporadic FFI or nvCJD in TEXAS ? &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Wednesday, November 09, 2011&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Case report Sporadic fatal insomnia in a young woman: A diagnostic  challenge: Case Report TEXAS&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;HOW TO TURN A POTENTIAL MAD COW VICTIM IN THE USA, INTO A HAPPENSTANCE OF  BAD LUCK, A SPONTANEOUS MUTATION FROM NOTHING.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;OR WAS IT $$$&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;===================&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Clinical findings In February 2007, the Centers for Disease Control and  Prevention (CDC) and the National Prion Disease Pathology Surveillance Center  (NPDPSC) notified the Texas Department of State Health Services (DSHS) of a  32-year-old woman with an 18-month history of progressive neurological symptoms  suggestive of CJD. (Table 1) Based on the medical record and her neurologist,  her illness began in August 2005 with attention deficits and progressive memory  loss. In June 2006, she demonstrated anisocoria and bizarre behavior, including  talking incoherently to herself, and she was then referred to psychiatry.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;=====================&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2011/11/case-report-sporadic-fatal-insomnia-in.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2011/11/case-report-sporadic-fatal-insomnia-in.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://cjdtexas.blogspot.com/2009/10/creutzfeldt-jakob-disease-surveillance.html"&gt;http://cjdtexas.blogspot.com/2009/10/creutzfeldt-jakob-disease-surveillance.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;AND THAT MY FRIENDS, IS HOW YOU EXPLAIN SOMETHING AWAY INTO NOTHING. IT'S  THE USDA ET AL MAD COW WAY $$$&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;how many times have we seen this happen? time and time again.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;sporadic FFI or nvCJD Texas style ???&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Tuesday, June 1, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;USA cases of dpCJD rising with 24 cases so far in 2010 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://cjdtexas.blogspot.com/2010/06/usa-cases-of-dpcjd-rising-with-24-cases.html"&gt;http://cjdtexas.blogspot.com/2010/06/usa-cases-of-dpcjd-rising-with-24-cases.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Monday, April 5, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;UPDATE - CJD TEXAS 38 YEAR OLD FEMALE WORKED SLAUGHTERING CATTLE EXPOSED TO  BRAIN AND SPINAL CORD MATTER&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionunitusaupdate2008.blogspot.com/2010/04/update-cjd-texas-38-year-old-female.html"&gt;http://prionunitusaupdate2008.blogspot.com/2010/04/update-cjd-texas-38-year-old-female.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Monday, March 29, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Irma Linda Andablo CJD Victim, she died at 38 years old on February 6, 2010  in Mesquite Texas&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2010/03/irma-linda-andablo-cjd-victim-she-died.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2010/03/irma-linda-andablo-cjd-victim-she-died.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;CJD TEXAS 38 YEAR OLD FEMALE WORKED SLAUGHTERING CATTLE EXPOSED TO BRAIN  AND SPINAL CORD MATTER&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://cjdtexas.blogspot.com/2010/03/cjd-texas-38-year-old-female-worked.html"&gt;http://cjdtexas.blogspot.com/2010/03/cjd-texas-38-year-old-female-worked.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;DEEP THROAT TO TSS 2000-2001 (take these old snips of emails with how ever  many grains of salt you wish. ...tss)&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The most frightening thing I have read all day is the report of Gambetti's  finding of a new strain of sporadic cjd in young people...Dear God, what in the  name of all that is holy is that!!! If the US has different strains of  scrapie.....why????than the UK...then would the same mechanisms that make  different strains of scrapie here make different strains of BSE...if the  patterns are different in sheep and mice for scrapie.....could not the BSE be  different in the cattle, in the mink, in the humans.......I really think the  slides or tissues and everything from these young people with the new strain of  sporadic cjd should be put up to be analyzed by many, many experts in  cjd........bse.....scrapie Scrape the damn slide and put it into  mice.....wait.....chop up the mouse brain and and spinal cord........put into  some more mice.....dammit amplify the thing and start the damned  research.....This is NOT rocket science...we need to use what we know and get  off our butts and move....the whining about how long everything takes.....well  it takes a whole lot longer if you whine for a year and then start the  research!!! Not sure where I read this but it was a recent press release or  something like that: I thought I would fall out of my chair when I read about  how there was no worry about infectivity from a histopath slide or tissues  because they are preserved in formic acid, or formalin or formaldehyde.....for  God's sake........ Ask any pathologist in the UK what the brain tissues in the  formalin looks like after a year.......it is a big fat sponge...the agent  continues to eat the brain ......you can't make slides anymore because the agent  has never stopped........and the old slides that are stained with Hemolysin and  Eosin......they get holier and holier and degenerate and continue...what you  looked at 6 months ago is not there........Gambetti better be photographing  every damned thing he is looking at.....&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Okay, you need to know. You don't need to pass it on as nothing will come  of it and there is not a damned thing anyone can do about it. Don't even hint at  it as it will be denied and laughed at.......... USDA is gonna do as little as  possible until there is actually a human case in the USA of the nvcjd........if  you want to move this thing along and shake the earth....then we gotta get the  victims families to make sure whoever is doing the autopsy is credible,  trustworthy, and a saint with the courage of Joan of Arc........I am not  kidding!!!! so, unless we get a human death from EXACTLY the same form with  EXACTLY the same histopath lesions as seen in the UK nvcjd........forget any  action........it is ALL gonna be sporadic!!!&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;And, if there is a case.......there is gonna be every effort to link it to  international travel, international food, etc. etc. etc. etc. etc. They will go  so far as to find out if a sex partner had ever traveled to the UK/europe, etc.  etc. .... It is gonna be a long, lonely, dangerous twisted journey to the truth.  They have all the cards, all the money, and are willing to threaten and carry  out those threats....and this may be their biggest downfall...&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thanks as always for your help. (Recently had a very startling revelation  from a rather senior person in government here..........knocked me out of my  chair........you must keep pushing. If I was a power person....I would be  demanding that there be a least a million bovine tested as soon as possible and  agressively seeking this disease. The big players are coming out of the woodwork  as there is money to be made!!! In short: "FIRE AT WILL"!!! for the very  dumb....who's "will"! "Will be the burden to bare if there is any  coverup!"&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;again it was said years ago and it should be taken seriously....BSE will  NEVER be found in the US! As for the BSE conference call...I think you did a  great service to freedom of information and making some people feign  integrity...I find it scary to see that most of the "experts" are employed by  the federal government or are supported on the "teat" of federal funds. A scary  picture! I hope there is a confidential panel organized by the new government to  really investigate this thing.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;You need to watch your back........but keep picking at them.......like a  buzzard to the bone...you just may get to the truth!!! (You probably have more  support than you know. Too many people are afraid to show you or let anyone else  know. I have heard a few things myself... you ask the questions that everyone  else is too afraid to ask.)&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;END...TSS&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;SEE USA PRION REPORTS HERE ;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;span style="color: #29303b; font-family: Georgia;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="color: #29303b; font-family: Georgia; font-size: large;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionunitusaupdate2008.blogspot.com/" title="http://prionunitusaupdate2008.blogspot.com/"&gt;http://prionunitusaupdate2008.blogspot.com/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;h2 class="date-header" style="letter-spacing: 1px; margin: 0px; text-transform: uppercase; word-wrap: break-word;"&gt;&lt;br /&gt;&lt;/h2&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;nvCJD Clinical course&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The clinical course of disease in the ten patients was distinct from that  usually seen in sporadic CJD (table 2). Nine had behavioural changes as an early  clinical feature and were referred to a psychiatrist. In four patients, an early  symptom was dysaesthesiae and in another, pain in the feet persisted throughout  the illness. Nine patients developed ataxia early in the course of the disease.  While all patients developed progressive dementia, in only two was memory  impairment part of initial clinical presentation. Seven of the patients  developed myoclonus, often late in the course of the disease, and three had  choreoathetosis. None of the cases had the electroencephalographic (EEG)  features usually associated with CJD.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.cjd.ed.ac.uk/lancet.htm"&gt;http://www.cjd.ed.ac.uk/lancet.htm&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://cjdmadcowbaseoct2007.blogspot.com/2008/07/new-prionopathy-update-july-10-2008.html"&gt;http://cjdmadcowbaseoct2007.blogspot.com/2008/07/new-prionopathy-update-july-10-2008.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;I try and keep a file here for Texas ;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://cjdtexas.blogspot.com/"&gt;http://cjdtexas.blogspot.com/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;8. Project Title: Creutzfeldt - Jakob disease (CJD) Surveillance Utilizing  Certificates of Death&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Supervisor: Karen Moody, Infectious Disease Control Unit, Emerging and  Acute Infectious Disease Branch&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Prions are infectious particles composed of proteins that cause  transmissible spongiform encephalopathies (TSEs) – diseases that are 100% fatal  in animals and humans. Prion diseases in animals include scrapie and mad cow  disease; human diseases include kuru and Creutzfeldt-Jakob Disease (CJD).  Neuropathological examination through brain autopsy or biopsy is the only way of  confirming a diagnosis of prion disease. The student intern selected for this  project will conduct a study to determine if Texas death records in the state  database accurately reflect deaths due to CJD. The student will compare  confirmed CJD cases with death records determining whether CJD was documented on  the death record as an underlying or contributing cause of death. Before  beginning the study, the student will do a literature review to become familiar  with the natural history of CJD and case definitions. The intern will explore  demographic and medical record variables to assess their association with  accurate death coding and evaluate most common coding inaccuracies.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.biosci.utexas.edu/publichealth/pdfs/Public_Health_Internship_Descriptions_Fall_2011.pdf"&gt;http://www.biosci.utexas.edu/publichealth/pdfs/Public_Health_Internship_Descriptions_Fall_2011.pdf&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Tuesday, November 08, 2011 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Can Mortality Data Provide Reliable Indicators for Creutzfeldt-Jakob  Disease Surveillance? &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;A Study in France from 2000 to 2008 Vol. 37, No. 3-4, 2011 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Original Paper &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Conclusions:These findings raise doubt about the possibility of a reliable  CJD surveillance only based on mortality data. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2011/11/can-mortality-data-provide-reliable.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2011/11/can-mortality-data-provide-reliable.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/"&gt;http://creutzfeldt-jakob-disease.blogspot.com/&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Monday, August 9, 2010 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;National Prion Disease Pathology Surveillance Center Cases Examined (July  31, 2010) &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;(please watch and listen to the video and the scientist speaking about  atypical BSE and sporadic CJD and listen to Professor Aguzzi) &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://prionunitusaupdate2008.blogspot.com/2010/08/national-prion-disease-pathology.html"&gt;http://prionunitusaupdate2008.blogspot.com/2010/08/national-prion-disease-pathology.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;span style="font-family: Times New Roman;"&gt;Friday, February 10, 2012  &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Creutzfeldt-Jakob disease (CJD) biannual update (2012/1) potential  iatrogenic (healthcare-acquired) exposure to CJD, and on the National Anonymous  Tonsil Archive &lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2012/02/creutzfeldt-jakob-disease-cjd-biannual.html"&gt;&lt;span style="font-family: Times New Roman;"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2012/02/creutzfeldt-jakob-disease-cjd-biannual.html&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thursday, July 08, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;GLOBAL CLUSTERS OF CREUTZFELDT JAKOB DISEASE - A REVIEW 2010 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2010/07/global-clusters-of-creutzfeldt-jakob.html" title="http://creutzfeldt-jakob-disease.blogspot.com/2010/07/global-clusters-of-creutzfeldt-jakob.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2010/07/global-clusters-of-creutzfeldt-jakob.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2009 UPDATE ON ALABAMA AND TEXAS MAD COWS 2005 and 2006&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://bse-atypical.blogspot.com/2006/08/bse-atypical-texas-and-alabama-update.html"&gt;http://bse-atypical.blogspot.com/2006/08/bse-atypical-texas-and-alabama-update.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;of course, Texas does cover up it’s mad cows either, they test every  one...not!&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;FDA STATEMENT&lt;/div&gt;&lt;br /&gt;&lt;div&gt;FOR IMMEDIATE RELEASE&lt;/div&gt;&lt;br /&gt;&lt;div&gt;May 4, 2004&lt;/div&gt;&lt;br /&gt;&lt;div&gt; Media Inquiries: 301-827-6242&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Consumer Inquiries: 888-INFO-FDA&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Statement on Texas Cow With Central Nervous System Symptoms &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;On Friday, April 30th, the Food and Drug Administration learned that a cow  with central nervous system symptoms had been killed and shipped to a processor  for rendering into animal protein for use in animal feed.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;FDA, which is responsible for the safety of animal feed, immediately began  an investigation. On Friday and throughout the weekend, FDA investigators  inspected the slaughterhouse, the rendering facility, the farm where the animal  came from, and the processor that initially received the cow from the  slaughterhouse.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;FDA's investigation showed that the animal in question had already been  rendered into "meat and bone meal" (a type of protein animal feed). Over the  weekend FDA was able to track down all the implicated material. That material is  being held by the firm, which is cooperating fully with FDA.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Cattle with central nervous system symptoms are of particular interest  because cattle with bovine spongiform encephalopathy or BSE, also known as "mad  cow disease," can exhibit such symptoms. In this case, there is no way now to  test for BSE. But even if the cow had BSE, FDA's animal feed rule would prohibit  the feeding of its rendered protein to other ruminant animals (e.g., cows,  goats, sheep, bison).&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;FDA is sending a letter to the firm summarizing its findings and informing  the firm that FDA will not object to use of this material in swine feed only. If  it is not used in swine feed, this material will be destroyed. Pigs have been  shown not to be susceptible to BSE. If the firm agrees to use the material for  swine feed only, FDA will track the material all the way through the supply  chain from the processor to the farm to ensure that the feed is properly  monitored and used only as feed for pigs.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;To protect the U.S. against BSE, FDA works to keep certain mammalian  protein out of animal feed for cattle and other ruminant animals. FDA  established its animal feed rule in 1997 after the BSE epidemic in the U.K.  showed that the disease spreads by feeding infected ruminant protein to  cattle.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Under the current regulation, the material from this Texas cow is not  allowed in feed for cattle or other ruminant animals. FDA's action specifying  that the material go only into swine feed means also that it will not be fed to  poultry.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;FDA is committed to protecting the U.S. from BSE and collaborates closely  with the U.S. Department of Agriculture on all BSE issues. The animal feed rule  provides crucial protection against the spread of BSE, but it is only one of  several such firewalls. FDA will soon be improving the animal feed rule, to make  this strong system even stronger.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;#&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;RSS Feed for FDA News Releases1 [what is RSS?]2&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108292.htm"&gt;http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108292.htm&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;of course, Texas does not feed it’s cows suspect mad cow protein  either...not $$$&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;FDA Announces Animal Feed Recall&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;On January 30, 2001, FDA issued a Press Release announcing the results of  tests taken on feed used at a Texas feedlot that was suspected of containing  meat and bone meal from other domestic cattle -- a violation of FDA's 1997  prohibition on using ruminant material in feed for other ruminants. The results  indicated that a very low level of prohibited material was found in the feed fed  to cattle.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;FDA determined that each animal could have consumed, at most and in total,  five-and-one-half grams - approximately a quarter ounce -- of prohibited  material. These animals weigh approximately 600 pounds. It is important to note  that the prohibited material was domestic in origin (therefore not likely to  contain infected material because there is no evidence of BSE in U.S. cattle),  fed at a very low level, and fed only once. The potential risk of BSE to such  cattle was therefore exceedingly low, even if the feed were contaminated.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;According to Dr. Bernard Schwetz, FDA's Acting Principal Deputy  Commissioner, "The challenge to regulators and industry is to keep this disease  out of the United States. One important defense is to prohibit the use of any  ruminant animal materials in feed for other ruminant animals. Combined with  other steps, like U.S. Department of Agriculture's (USDA) ban on the importation  of live ruminant animals from affected countries, these steps represent a series  of protections, to keep American cattle free of BSE."&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Despite this negligible risk, Purina Mills, Inc., nonetheless announced  that it was voluntarily purchasing all 1,222 of the animals held in Texas and  mistakenly fed the animal feed containing the prohibited material. Therefore,  meat from those animals would not enter the human food supply. FDA believes any  cattle that did not consume feed containing the prohibited material was  unaffected by this incident, and should be handled in the beef supply clearance  process as usual.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;FDA believes that Purina Mills acted responsibly by first reporting the  human error that resulted in the misformulation of the animal feed supplement  and then by working closely with State and Federal authorities. This episode  indicates that the multi-layered safeguard system put into place is essential  for protecting the food supply and that continued vigilance needs to be taken,  by all concerned, to ensure these rules are followed routinely. FDA continues to  work with USDA as well as State and local officials to ensure that companies and  individuals comply with all laws and regulations designed to protect the U.S.  food supply.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.fda.gov/ICECI/EnforcementActions/EnforcementStory/EnforcementStoryArchive/ucm107472.htm"&gt;http://www.fda.gov/ICECI/EnforcementActions/EnforcementStory/EnforcementStoryArchive/ucm107472.htm&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;''FDA has determined that each animal could have consumed, at most and in  total, five-and-one-half grams - approximately a quarter ounce -- of prohibited  material. These animals weigh approximately 600 pounds.''&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.fda.gov/bbs/topics/news/2001/new00752.html"&gt;http://www.fda.gov/bbs/topics/news/2001/new00752.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;how many cows could five-and-one-half grams - approximately a quarter ounce  infect ???&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;look at the table and you'll see that as little as 1 mg (or 0.001 gm)  caused 7% (1 of 14) of the cows to come down with BSE;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Risk of oral infection with bovine spongiform encephalopathy agent in  primates&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Corinne Ida Lasmézas, Emmanuel Comoy, Stephen Hawkins, Christian Herzog,  Franck Mouthon, Timm Konold, Frédéric Auvré, Evelyne Correia, Nathalie  Lescoutra-Etchegaray, Nicole Salès, Gerald Wells, Paul Brown, Jean-Philippe  Deslys Summary The uncertain extent of human exposure to bovine spongiform  encephalopathy (BSE)--which can lead to variant Creutzfeldt-Jakob disease  (vCJD)--is compounded by incomplete knowledge about the efficiency of oral  infection and the magnitude of any bovine-to-human biological barrier to  transmission. We therefore investigated oral transmission of BSE to non-human  primates. We gave two macaques a 5 g oral dose of brain homogenate from a  BSE-infected cow. One macaque developed vCJD-like neurological disease 60 months  after exposure, whereas the other remained free of disease at 76 months. On the  basis of these findings and data from other studies, we made a preliminary  estimate of the food exposure risk for man, which provides additional assurance  that existing public health measures can prevent transmission of BSE to  man.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;snip...&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;BSE bovine brain inoculum&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;100 g 10 g 5 g 1 g 100 mg 10 mg 1 mg 0·1 mg 0·01 mg&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Primate (oral route)* 1/2 (50%)&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Cattle (oral route)* 10/10 (100%) 7/9 (78%) 7/10 (70%) 3/15 (20%) 1/15 (7%)  1/15 (7%)&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;RIII mice (ic ip route)* 17/18 (94%) 15/17 (88%) 1/14 (7%)&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;PrPres biochemical detection&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The comparison is made on the basis of calibration of the bovine inoculum  used in our study with primates against a bovine brain inoculum with a similar  PrPres concentration that was inoculated into mice and cattle.8 *Data are number  of animals positive/number of animals surviving at the time of clinical onset of  disease in the first positive animal (%). The accuracy of bioassays is generally  judged to be about plus or minus 1 log. ic ip=intracerebral and  intraperitoneal.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Table 1: Comparison of transmission rates in primates and cattle infected  orally with similar BSE brain inocula&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Published online January 27, 2005&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.thelancet.com/journal/journal.isa"&gt;http://www.thelancet.com/journal/journal.isa&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Experimental BSE Infection of Non-human Primates: Efficacy of the Oral  Route&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Holznagel, E1; Yutzy, B1; Deslys, J-P2; Lasmézas, C2; Pocchiari, M3;  Ingrosso, L3; Bierke, P4; Schulz-Schaeffer, W5; Motzkus, D6; Hunsmann, G6;  Löwer, J1 1Paul-Ehrlich-Institut, Germany; 2Commissariat à l´Energie Atomique,  France; 3Instituto Superiore di Sanità, Italy; 4Swedish Institute for Infectious  Disease control, Sweden; 5Georg August University, Germany; 6German Primate  Center, Germany&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Background: In 2001, a study was initiated in primates to assess the risk  for humans to contract BSE through contaminated food. For this purpose, BSE  brain was titrated in cynomolgus monkeys.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Aims: The primary objective is the determination of the minimal infectious  dose (MID50) for oral exposure to BSE in a simian model, and, by in doing this,  to assess the risk for humans. Secondly, we aimed at examining the course of the  disease to identify possible biomarkers.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Methods: Groups with six monkeys each were orally dosed with lowering  amounts of BSE brain: 16g, 5g, 0.5g, 0.05g, and 0.005g. In a second titration  study, animals were intracerebrally (i.c.) dosed (50, 5, 0.5, 0.05, and 0.005  mg).&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Results: In an ongoing study, a considerable number of high-dosed macaques  already developed simian vCJD upon oral or intracerebral exposure or are at the  onset of the clinical phase. However, there are differences in the clinical  course between orally and intracerebrally infected animals that may influence  the detection of biomarkers.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Conclusions: Simian vCJD can be easily triggered in cynomolgus monkeys on  the oral route using less than 5 g BSE brain homogenate. The difference in the  incubation period between 5 g oral and 5 mg i.c. is only 1 year (5 years versus  4 years). However, there are rapid progressors among orally dosed monkeys that  develop simian vCJD as fast as intracerebrally inoculated animals.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The work referenced was performed in partial fulfilment of the study “BSE  in primates“ supported by the EU (QLK1-2002-01096).&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.neuroprion.org/resources/pdf_docs/conferences/prion2007/abstract_book.pdf"&gt;http://www.neuroprion.org/resources/pdf_docs/conferences/prion2007/abstract_book.pdf&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Simian vCJD can be easily triggered in cynomolgus monkeys on the oral route  using less than 5 g BSE brain homogenate.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf"&gt;http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;It is clear that the designing scientists must also have shared Mr Bradleys  surprise at the results because all the dose levels right down to 1 gram  triggered infection.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://web.archive.org/web/20040523230128/www.bseinquiry.gov.uk/files/ws/s145d.pdf"&gt;http://web.archive.org/web/20040523230128/www.bseinquiry.gov.uk/files/ws/s145d.pdf&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;it is clear that the designing scientists must have also shared Mr  Bradleyâs surprise at the results because all the dose levels right down to 1  gram triggered infection.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://web.archive.org/web/20030526212610/http://www.bseinquiry.gov.uk/files/ws/s147f.pdf"&gt;http://web.archive.org/web/20030526212610/http://www.bseinquiry.gov.uk/files/ws/s147f.pdf&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Friday, December 23, 2011 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Oral Transmission of L-type Bovine Spongiform Encephalopathy in Primate  Model &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Volume 18, Number 1—January 2012 Dispatch &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/12/oral-transmission-of-l-type-bovine.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/12/oral-transmission-of-l-type-bovine.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Saturday, June 25, 2011&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Transmissibility of BSE-L and Cattle-Adapted TME Prion Strain to Cynomolgus  Macaque &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"BSE-L in North America may have existed for decades" &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/transmissibility-of-bse-l-and-cattle.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/transmissibility-of-bse-l-and-cattle.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Saturday, November 19, 2011 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Novel Prion Protein in BSE-affected Cattle, Switzerland &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/11/novel-prion-protein-in-bse-affected.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/11/novel-prion-protein-in-bse-affected.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;SPORADIC CJD RISING IN TEXAS, WITH NEW PENDING CLASSIFICATION I.E. SPORADIC  FFI in young, you know the one, the one that is NOT genetically related to the  FAMILY, but IS genetically related to the COWS IN THE USA. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;This cases was in a 32 year old, and the clinical presentation lasted 18  months. sound familiar folks with nvCJD ?&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;nope, can’t happen in the USA, because the USDA says so. if I am not  mistaken, the USDA are the ones now announcing final results for the CDC and  CWRU prion unit for human deaths now from CJD. at least that’s how it was here  ;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;USDA says US beef is safe Posted on: 5.4.2008 6:30:19 PM &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;USDA AND FEED INDUSTRY ANNOUNCES SUSPECT 23 YEAR OLD PORTSMOUTH WOMAN DOES  NOT HAVE NVCJD UNDER PARTIAL CONFIDENTIALITY CLAUSE &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;nope, when consumers want to know about victims of suspect TSE Prion  disease, you cannot get anything due to confidentiality clause, HOWEVER, with  the USDA it’s a different story $$$&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The program, which now faces charges for playing up the possibility that  the woman died of vCJD, said, “The CDC last Thursday announced the cause of  death of Aretha Vinson, who died of symptoms similar to vCJD.” It quoted the CDC  as saying although the suspected case received international media attention,  the National Prion Disease Pathology Surveillance Center determined that the  cause of death was not due to vCJD, a finding, it pointed out, that was similar  to an announcement by the Department of Agriculture.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://english.chosun.com/w21data/html/news/200806/200806170006.html"&gt;http://english.chosun.com/w21data/html/news/200806/200806170006.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;22 year old sporadic CJD ???&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;we will never know ; In a telephone interview with the Chosun Ilbo, CDC  spokesman Dave Daigle on Monday said the centers posted the announcement after  performing their own checkup once the NPDPSC finished its investigation. He  added that because the CDC only provide information on diseases, they have no  plans to make a separate press release on the issue including the result of the  investigation. ...&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://english.chosun.com/w21data/html/news/200806/200806170006.html"&gt;http://english.chosun.com/w21data/html/news/200806/200806170006.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;now, the cdc et al usually hide behind patient confidentiality to hide cjd  cases. but in this 22 years old, confidentiality was not the case, she was well  known around the world, and the cdc et al chose to hide her final diagnosis.  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;why, because it was another young victim in the USA with sporadic CJD  ???&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;SEE FULL TEXT ;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Tuesday, June 17, 2008&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Portsmouth woman did not die of mad cow-related condition, USDA says&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;UPDATE Updated Jun.17, 2008 08:34 KST&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://cjdmadcowbaseoct2007.blogspot.com/2008/06/portsmouth-woman-did-not-die-of-mad-cow.html"&gt;http://cjdmadcowbaseoct2007.blogspot.com/2008/06/portsmouth-woman-did-not-die-of-mad-cow.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Wednesday, February 10, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The Honorable Ms. Kim Min-sun Anti-US Beef Actress Prevails in Court &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://usdavskorea.blogspot.com/2010/02/honorable-ms-kim-min-sun-anti-us-beef.html"&gt;http://usdavskorea.blogspot.com/2010/02/honorable-ms-kim-min-sun-anti-us-beef.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Wednesday, January 13, 2010&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;High Court Rules In Favor of PD Notebook &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;01-13-2010 21:21&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://usdavskorea.blogspot.com/2010/01/high-court-rules-in-favor-of-pd.html"&gt;http://usdavskorea.blogspot.com/2010/01/high-court-rules-in-favor-of-pd.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Health News&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Questions linger in U.S. CJD cases&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Published: Oct. 21, 2005 at 9:49 PM &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;By STEVE MITCHELL, Senior Medical Correspondent &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;WASHINGTON, Oct. 21 (UPI) -- French researchers have ruled out the human  form of mad cow disease in a deceased California man, even though they did not  conduct the critical test widely regarded as the only way to determine precisely  the nature of his disease, United Press International has learned. The case of  Patrick Hicks, who died last November from his condition, has remained murky  from the beginning. Dr. Ron Bailey, of Riverside, Calif., the man's neurologist,  had suspected the 49-year-old Hicks of having contracted variant Creutzfeldt  Jakob disease -- a fatal, brain-wasting illness humans can contract from eating  beef products contaminated with the mad cow pathogen -- and both he and the  family wanted an autopsy conducted to determine if Hicks had succumbed to the  disorder. Bailey became concerned that Hicks might have contracted vCJD because  he initially had exhibited psychiatric symptoms, his illness appears to have  lasted for more than one year and he showed normal brain-wave patterns via EEGs  until the late stages -- all consistent with the disease. In addition, Hicks's  relatively young age raised concerns, because nearly all of the more than 150  cases of vCJD detected worldwide have occurred in people under age 55. The first  hint of oddness began when, according to both Hicks's brother and mother, a team  of six doctors, who they suspect were with the Centers for Disease Control and  Prevention in Atlanta, visited Patrick last October while he was still alive and  under care at Loma Linda University Medical Center in Loma Linda, Calif. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;They said they were asked to leave when the doctors arrived to examine  Patrick. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;CDC officials would not confirm to UPI whether they had investigated the  case, but the agency's policy does require examining all suspected cases of vCJD  in anyone under 55. The family also said Loma Linda refused to released Hicks's  medical records to them. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The oddities continued after Hicks's death. Bailey found it almost  impossible to get an autopsy conducted on Hicks, the only way to determine  conclusively whether he had variant or sporadic CJD -- a version of the disease  not related to mad cow. One county coroner's office referred him to another and  both refused to conduct the procedure, he said. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Then, the National Prion Disease Pathology Surveillance Center in  Cleveland, Ohio -- which was established by the CDC to investigate potential  vCJD cases in the United States -- dispatched a mobile autopsy company called  1-800-Autopsy, but the company failed to follow the center's protocol and did  not collect frozen sections of brain, which are required for tests to determine  whether the disease is vCJD or sCJD. Instead, the autopsy company fixed the  entire brain in formalin. The NPDPSC, however, considers the collection of  frozen brain tissue essential to distinguishing vCJD from other forms of CJD.  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"Only frozen brain tissue examination definitely confirms or excludes the  diagnosis of prion disease and provides the information to identify the type of  prion disease," the center's Web site says. Prions are abnormal proteins thought  to play a role in causing vCJD and sCJD. The problem raised enough concern that  both Bailey and Hicks's family sought a second opinion. Experts had told them  that animal-injection studies could be done with formalin-fixed tissue, so the  family arranged to have a sample of Patrick's brain sent to Dr. Jean Jacques  Hauw at the Laboratoire De Neuropathologie at the Groupe Hospitalier  Pitie-Salpetriere in Paris, who they thought had agreed to do the studies. The  NPDPSC, however, delayed sending the sample to France for two months after the  family's request last March. During the delay, Pierluigi Gambetti, the NPDPSC's  director, sent a letter to Hicks's wife. "We can definitely rule out the  diagnosis of variant CJD," the letter stated. Gambetti's strong conclusion  sounded strange to Bailey, because the NPDPSC had not conducted further tests  since January, when they had said vCJD was unlikely but that they were unable to  rule it out entirely. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;After examining the brain tissue, Hauw's team told the family the disease  was consistent with sCJD, but to date they have not explained why they did not  conduct the animal-injection studies -- the family's reason for sending samples  of his brain to France. Asked the reasons for not following the family's wishes  and conducting the animal studies, Hauw told UPI, "I cannot answer your  question," citing French regulations that prohibited him from providing  information about a specific patient. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;He did say, however, that "animal injection is not needed for the routine  diagnosis of Creutzfeldt-Jakob disease and its various variants, at least in  France and in the United Kingdom." That may be true, but it remains unclear why  he accepted the case in the first place, knowing that is what the family wanted.  Moreover, this was not a "routine diagnosis." If Hicks suffered from vCJD, he  potentially would have been the first person in the United States to have  acquired the disease domestically, a development with significant domestic and  international ramifications. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;In addition, other experts, such as Dr. Laura Manuelidis, section chief of  surgery in the neuropathology department at Yale University, have said the only  way to know conclusively whether the disease is due to sCJD or vCJD is through  animal-injection studies. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"From what I gather, the result was merely rubber stamped," Bailey told  UPI. "I guess we will never really know for sure." The handling of the case is  noteworthy, because the NPDPSC currently is investigating nine potential sCJD  cases in Idaho. Experts suspect some of those cases could be vCJD. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Bailey and some patient advocates said they are now skeptical of the  NPDPSC's behavior. "How could my experience with the Hicks case ... and the  interaction with NPDPSC not lessen my confidence?" Bailey asked. "I anticipate  that all of the Idaho cluster of CJD patients will turn out to have sCJD. I  cannot for a minute see their results indicating anything but this. After all,  if any patient were to have vCJD, it would have been Patrick Hicks. The results  of NPDPSC are not definitive in excluding Hicks as not having vCJD. There  certainly will always be that question in my mind." Terry Singletary, a patient  advocate whose mother died of a form of the disease called Heidenhain variant,  told UPI he likewise had lost confidence in the NPDPSC. "I do not trust them,"  Singletary said. "It's all going to be sporadic. This is the way they want it.  They do not want to find out all the routes and sources of this agent." &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Both vCJD and mad cow disease are politically sensitive issues because they  can impact international trade. Dozens of nations closed their borders to  American beef after a lone U.S. cow tested positive for the disease in 2003,  resulting in more than $4.7 billion in losses for the industry, and the U.S.  Department of Agriculture delayed doing confirmatory tests for seven months on  what turned out to be a second case of mad cow. The NPDPSC did not respond to  UPI's phone call requesting comment about the Idaho cases. The CDC referred UPI  to Idaho officials. Of the nine Idaho cases, three people have tested positive  for a CJD-like illness, but officials are conducting further tests to determine  whether the disease is sCJD. Two others tested negative and four were buried  without autopsies. The cases could just be a statistical fluke, but the state  averages about 1.2 sCJD cases per year and has never had more than three in a  single year. The disease is rare and generally is thought to occur at the rate  of one case per million people. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Several CJD clusters in other states have far exceeded that rate, however.  These included: &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;--southern New Jersey (2000-2003), &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;--Lehigh, Pa. (1986-90), &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;--Allentown, Pa. (1989-92), &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;--Tampa, Fla. (1996-97), &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;--Oregon (2001-02), and &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;--Nassau County, N.Y. (1999-2000). &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Some of the clusters involved as many as 18 deaths, and ranged from a rate  of four to eight cases per million people. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;A group of J.P. Morgan analysts issued an advisory last year on the impact  the clusters could have on the beef industry, and said that some of the cases  could be due to vCJD. "The existence of clusters raises the question of  'contamination' or 'infection,' and also raises the hypothesis that rather than  cases of sCJD, these might have been cases of vCJD," the advisory said. "Given  that sCJD occurs randomly in one out of 1 million cases, it is a statistical  rarity to find an sCJD cluster -- let alone six." &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;If that assessment is accurate, another cluster in Idaho would be even more  unlikely. Another possibility is some of the Idaho cases could be due to chronic  wasting disease, which is similar to mad cow disease and currently is epidemic  among deer and elk in several states, including Idaho's neighbors Wyoming and  Utah. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;No human cases of CWD have ever been confirmed, but the disease has been  shown to infect human cells in a lab dish. Also, a team of researchers led by  Jason Bartz of Creighton University in Omaha, Neb., report in the November issue  of the Journal of Virology they had experimentally transmitted CWD to squirrel  monkeys --the first reported transmission of CWD to primates. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;If CWD is capable of infecting humans, it is unknown whether the resulting  disease would resemble sCJD, vCJD or a novel disorder. If the disease looks like  sCJD, cases could be going undetected or misdiagnosed. -- E-mail: &lt;a href="mailto:healthbiz@upi.com"&gt;healthbiz@upi.com&lt;/a&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.upi.com/Health_News/2005/10/21/Questions-linger-in-US-CJD-cases/UPI-65761129945790/" title="http://www.upi.com/Health_News/2005/10/21/Questions-linger-in-US-CJD-cases/UPI-65761129945790/"&gt;http://www.upi.com/Health_News/2005/10/21/Questions-linger-in-US-CJD-cases/UPI-65761129945790/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.upi.com/Science_News/2005/03/24/NIH-may-destroy-human-brain-collection/UPI-36201111698400/" title="http://www.upi.com/Science_News/2005/03/24/NIH-may-destroy-human-brain-collection/UPI-36201111698400/"&gt;http://www.upi.com/Science_News/2005/03/24/NIH-may-destroy-human-brain-collection/UPI-36201111698400/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.upi.com/Science_News/2005/04/01/Groups-seek-to-save-NIH-brain-collection/UPI-32301112391588/" title="http://www.upi.com/Science_News/2005/04/01/Groups-seek-to-save-NIH-brain-collection/UPI-32301112391588/"&gt;http://www.upi.com/Science_News/2005/04/01/Groups-seek-to-save-NIH-brain-collection/UPI-32301112391588/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;NIH sends mixed signals on CJD brains &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;By Steve Mitchell &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Medical Correspondent &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Washington, DC, Apr. 7 (UPI) -- A National Institutes of Health official  who told United Press International the agency might destroy its collection of  brains from human patients afflicted with a condition similar to mad cow disease  reportedly has told the head of a patient-advocate group the collection would be  preserved.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The official, Eugene Major, acting director of the basic neuroscience  program at the NIH, has not responded to e-mail or a phone call from UPI seeking  clarification of his remarks, and the official status of the collection remains  unknown.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;As reported by UPI on March 24, the collection is stored in freezers by the  NIH's National Institute for Neurological Disorders and Stroke in Bethesda, Md.  It contains brains and other tissue samples from hundreds of people who died  from the brain-wasting illness Creutzfeldt Jakob disease, as well as tissues  from an untold number of experimental animals.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The consensus of scientists in this field is the collection, which dates  back to 1963, is invaluable for research and could even provide insight into  treatments for the fatal disorder. Currently, there is no cure for CJD and  patients typically die within a year after symptoms begin.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Florence Kranitz, president of the non-profit advocacy group CJD  Foundation, told UPI she had "a very long conversation" with Major, in which he  told her the remaining tissues in the collection would not be destroyed.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"He reassured me in no uncertain terms," Kranitz said, noting constituents  of the foundation and other CJD advocacy groups had been expressing concerns to  her the tissues would be destroyed.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Kranitz, who has personal reasons for wanting the collection preserved --  her husband died of CJD in 2000 -- said she plans to meet with Major at the end  of April to discuss the issue further.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;CJD belongs to a group of diseases collectively known as transmissible  spongiform encephalopathies, or TSEs, that includes mad cow disease in cows,  chronic wasting disease in deer and elk, and scrapie in sheep. All TSEs are  incurable and fatal.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Major previously told UPI some samples already have been destroyed and  others have been given to researchers at the Food and Drug Administration and  the National Prion Disease Pathology Surveillance Center in Cleveland.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Major said the remaining collection "has very little remaining value" and  could be destroyed if another entity does not claim them.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Bruce Johnson, a former NIH scientist who retired at the end of 2003, said  he had been told the collection would be destroyed in two years if no one took  the samples from the NIH.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;In response to hearing that Major had failed to confirm to UPI the brain  collection would not be destroyed, Patricia Ewanitz, who lives in Port Jefferson  Station, N.Y., and is founder of the advocacy group CJD Voice, said, "The brain  tissue might not be indispensable to the National Institutes of Health but it is  absolutely necessary to the families who thought enough of science to donate the  brains, brain tissue and blood in hopes of someday finding an answer to why  their loved one died."&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Ewanitz, whose husband died of CJD in 1997, added, "It now seems like such  a joke."&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Terry Singeltary, whose mother passed away from a type of CJD in 1997, said  the NIH should use the samples for scientific research, not just store them in  freezers.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Both Singeltary and Ewanitz said they would feel more reassured if Major  verified in writing the collection will not be destroyed.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"I would go further and ask Major what he plans to do with them,"  Singeltary said. "If the samples are just going to sit up there and go bad, then  they should give them out to researchers looking for cause and cure."&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The revelation the NIH might destroy part or all of the collection sparked  an outcry from patient advocates, consumer groups and scientists.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Advocates have been contacting their members of Congress, urging them to  investigate and prevent the NIH from destroying the brains. Consumer groups also  have gotten involved and scientists have taken steps to obtain the collection or  have urged Major not to destroy the samples.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Felicia Nestor, who serves as a consultant to Public Citizen, told UPI she  had contacted certain legislators and at least one was considering looking into  the situation. Nestor asked the legislator's name be withheld.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Kranitz said Major also told her he plans "to advertise in professional  neurological journals and by whatever means necessary to make it known" to  researchers in the field the tissues are available.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Major previously said, however, that efforts to inform researchers of the  availability of the collection were already underway and included informing NIH  grantees. He added he had personally notified researchers at scientific  meetings, but no TSE researcher contacted by UPI was aware of this.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"I was never informed," said Laura Manuelidis, an expert on these diseases  and section chief of surgery in the neuropathology department at Yale  University. She said the first she had heard of the situation was in UPI's March  24 report.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Manuelidis also said she contacted Major, expressing interest in the  specimens, but so far has not received a response.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"I sent a letter to (Major) on (March 25) about our interest in these  specimens, but he has not replied," she told UPI in an e-mail.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Neil Cashman, a TSE expert at the University of Toronto, who said he was  not aware the samples might be destroyed, has lobbied colleagues at the  University of British Columbia -- where Cashman is scheduled to move to this  summer -- to help draft a letter requesting the collection.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The Memorial Institute for Neurodegenerative Diseases Inc., a non-profit  organization consisting of more than 40 university and institute researchers  from the United States, Canada, the United Kingdom and France, requested the  collection in January, 2004. So far, the institute has not been informed of a  decision by the NIH.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Asked if Major had told him whether the collection would be preserved, MIND  Executive Director Harry Peery said, "We have heard nothing further from Eugene  Major or anyone else at the NIH regarding the brain collection."&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;-- &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;E-mail: sciencemail@upi.com &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://washingtontimes.com/upi-breaking"&gt;http://washingtontimes.com/upi-breaking&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;===================== &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;JOHN CORNYN &lt;/div&gt;&lt;br /&gt;&lt;div&gt;TEXAS &lt;/div&gt;&lt;br /&gt;&lt;div&gt;UNITED STATES SENATE &lt;/div&gt;&lt;br /&gt;&lt;div&gt;WASHINGTON, DC 20510-4305 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;April 26,2005 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Mr. Terry Singeltary &lt;/div&gt;&lt;br /&gt;&lt;div&gt;P.O. Box 42 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Bacliff, Texas 77518 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Dear Mr. Singeltary: &lt;/div&gt;&lt;br /&gt;&lt;div&gt;In response to your recent request for my assistance, I have contacted the  National Institutes ofHealth. I will write you again as soon as I receive a  reply.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; I appreciate having the opportunity to represent you in the United States  Senate and to be of service in this matter.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; Sincerely, &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;JOHN CORNYN &lt;/div&gt;&lt;br /&gt;&lt;div&gt;United States Senator &lt;/div&gt;&lt;br /&gt;&lt;div&gt;JC:djl &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;=============== &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;JOHN CORNYN &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;TEXAS &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;UNITED STATES SENATE &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;WASHINGTON, DC 20510-4305 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;May 18,2005 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Mr. Terry SingeltaryP.O. Box 42Bacliff, Texas 77518 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Dear Mr. Singeltary: &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Enclosed is the reply I received from the Department of Health and Human  Services in&lt;/div&gt;&lt;br /&gt;&lt;div&gt; response to my earlier inquiry on your behalf. I hope this will be useful  to you.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; I appreciate having the opportunity to represent you in the United States  Senate.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thank you for taking time to contact me. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sincerely, &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;JOHN CORNYN &lt;/div&gt;&lt;br /&gt;&lt;div&gt;United States Senate &lt;/div&gt;&lt;br /&gt;&lt;div&gt;JC:djl &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Enclosure &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;DEPARTMENT OF HEALTH &amp;amp; HUMAN SERVICES &lt;/div&gt;&lt;br /&gt;&lt;div&gt;National Institutes of HealthNational Institute of NeurologicalDisorders  and Stroke&lt;/div&gt;&lt;br /&gt;&lt;div&gt; NINDS &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Building 31, Room 8A52 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;31 Center Dr., MSC 2540 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Bethesda, Maryland 20892-2540 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Phone: 301-496-9746 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Fax: 301-496-0296 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Email: [log in to unmask] &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;May 10, 2005 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The Honorable John Cornyn &lt;/div&gt;&lt;br /&gt;&lt;div&gt;United States Senator &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Occidental Tower5005 LBJ Freeway, Suite 1150 &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Dallas, Texas 75244-6199 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Dear Senator Cornyn: &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Your letter to the National Institutes of Health (NIH) forwarding  correspondence from Mr. Terry S. Singeltary, Sr., has been forwarded to me for  reply. Mr. Singeltary is concerned about thepreservation of Creutzfeldt-Jakob  disease (CJD) brain samples that have been maintained by theNational Institute  of Neurological Disorders and Stroke (NINDS) Intramural Research programfor many  years.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;I am sorry to learn that Mr. Singeltary's mother died of CJD and can  certainly understand hisdesire that any tissues that could help investigators  unravel the puzzle of this deadly disease arepreserved. I hope he will be  pleased to learn that all the brains and other tissues with potential tohelp  scientists learn about CJD are, and will continue to be, conserved. (The tissues  that arediscarded are those that have either decayed to an extent that renders  them no longer appropriatefor research or those for which we do not have  sufficient identification.)&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The purpose of gathering these brains and tissues is to help scientists  learn about CJD. To that end, some of the NINDS-held samples are distributed to  investigators who can demonstrate thatthey have a compelling research or public  health need for such materials. For example, sampleshave been transferred to NIH  grantee Dr. Pierluigi Gambetti, who heads the National PrionDiseases Pathology  Surveillance Center at Case Western Reserve University in Ohio and workswith the  Centers for Disease Control and Prevention to monitor all cases of CJD in the  UnitedStates. Dr. Gambetti studies the tissues to learn about the formation,  physical and chemicalproperties, and pathogenic mechanisms of prion proteins,  which are believed to be involved inthe cause of CJD. Samples have also been  transferred to Dr. David Asher, at the U.S. Food andDrug Administration, for use  in assessing a potential diagnostic test for CJD.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Page 2 - The Honorable John Cornyn &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;in closing, we know that donating organs and tissue from loved ones is a  very difficult andpersonal choice that must often be made at the most stressful  of times. We at the NINDS aregrateful to those stalwart family members who make  this choice in the selfless hope that it willhelp others afflicted with CJD. We  also know the invaluable contribution such donations maketo the advancement of  medical science, and we are dedicated to the preservation of all of thetissue  samples that can help in our efforts to overcome CJD.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;I hope this information is helpful to you in responding to Mr. Singeltary.  &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sincerely, &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Story C. Landis, Ph.D. &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Director, National Institute ofNeurological Disorders and Stroke &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;================================== &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;NIH says it will preserve CJD brains &lt;/div&gt;&lt;br /&gt;&lt;div&gt;By STEVE MITCHELL &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;WASHINGTON, May 31 (UPI) -- The National Institutes of Health apparently  has reversed its position on the fate of an invaluable collection of brains from  people afflicted with a condition similar to mad cow disease, saying in a letter  to a U.S. senator it will not destroy the collection.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;An NIH official had told United Press International previously that the  brain collection, which consists of samples from hundreds of people who died  from the brain-wasting illness called Creutzfeldt Jakob disease, could be  discarded if another entity does not claim them.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;That sparked an outcry from patient-advocacy groups, consumer watchdogs and  scientists, and the agency now appears to have backed away from that  course.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"All the brains and other tissues with potential to help scientists learn  about CJD are, and will continue to be, conserved," Story Landis, director of  the National Institute of Neurological Disorders and Stroke, which oversees the  brain collection, wrote in a May 10 letter to Sen. John Cornyn, R-Texas.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Cornyn had inquired about the status of the collection in April. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Last March, Eugene Major, acting director of the basic neuroscience program  at the NIH, told UPI the useful portions of the collection had been doled out to  scientists and the remaining samples had "very little remaining value" and could  be destroyed.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Landis could not be reached for comment Tuesday. NINDS spokesman Paul  Girolami told UPI he had been unable to locate her.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Scientists think the collection, which dates back to 1963, is invaluable  for research on CJD and similar diseases and could even provide insight into  treatments. There is no cure for CJD and patients typically die within a year  after symptoms begin.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"Absolutely, the collection is worth keeping," Bruce Johnson, a former NIH  scientist who said he had been told the collection would be destroyed in two  years if no one took the samples from the agency, told UPI.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The Memorial Institute for Neurodegenerative Diseases Inc., a non-profit  organization consisting of more than 40 researchers from several countries,  offered to take the collection off of NIH's hands more than a year ago and so  far has not heard anything from the agency, Harry Peery, MIND's executive  director, told UPI.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;CJD belongs to a group of incurable and fatal diseases collectively known  as transmissible spongiform encephalopathies, or TSEs, that includes mad cow  disease in cows, chronic wasting disease in deer and elk, and scrapie in  sheep.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Variant CJD, or vCJD, is a relatively new TSE, which people can contract  from consuming beef products infected with the mad cow pathogen.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Despite Landis' assurance the collection will be preserved, some family  members of the patients who donated their brains to the NIH are still skeptical.  This is because the wording Landis used in the letter leaves open the  possibility that some brain samples are being destroyed.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"The tissues that are discarded are those that have either decayed to an  extent that renders them no longer appropriate for research or those for which  we do not have sufficient identification," Landis wrote.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"Which ones" are being destroyed? asked Terry Singeltary, who is involved  with several CJD patient groups.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"With a system like this, they could destroy whatever and whenever they  wanted, for whatever reason they wanted," Singeltary, whose mother died of CJD  in 1997, told UPI.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"It's a perfect excuse to discard some suspicious tissue resembling vCJD or  some atypical TSE related to animal TSEs in the USA," he added.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Although the collection includes samples from CJD patients as young as 16  that could make them candidates for possible vCJD, the brains have never been  screened for evidence of the disease. The only confirmed vCJD case in the United  States occurred in a Florida woman who is thought to have contracted the disease  in England.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Johnson said he along with renowned CJD expert Paul Brown were in the  process of sorting through the samples to match them up with patient  identification documents until they both retired. Some of the samples may prove  impossible to identify, he said, but he and Brown are the only ones familiar  enough with the collection to organize it and neither has been asked back by the  agency to aid in the identification process.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Steve Mitchell is UPI's Medical Correspondent. E-mail: [log in to unmask]  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Copyright 2005 by United Press International. All Rights Reserved. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://washingtontimes.com/"&gt;http://washingtontimes.com/&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.sciencedaily.com/"&gt;http://www.sciencedaily.com/&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;h2 class="date-header" style="letter-spacing: 2px; line-height: 13.09pt; margin: 18px 0px 6px; text-transform: uppercase;"&gt;&lt;span style="font-family: Trebuchet MS;"&gt;&lt;span style="color: #777744;"&gt;&lt;span style="font-size: 9.3pt;"&gt;&lt;span style="font-weight: normal;"&gt;Friday, February 10,  2012&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h2&gt;&lt;br /&gt;&lt;div class="date-header" style="letter-spacing: 2px; line-height: 13.09pt; margin: 18px 0px 6px; text-transform: uppercase;"&gt; &lt;/div&gt;&lt;br /&gt;&lt;div class="date-header" style="letter-spacing: 2px; line-height: 13.09pt; margin: 18px 0px 6px; text-transform: uppercase;"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div class="post" style="border-bottom-color: rgb(255, 255, 255); border-bottom-style: dotted; border-bottom-width: 1px; margin: 8px 0px 24px; padding-bottom: 24px;"&gt;&lt;a href="" name="619127567626610350"&gt;&lt;/a&gt; &lt;h3 class="post-title" style="line-height: 23.52pt; margin: 5px 0px 0px; padding-bottom: 4px;"&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #cc8800;"&gt;&lt;span style="font-size: 16.8pt;"&gt;&lt;span style="font-weight: normal;"&gt;Mad cow disease  experts at UC Davis want to discuss claims o&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #cc8800;"&gt;&lt;span style="font-size: 16.8pt;"&gt;&lt;span style="font-weight: normal;"&gt;f TWO HUMAN CASES RECENTLY  &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h3&gt;&lt;h3 class="post-title" style="line-height: 23.52pt; margin: 5px 0px 0px; padding-bottom: 4px;"&gt; &lt;/h3&gt;&lt;div class="post-title" style="line-height: 23.52pt; margin: 5px 0px 0px; padding-bottom: 4px;"&gt;&lt;/div&gt;&lt;div class="post-title" style="line-height: 23.52pt; margin: 5px 0px 0px; padding-bottom: 4px;"&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2012/02/from-terry-s.html" title="http://creutzfeldt-jakob-disease.blogspot.com/2012/02/from-terry-s.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2012/02/from-terry-s.html&lt;/a&gt;&lt;/div&gt;&lt;div class="post-title" style="line-height: 23.52pt; margin: 5px 0px 0px; padding-bottom: 4px;"&gt; &lt;/div&gt;&lt;div class="post-title" style="line-height: 23.52pt; margin: 5px 0px 0px; padding-bottom: 4px;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Owens, Julie&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;From: Terry S. Singeltary Sr. [flounder9@verizon.net]&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Sent: Monday, July 24, 2006 1:09 PM&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;To: FSIS RegulationsComments&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Subject: [Docket No. FSIS-2006-0011] FSIS Harvard Risk Assessment of Bovine  Spongiform Encephalopathy (BSE)&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Page 1 of 98&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.fsis.usda.gov/OPPDE/Comments/2006-0011/2006-0011-1.pdf"&gt;http://www.fsis.usda.gov/OPPDE/Comments/2006-0011/2006-0011-1.pdf&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;FSIS RFEPLY TO TSS ; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Harvard Risk Assessment of Bovine Spongiform Encephalopathy Update, October  31, 2005 INTRODUCTION The United States Department of Agriculture’s Food Safety  and Inspection Service (FSIS) held a public meeting on July 25, 2006 in  Washington, D.C. to present findings from the Harvard Risk Assessment of Bovine  Spongiform Encephalopathy Update, October 31, 2005 (report and model located on  the FSIS website: &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.fsis.usda.gov/Science/Risk_Assessments/index.asp)"&gt;http://www.fsis.usda.gov/Science/Risk_Assessments/index.asp)&lt;/a&gt;.  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Comments on technical aspects of the risk assessment were then submitted to  FSIS. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Comments were received from Food and Water Watch, Food Animal Concerns  Trust (FACT), Farm Sanctuary, R-CALF USA, Linda A Detwiler, and Terry S.  Singeltary. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;This document provides itemized replies to the public comments received on  the 2005 updated Harvard BSE risk assessment. Please bear the following points  in mind: &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.fsis.usda.gov/PDF/BSE_Risk_Assess_Response_Public_Comments.pdf"&gt;http://www.fsis.usda.gov/PDF/BSE_Risk_Assess_Response_Public_Comments.pdf&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;THE steady rise of sporadic CJD cases in Canada AND USA, with many unusual  cases of ''PENDING CLASSIFICATIONS" which have been pending now FOR 3 YEARS. HOW  long can this cover-up continue $$$ &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The most recent assessments (and reassessments) were published in June 2005  (Table I; 18), and included the categorisation of Canada, the USA, and Mexico as  GBR III. Although only Canada and the USA have reported cases, the historically  open system of trade in North America suggests that it is likely that BSE is  present also in Mexico. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.oie.int/boutique/extrait/06heim937950.pdf"&gt;http://www.oie.int/boutique/extrait/06heim937950.pdf&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;SEE FULL TEXT AND MORE HERE ; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Saturday, March 5, 2011 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;MAD COW ATYPICAL CJD PRION TSE CASES WITH CLASSIFICATIONS PENDING ON THE  RISE IN NORTH AMERICA &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/03/mad-cow-atypical-cjd-prion-tse-cases.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/03/mad-cow-atypical-cjd-prion-tse-cases.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Friday, February 10, 2012 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Creutzfeldt-Jakob disease (CJD) biannual update (2012/1) potential  iatrogenic (healthcare-acquired) exposure to CJD, and on the National Anonymous  Tonsil Archive &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://creutzfeldt-jakob-disease.blogspot.com/2012/02/creutzfeldt-jakob-disease-cjd-biannual.html"&gt;http://creutzfeldt-jakob-disease.blogspot.com/2012/02/creutzfeldt-jakob-disease-cjd-biannual.html&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;hmmm, no I ponder why some of these sporadic CJD cases, are now being  linked to a genetic TSE, that has NO link to the family ?&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;hmmm, could it be these atypical TSE in animals, that are linked to the  human TSE in the USA, and also, these animals have been fed back and forth to  each other ?&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;hmmm, why no link there $$$&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Thursday, August 12, 2010 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Seven main threats for the future linked to prions&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;First threat&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The TSE road map defining the evolution of European policy for protection  against prion diseases is based on a certain numbers of hypotheses some of which  may turn out to be erroneous. In particular, a form of BSE (called atypical  Bovine Spongiform Encephalopathy), recently identified by systematic testing in  aged cattle without clinical signs, may be the origin of classical BSE and thus  potentially constitute a reservoir, which may be impossible to eradicate if a  sporadic origin is confirmed.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;***Also, a link is suspected between atypical BSE and some apparently  sporadic cases of Creutzfeldt-Jakob disease in humans. These atypical BSE cases  constitute an unforeseen first threat that could sharply modify the European  approach to prion diseases. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Second threat&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;snip...&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.neuroprion.org/en/np-neuroprion.html"&gt;http://www.neuroprion.org/en/np-neuroprion.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Rural and Regional Affairs and Transport References Committee &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The possible impacts and consequences for public health, trade and  agriculture of the Government's decision to relax import restrictions on beef  Final report June 2010 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2.65 At its hearing on 14 May 2010, the committee heard evidence from Dr  Alan Fahey who has recently submitted a thesis on the clinical neuropsychiatric,  epidemiological and diagnostic features of Creutzfeldt-Jakob disease.48 Dr Fahey  told the committee of his concerns regarding the lengthy incubation period for  transmissible spongiform encephalopathies, the inadequacy of current tests and  the limited nature of our current understanding of this group of diseases.49  &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2.66 Dr Fahey also told the committee that in the last two years a link has  been established between forms of atypical CJD and atypical BSE. Dr Fahey said  that: They now believe that those atypical BSEs overseas are in fact causing  sporadic Creutzfeldt-Jakob disease. They were not sure if it was due to mad  sheep disease or a different form. If you look in the textbooks it looks like  this is just arising by itself. But in my research I have a summary of a  document which states that there has never been any proof that sporadic  Creutzfeldt-Jakob disease has arisen de novo-has arisen of itself. There is no  proof of that. The recent research is that in fact it is due to atypical forms  of mad cow disease which have been found across Europe, have been found in  America and have been found in Asia. These atypical forms of mad cow disease  typically have even longer incubation periods than the classical mad cow  disease.50 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.aph.gov.au/senate/committee/rrat_ctte/mad_cows/report/report.pdf"&gt;http://www.aph.gov.au/senate/committee/rrat_ctte/mad_cows/report/report.pdf&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;span style="font-family: Georgia;"&gt;&lt;span style="color: #29303b;"&gt;see also  ;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://www.aph.gov.au/hansard/senate/commttee/S12742.pdf" style="word-wrap: break-word;"&gt;&lt;span style="color: #473624; font-family: Georgia;"&gt;http://www.aph.gov.au/hansard/senate/commttee/S12742.pdf&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Wednesday, March 31, 2010 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Atypical BSE in Cattle &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;To date the OIE/WAHO assumes that the human and animal health standards set  out in the BSE chapter for classical BSE (C-Type) applies to all forms of BSE  which include the H-type and L-type atypical forms. This assumption is  scientifically not completely justified and accumulating evidence suggests that  this may in fact not be the case. Molecular characterization and the spatial  distribution pattern of histopathologic lesions and immunohistochemistry (IHC)  signals are used to identify and characterize atypical BSE. Both the L-type and  H-type atypical cases display significant differences in the conformation and  spatial accumulation of the disease associated prion protein (PrPSc) in brains  of afflicted cattle. Transmission studies in bovine transgenic and wild type  mouse models support that the atypical BSE types might be unique strains because  they have different incubation times and lesion profiles when compared to C-type  BSE. When L-type BSE was inoculated into ovine transgenic mice and Syrian  hamster the resulting molecular fingerprint had changed, either in the first or  a subsequent passage, from L-type into C-type BSE.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;In addition, non-human primates are specifically susceptible for atypical  BSE as demonstrated by an approximately 50% shortened incubation time for L-type  BSE as compared to C-type. Considering the current scientific information  available, it cannot be assumed that these different BSE types pose the same  human health risks as C-type BSE or that these risks are mitigated by the same  protective measures. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;This study will contribute to a correct definition of specified risk   material (SRM) in atypical BSE. The incumbent of this position will develop new  and transfer existing, ultra-sensitive methods for the detection of atypical BSE  in tissue of experimentally infected cattle.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2"&gt;http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;2010-2011 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;When L-type BSE was inoculated into ovine transgenic mice and Syrian  hamster the resulting molecular fingerprint had changed, either in the first or  a subsequent passage, from L-type into C-type BSE. In addition, non-human  primates are specifically susceptible for atypical BSE as demonstrated by an  approximately 50% shortened incubation time for L-type BSE as compared to  C-type. Considering the current scientific information available, it cannot be  assumed that these different BSE types pose the same human health risks as  C-type BSE or that these risks are mitigated by the same protective measures.  This study will contribute to a correct definition of specified risk material  (SRM) in atypical BSE. The incumbent of this position will develop new and  transfer existing, ultra-sensitive methods for the detection of atypical BSE in  tissue of experimentally infected cattle. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2"&gt;http://www.prionetcanada.ca/detail.aspx?menu=5&amp;amp;dt=293380&amp;amp;app=93&amp;amp;cat1=387&amp;amp;tp=20&amp;amp;lk=no&amp;amp;cat2&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;EFSA Journal 2011 The European Response to BSE: A Success Story &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;This is an interesting editorial about the Mad Cow Disease debacle, and  it's ramifications that will continue to play out for decades to come ;&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Monday, October 10, 2011&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;EFSA Journal 2011 The European Response to BSE: A Success Story &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;snip... &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;EFSA and the European Centre for Disease Prevention and Control (ECDC)  recently delivered a scientific opinion on any possible epidemiological or  molecular association between TSEs in animals and humans (EFSA Panel on  Biological Hazards (BIOHAZ) and ECDC, 2011). This opinion confirmed Classical  BSE prions as the only TSE agents demonstrated to be zoonotic so far but the  possibility that a small proportion of human cases so far classified as  "sporadic" CJD are of zoonotic origin could not be excluded. Moreover,  transmission experiments to non-human primates suggest that some TSE agents in  addition to Classical BSE prions in cattle (namely L-type Atypical BSE,  Classical BSE in sheep, transmissible mink encephalopathy (TME) and chronic  wasting disease (CWD) agents) might have zoonotic potential.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;snip... &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;a href="http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1"&gt;http://www.efsa.europa.eu/en/efsajournal/pub/e991.htm?emt=1&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;a href="http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf"&gt;http://www.efsa.europa.eu/en/efsajournal/doc/e991.pdf&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;see follow-up here about North America BSE Mad Cow TSE prion risk factors,  and the ever emerging strains of Transmissible Spongiform Encephalopathy in many  species here in the USA, including humans ; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/10/efsa-journal-2011-european-response-to.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Saturday, June 25, 2011 &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Transmissibility of BSE-L and Cattle-Adapted TME Prion Strain to Cynomolgus  Macaque &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;"BSE-L in North America may have existed for decades" &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/transmissibility-of-bse-l-and-cattle.html"&gt;http://transmissiblespongiformencephalopathy.blogspot.com/2011/06/transmissibility-of-bse-l-and-cattle.html&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Over the next 8-10 weeks, approximately 40% of all the adult mink on the  farm died from TME. &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;snip... &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;The rancher was a ''dead stock'' feeder using mostly (&amp;gt;95%) downer or  dead dairy cattle... &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://web.archive.org/web/20030516051623/http://www.bseinquiry.gov.uk/files/mb/m09/tab05.pdf"&gt;http://web.archive.org/web/20030516051623/http://www.bseinquiry.gov.uk/files/mb/m09/tab05.pdf&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;P03.141&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Aspects of the Cerebellar Neuropathology in Nor98&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Gavier-Widén, D1; Benestad, SL2; Ottander, L1; Westergren, E1 1National  Veterinary Insitute, Sweden; 2National Veterinary Institute,&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Norway Nor98 is a prion disease of old sheep and goats. This atypical form  of scrapie was first described in Norway in 1998. Several features of Nor98 were  shown to be different from classical scrapie including the distribution of  disease associated prion protein (PrPd) accumulation in the brain. The  cerebellum is generally the most affected brain area in Nor98. The study here  presented aimed at adding information on the neuropathology in the cerebellum of  Nor98 naturally affected sheep of various genotypes in Sweden and Norway. A  panel of histochemical and immunohistochemical (IHC) stainings such as IHC for  PrPd, synaptophysin, glial fibrillary acidic protein, amyloid, and cell markers  for phagocytic cells were conducted. The type of histological lesions and tissue  reactions were evaluated. The types of PrPd deposition were characterized. The  cerebellar cortex was regularly affected, even though there was a variation in  the severity of the lesions from case to case. Neuropil vacuolation was more  marked in the molecular layer, but affected also the granular cell layer. There  was a loss of granule cells. Punctate deposition of PrPd was characteristic. It  was morphologically and in distribution identical with that of synaptophysin,  suggesting that PrPd accumulates in the synaptic structures. PrPd was also  observed in the granule cell layer and in the white matter. The pathology  features of Nor98 in the cerebellum of the affected sheep showed similarities  with those of sporadic Creutzfeldt-Jakob disease in humans.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;***The pathology features of Nor98 in the cerebellum of the affected sheep  showed similarities with those of sporadic Creutzfeldt-Jakob disease in  humans.&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;a href="http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf"&gt;http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf&lt;/a&gt;  &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;PR-26&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;NOR98 SHOWS MOLECULAR FEATURES REMINISCENT OF GSS&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;R. Nonno1, E. Esposito1, G. Vaccari1, E. Bandino2, M. Conte1, B.  Chiappini1, S. Marcon1, M. Di Bari1, S.L. Benestad3, U. Agrimi1 1 Istituto  Superiore di Sanità, Department of Food Safety and Veterinary Public Health,  Rome, Italy (romolo.nonno@iss.it); 2 Istituto Zooprofilattico della Sardegna,  Sassari, Italy; 3 National Veterinary Institute, Department of Pathology, Oslo,  Norway&lt;/div&gt;&lt;br /&gt;&lt;div&gt; &lt;/div&gt;&lt;br /&gt;&lt;div&gt;Molecular variants of PrPSc are being increasingly investigated in sheep  scrapie and are generally referred to as "atypical" scrapie, as opposed to  "classical scrapie". Among the atypical group, Nor98 seems to be the best  identified. We studied the molecular properties of Italian and Norwegian Nor98  samples by WB analysis of brain homogenates, either untreated, digested with  different concentrations of proteinase K, or subjected to enzymatic  deglycosylation. The identity of PrP fragments was inferred by means of  antibodies spanning the full PrP sequence. We found that undigested brain  homogenates contain a Nor98-specific PrP fragment migrating at 11 kDa (PrP11),  truncated at both the C-terminus and the N-terminus, and not N-glycosylated.  After mild PK digestion, Nor98 displayed full-length PrP (FL-PrP) and  N-glycosylated C-terminal fragments (CTF), along with increased levels of PrP11.  Proteinase K digestion curves (0,006-6,4 mg/ml) showed that FL-PrP and CTF are  mainly digested above 0,01 mg/ml, while PrP11 is not entirely digested even at  the highest concentrations, similarly to PrP27-30 associated with classical  scrapie. Above 0,2 mg/ml PK, most Nor98 samples showed only PrP11 and a fragment  of 17 kDa with the same properties of PrP11, that was tentatively identified as  a dimer of PrP11. Detergent solubility studies showed that PrP11 is insoluble in  2% sodium laurylsorcosine and is mainly produced from detergentsoluble,  full-length PrPSc. Furthermore, among Italian scrapie isolates, we found that a  sample with molecular and pathological properties consistent with Nor98 showed  plaque-like deposits of PrPSc in the thalamus
